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PREFACE 
We are surrounded by largely invisible electromagnetic radiation. Only a minor portion of 
these rays are responsible for the world as we see it - the visible light. Light plays a pivotal 
role in ophthalmology. Patients with ocular diseases experience reduced reception and 
processing of light. Ophthalmologists use light to diagnose and treat ocular disorders. 
Photography, literally ‘writings in light’, is a central diagnostic tool to investigate diseases of 
the retina. The interaction of light with the unhealthy retina yields surprisingly beautiful 
patterns that may be recognized as the signature of a specific disorder.  
However, retinal imaging is more than just photography. Light reflected by and interacting 
with the retina allows us to assess structural and metabolic changes. New imaging techniques 
are crucial for our understanding of the mechanisms of retinal disease and continue to point us 
to new ways to help to restore vision. 
This book is written by someone fascinated by light writings of the eye and the insights they 
provide. I am convinced that this book and its illustrations will convey this enthusiasm. 
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RETINAL IMAGING 
Over the past twenty years, interest in retinal imaging within ophthalmology has significantly 
grown. Since 1991, the number of published items per year focused on retinal imaging 
techniques has increased by a factor of about 20 (ISI web of knowledge, assessed on February 
24, 2010 at http://apps.isiknowledge. com.proxy.ubn.ru.nl:8080) Retinal imaging covers a 
variety of techniques, including fundus photography, fluorescein and indocyanine green 
angiography, fundus autofluorescence, fundus reflectance, fundus densitometry, and finally 
optical coherence tomography (OCT) as the most popular technique. 
Retinal imaging comprises several difficulties. Light has to enter and to leave the eye through 
a very small aperture, the pupil, which if not dilated, continuously varies in size. In addition, 
rapid eye movements (saccades) cause a continuously moving image that hinders the use of 
long exposure times. The fundus consists of structures that have very diverse reflectivity and 
absorption spectra that call for the use of different spectra of light depending on the structures 
examined. Furthermore, several retinal diseases cause increased sensitivity or vulnerability for 
light, which excludes the use of strong luminosity. Besides photographic techniques, fundus 
imaging has been addressed by several other techniques. Two very important developments in 
retinal imaging within the last twenty years are OCT and confocal scanning laser 
ophthalmoscopy (cSLO).1;2  
In general, two imaging strategies for the retina can be distinguished. Firstly, en face imaging 
offers a classic view on the ocular fundus. This is typically achieved by fundus photography 
and cSLO. En face techniques are mostly two-dimensional and do not allow exact depth 
localization of pathologies. Conversely, topographic imaging techniques like OCT allow for 
three-dimensional analysis of the ocular fundus and provide insight into changes within the 
retinal layers. Due to the diversity of applications, a potential user has to be familiar with the 
potential advantages and shortcomings of the various techniques. Several methods can be 
combined to gain additional information about functional retinal anatomy by multimodal 
imaging. 
AIM AND OUTLINE OF THIS THESIS 
This research focuses on cSLO imaging performed at the borders of the visible spectrum of 
light. Two main imaging techniques will be used. First, fundus reflectance imaging will be 
studied in the near infrared to assess retinal changes associated with sub-retinal pathologies. 
Second, fundus autofluorescence (FAF) imaging, at short wavelengths as well as in the near 
infrared, will be used to study several aspects of retinal (patho-) physiology like visual 
pigment and macular pigment. Third, FAF will be used as a tool to study longitudinal changes 
in inherited retinal diseases. 
Chapter 1 provides a general introduction to retinal imaging, an overview on its historical 
background, and a description of the optical properties of the eye important for retinal image 
acquisition and analysis. Chapter 2 gives the reader an introduction to cSLO imaging, which 
is used in this research. Chapter 3 gives a broad overview of the concepts of digital retinal 
imaging and image analysis. An explanation is given of image processing using the 
biomedical image analysis software, ImageJ, which is freely available from the Internet and is 
16 Chapter 1 
 
increasingly used by many imaging research groups. Chapter 4 contains the first complete 
description of reflectance changes due to choroidal neovascularization in age-related macular 
degeneration (AMD) in the near infrared. This technique provides data that combine results of 
fluorescein angiography and OCT and may therefore be useful for follow-up in AMD 
treatment studies. Chapter 5 elucidates the role of FAF for clinical ophthalmology. The 
potential of FAF for analysis of visual pigments as a factor of retinal integrity is studied in 
healthy and diseased eyes. FAF in combination with fundus reflectometry helped my 
colleagues and me to detect the first ever described disease with congenital loss of macular 
pigment, the juvenile crystalline maculopathy in Sjögren-Larsson syndrome. The diagnostic 
value of FAF is shown for patients with a variety of inherited retinal diseases. FAF at two 
different wavelengths was used to discover clinically occult changes in retinal dystrophies 
that may give information on the future course of the disease. Chapter 6 offers a clinical atlas 
of near-infrared reflectance and fundus autofluorescence in acquired and inherited retinal 
diseases. Finally, this  contains a compact disc (CD) with color illustrations and additional 
data like movies to provide supplementary information on image analysis and longitudinal 
changes. All data available on CD are indicated by ◙. 
HISTORICAL BACKGROUND 
Fig. 1.1 
Herrmann von Helmholtz 
(1821-1894) 
In 1851, Herrmann Ludwig Ferdinand von Helmholtz (Fig. 1.1) opened a new horizon for the 
young medical discipline of ophthalmology. His Augenspiegel (eye mirror), which he 
invented at the age of 29, compromised just a lens and a mirror but allowed visualization of 
the living human retina for the first time.3 Von Helmholtz 
identified three essential components necessary to get an 
image of the inner parts of the eye: a light source, a mirror to 
direct the light into the eye, and a lens to focus the light onto 
the retina. Just one year after its introduction the term 
“ophthalmoscope” was initially used for the eye mirror.4 
Within the first decennia, oil lamps and later gas lamps 
replaced the previously used candles as light sources, which 
gave improved view on fundus structures and allowed more 
precise description of retinal pathologies. Finally, after the 
presentation of the first electric light ophthalmoscope in 1885 
by William Dennet,5 ophthalmoscopy became a widely used 
examination technique in ophthalmology, which led to the 
description of many important ocular diseases, like 
glaucomatous disc cupping (von Graefe, 1855) or diabetic 
retinopathy (Jaeger, 1856). 
The routine use of ophthalmoscopy by general ophthalmologists led to a clear need to 
document fundus pathology. In the majority of cases, the observed pathology was previously 
unknown. Fundus changes therefore had to be visualized so that ocular diseases could be 
studied and the successive examination of dynamic pathologic processes facilitated. Initially, 
fundus drawings of high artistic quality were necessary to fulfill these requirements (Fig. 1.2), 
which was very time-consuming. 
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Immediately after the invention of ophthalmoscopy, the physical principles could be applied 
to photography, an imaging technique only developed about forty years earlier. It was in 
1853, that the 23-year old Adrian Christopher Van Tright introduced fundus photography in 
his thesis “Dissertatio ophthalmologica Inauguralis de Speculo Oculi”. After that, it still took 
nearly fifty years before useful fundus photographs could be produced and published by 
Friedrich Dimmer (Fig. 1.3).6 He and his student Arnold Pillat were also the first to publish a 
photographic atlas of the ocular fundus in 1927.7  
Fig. 1.2 ◙ 
Fundus paintings in an atlas for ophthalmolo-
gy published 1870 by A. de Montmeja, entitled 
“Pathologie iconographique du Fond de 
l'Œil” (Stanford Medical History Center; 
with permission) 
In the second half of the 20th century, functional 
imaging of the retina became available following 
the invention of fluorescein angiography by two 
medical students,8 and later by the first 
diagnostic atlas of Achim Wessing in 1968.9 
Initially, fluorescein angiography suffered from 
poor image quality and reflexes, especially when 
attempts were made to achieve dynamic movies 
of blood flow within the eye. Important steps 
towards real functional imaging were the 
invention of the scanning laser ophthalmoscope (SLO) by Webb and coworkers in 198110 and 
the digitization of SLO imaging by Plesch and coworkers in 1987.11 With the SLO technique, 
fundus imaging with and without fluorescent dyes finally became possible in still image and 
video mode. The relatively low amounts of light used by digital SLO cameras allowed for 
long imaging sequences without an increased risk for light toxicity. 
 
 
Fig. 1.3  
Fundus photograph by Dimmer and Pillat, 1927, 
replicated from their 
„Atlas photographischer Bilder des menschlichen 
Augenhintergrundes“ 
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The development of a confocal SLO virtually eliminated stray light and increased image 
ontrast and depth resolution. This offered new ways to study the ocular fundus in three 
c
eractions between photons and matter take 
er or a camera. Unlike 
RUCTURES 
ble spectrum of light (400 – 780 nm). 
 may be harmful for the retina and 
ajor confounder of light scatter and absorbance within the visible 
. This influence increases with ageing, when lenticular transparency shifts away from 
c
dimensions for glaucomatous optic disc changes12 or macular pathologies.13 Finally, novel 
insights could be gained with the use of invisible, near-infrared light14 and by observing the 
very weak in vivo fluorescence (autofluorescence) of the human ocular fundus with the 
modern confocal SLO technique.15 Even though modern optical oherence tomography 
(OCT) is superior to SLO in three-dimensional tomography of the retina, a lot of information 
may be missed by OCT alone. Recent studies demonstrate that additional and highly valuable 
information is gained with combined SLO-OCT (multimodal) imaging in retinal diseases.16 
Now in the 21st century, ophthalmic fundus imaging has changed from pure anatomical 
documentation to the functional illustration of retinal physiology. 
OPTICAL ANATOMY OF THE EYE 
When light hits an object, numerous physical int
place, which finally result in an image that can be detected by an observ
superficial body structures, the ocular fundus has very dissimilar optical properties and can 
only be imaged indirectly by light passing through the anterior parts of the eye. Therefore, 
light will be prone to reflections, scatterings and absorbance not only by the fundus itself but 
also by the transparent media through which it travels on its way back and forth in the eye. 
Therefore, any retinal image will be influenced by the ocular media, the underlying tissues 
and the structure of the retina itself. 
TRANSPARENT OCULAR ST
The human eye is made for reception of the visi
Ultraviolet light as well as light of the infrared spectrum
cannot be visualized by the human eye. The transparent media (cornea, aqueous fluid, lens 
and vitreous body) largely absorb light outside the visible spectrum, and therefore, ultraviolet 
light below 400 nm and infrared light above 1300 nm will not sufficiently reach the fundus to 
be useful for in vivo retinal imaging.17 
LENS 
The ocular lens is the m
spectrum
shorter wavelengths and so, blue and (ultra-) violet light are increasingly filtered.18 For 
patients, this causes a gradual yellow shading of the visual appearance. Age-related coloring 
of the lens is of major importance if blue light is necessary for retinal image acquisition, like 
in macular pigment measurement or fundus autofluorescence imaging as discussed in detail in 
Chapter 5. In addition, ageing and cataract formation will lead to increased autofluorescence 
of the lens.19;20 This may decrease contrast of fundus autofluorescence (FAF) imaging and can 
be the source of artifacts called fundus pseudofluorescence, especially if non-confocal 
imaging systems are used. Hence, for short-wavelength retinal imaging like FAF or blue-light 
reflectance, it is essential to consider age and the type and degree of cataract formation as 
possible sources of measuring artifacts. 
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Fig.1.4 
Illustration of vignetting in 
FAF imaging through 
wrong distance between 
pupil and camera (A, ar-
rows). 
Reducing space between 
camera and eye improves 
image quality (B). 
 as an optical aperture, size and position of the pupil 
are important for the quality of a retinal image in fundus photography. If a pupil of 4 mm 
diameter is not dilated for fundus photography, about four times less light will pass than 
through a pupil of 8 mm diameter. Because light has to double pass the pupil, dilating the 
pupil for fundus photography may increase image brightness up to 8 times. While this is true 
for normal flood-illuminated imaging systems (standard fundus cameras), specified 
techniques like cSLO use a small flying laser spot (Chapter 2), which minimizes the influence 
of pupil size on imaging performance.21 
Besides the size of the pupil, distance, angulation and side-shift of the pupil in relation to the 
imaging device are important for so-called vignetting effects.22 Vignetting describes the 
gradual attenuation of image brightness from the image center (Fig.1.4). This may be 
symmetrical due to a wrong distance between camera and pupil, or it may be asymmetrical in 
cases of too lateral a position or angulation of the eye according to the optic of the imaging 
device. Vignetting may influence image quality in all imaging techniques. 
 
RETINA 
The most anterior part of the brain, the retina, is a thin, transparent neural layer that 
transforms light to electric signals, preprocesses them and transmits the visual information to 
the cerebrum. The light-sensitive parts of the human retina, the photoreceptors, are bent away 
from the pupil and so light must first pass all retinal layers before vision can be initiated (Fig. 
1.5). Due to the anatomical construction of the outer retina, light will largely double pass in a 
straight line (directionally) through the retina, and little scatter and absorbance will occur 
above 530 nm (green).23 Under pathological conditions, however, this may change 
dramatically and lead to significant alterations of retinal images (see Chapter 4). 
SHAPE OF THE RETINA 
The retina is the most inner part of the eyeball. Therefore, imaging of the retina means 
imaging a three-dimensional structure. Especially in confocal imaging (Chapter 2), parts of a 
retinal image may not be in focus and image brightness and contrast may be significantly 
influenced. The center of the retina, the foveal pit, causes a strong reflection at the retinal 
inner limiting membrane,24 which may be compared with a parabolic mirror. Conversely, the 
PUPIL 
As light has to pass the pupil of the eye
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surrounding slope of the fovea reflects less light and appears darker. This contrast in 
velengths (blue light) may be challenging in heavily 
 
reflectivity between fovea and parafovea can only be observed in healthy retinas and can help 
to detect even very slight pathological changes (Chapter 4).25 
LAYERS OF THE RETINA AND UNDERLYING TISSUES 
Due to the transparency of retinal tissue, a fundus image will be composed of interactions 
from light with three main layers, the retina, the choroid and the sclera. While light from the 
healthy retina is predominantly reflected directionally, light from other fundus layers shows 
non-directional reflection.23 Melanin and blood are the main absorbers of visible light,14 and 
in particular imaging with short wa
pigmented fundi. Light of short wavelengths is also strongly absorbed by non-bleached retinal 
photopigments, a factor that may be of influence for FAF examinations (Chapter 5). 
 
Fig. 1.5 
Anatomy of the human retina on OCT (left) and histology (right). The large arrow indi-
cates the direction of light entering from the pupil. Scale bar specifies normalized reflec-
he retinal layers on OCT. tivity of t
GCL=ganglion cell layer, INL=inner nuclear layer, IPL=inner plexiform layer, 
NFL=nerve fiber layer, ONL=outer nuclear layer, OPL=outer plexiform layer, 
PR=photoreceptors, RPE=retinal pigment epithelium. 
arrowhead=border between inner and outer segments of photoreceptors, small black 
arrow=inner limiting membrane, small white arrow=outer limiting membrane 
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TECHNICAL INTRODUCTION 
This research focuses on fundus imaging with a confocal scanning laser ophthalmoscope 
(cSLO). Several imaging procedures used could also have been performed with a standard 
fundus camera. However, due to some fundamental physical differences in image acquisition, 
the resulting fundus images from either a cSLO device or a fundus camera cannot be 
compared one by one. A brief introduction to conventional fundus photography is therefore 
given, even though this technique was not used in this thesis. 
CONVENTIONAL FUNDUS IMAGING 
Fundus imaging is usually performed by a fundus camera that takes an image after a single 
flash application. In the case of conventional fundus photography, the entire retina is 
concomitantly illuminated by a broad light beam, a technique termed flood illumination. This 
is in line with the original technique developed by von Helmholtz, who used a light source, a 
mirror with a hole and his own eye as image detector.1 The illuminating light beam must not 
cross the returning light beam so that reflection artifacts are kept to a minimum. A relatively 
large pupil is therefore required to allow for sufficient image brightness. This is typically 
realized by projecting a ring-shaped flashlight on the pupil plane (Fig. 2.1). To minimize 
motion-related blurring a flashlight with a relatively short exposure time is used. The optics of 
a conventional fundus camera record all light that returns from the eye. So, a significant 
amount of scattered light will be captured, which can influence image quality and 
measurement results.2 This is in contrast to cSLO imaging, where only light reflected from the 
focus plane, and not all light returning from the fundus, is detected and used for image 
formation. 
 
Fig. 2.1 
Outline of fundus camera optics. 
The flashlight (dashed lines) is 
ring-shaped (so-called donut of 
light) and focused on the pupil 
plane, resulting in diffuse fundus 
illumination. The pathways of 
flashlight and image (gray lines) 
do not cross. 
In a conventional fundus camera, the spectrum of the flashlight is right-shifted to longer 
wavelengths in order to avoid absorbance by the ocular media (Chapter 1). This may lead to 
underestimation of blue fundus reflections and necessitates higher flash intensities and a 
specific optical design if FAF imaging is desired.3 To address this problem, Spaide used 
modified filters to shift the excitation and emission spectra towards longer wavelength.4 This 
modified fundus camera appeared to be operational in daily practice, however, direct 
comparison with FAF images made by cSLO was limited due to differences in image quality.5 
In general, contrast was lower in photographs made with the modified fundus camera, there 
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were more artifacts in the case of pseudo-fluorescence and there was less influence of macular 
pigment on FAF images with the modified fundus camera. The details of FAF imaging will be 
discussed in Chapter 5.  
CONFOCAL SCANNING LASER FUNDUS IMAGING 
Image recording by a confocal scanning laser ophthalmoscope (cSLO) is fundamentally 
different from fundus photography. Unlike a fundus camera, a cSLO image is not taken all at 
once but is detected over time from the returning light of a narrow laser beam scanning the 
retina in a raster pattern.6 The shape of the laser beam is focused on the retina through a 2 mm 
aperture of a mirror used as beam splitter for illuminating and reflected light. Using a system 
of mirrors, the laser is deflected to allow for a two-dimensional raster scan of the retina. In 
detail this involves a rotating polygon mirror causing horizontal laser movements and a 
galvanic mirror shifting these scanning lines vertically. The scanning raster is focused at the 
patient’s lens by a spherical mirror to allow for a small entrance pupil. Unlike fundus 
photography, the pathways of illuminating and returning light are the same in a cSLO. Pixel 
by pixel, the scattered light from the focus plane is recorded by a small detector and sent to a 
frame grabber interfaced with a computer. Subsequently, a two-dimensional image is 
reconstructed from the resulting pixel intensities.7  
Fundus imaging by a narrow laser beam instead of a broad light beam has several advantages. 
First, imaging through a small pupil is possible and will not lead to a significant reduction of 
image quality in most patients.8 This is particularly true in case of near-infrared (NIR) 
imaging, where light is not detected by the eye and therefore, no miotic pupil reflex will 
occur. A second advantage is the reduced amount of light necessary to produce an image.9 
With this, improved patient comfort allows for better fixation and long exposure times 
without the danger of light toxicity, as the maximum laser irradiance on the retina stays well 
below international safety standards.10 Furthermore, the acquisition time for a cSLO fundus 
image is usually not more than several milliseconds, which makes the techniques largely 
independent of artifacts due to eye movements.7 
 
Fig. 2.2 
Schematic of the pathways of light in confocal 
scanning laser ophthalmoscopy (camera optics 
and ocular media not shown). Light of the 
scanning laser beam (large white arrow) is 
reflected and scattered by retinal layers, 
choroid and sclera (thin arrows). Only light 
reflected from the focus plane (black arrows) 
can enter the camera through the confocal 
aperture and finally reach the detector. Light 
from other planes and scattered light (gray 
arrows) misses the aperture and is not detected. 
 
The most important difference between conventional fundus photography and cSLO imaging 
is the use of a confocal aperture, which allows image acquisition virtually free from scattered 
light (Fig. 2.2). The aperture acts like a filter that allows only light from the focal plane to 
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reach the detector. The diminishing of out-of-focus photons significantly improves image 
contrast and depth resolution. In particular, unwanted signals from areas anterior from the 
retina (i.e. cornea, lens and vitreous) are effectively reduced. The optimal diameter for a 
confocal pinhole has been found to be 200µm for red light.  
During the acquisition of image series or movies using cSLO, eye movements may become a 
major problem. In the case of minor image shifts, image registration can assist in the 
performance of a reliable analysis (Chapter 3). For multimodal imaging, microperimetry or 
for therapeutic applications like online retinal laser treatment, a still retinal image is required. 
A cSLO combined with an eye tracker has recently been developed and this is commercially 
available in the SPECTRALIS™ device.11;12 Eye trackers use laser beams to track retinal 
features like vessels. The tracking beam data are used to move a galvanic mirror for 
adjustment of the entire scanning raster. Saccades up to 500°/sec were tracked with an 
accuracy of 0.05°.11 
CLINICAL APPLICATIONS 
Currently three different devices using scanning laser ophthalmoscopy are available. Two are 
produced by Heidelberg Engineering (Heidelberg, Germany) and one is manufactured by Carl 
Zeiss Meditec (Dublin, CA, USA). 
The Heidelberg Retina Tomograph (HRT, Heidelberg Engineering) performs three-
dimensional scans of the posterior segment of the eye with a 670 nm (red) diode laser. Up to 
64 equidistant optical slices of 384×384 pixels, each at 15°×15° field of view, are used to 
reconstruct the retinal volume and surface shape. The resolution is 10 µm horizontally and 64 
µm vertically. The main application is diagnostic of the optic nerve head in glaucoma, but 
also retinal edema can be evaluated. The device may also be used for cornea imaging 
applying the Rostock Cornea Module (http://www.heidelbergengineering.com/products/hrt-
glaucoma-module/hrt-product-specifications/, assessed March 5, 2010). 
The Heidelberg Retina Angiograph (HRA 2, Heidelberg Engineering) can be used for 
reflectance imaging with blue and infrared light, for fluorescein and indocyanine angiography 
and for autofluorescence imaging in the short-wavelength and near-infrared light spectra. A 
new development is the combination with Fourier-domain OCT to a multimodal imaging 
device. Details of the HRA 2 are described below. 
The Nerve Fiber Analyzer (latest commercial release GDx PRO™, Carl Zeiss Meditec) is 
particularly designed to examine the retina nerve fiber layer (RNFL). It uses polarized light of 
a near-infrared diode laser of 780 nm (scanning laser polarimetry) and applies a field of view 
of 40°×20° at 256×128 pixels. The resulting transversal resolution is 500 µm/pixel. The 
device measures the birefringence of the RNFL, which is based on splitting and phase shift of 
polarized light by the intra-axonal microtubules. The amount of phase shift determined (so-
called retardation) is proportional to the thickness of the RNFL 
(http://www.zeiss.de/C125679E00525939/EmbedTitelIntern/GDxPrimerChapter2/$File/GDx
_Primer_Chapter2.pdf, assessed March 5, 2010). 
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THE HEIDELBERG RETINA ANGIOGRAPH 2 
Besides experimental setups, the HRA 2 is the only commercially available stand-alone cSLO 
for complex retinal imaging. Another version, the SPECTRALIS™ machine (Heidelberg 
Engineering, Heidelberg, Germany) combines the HRA with a Fourier-domain OCT, which 
allows for multimodal retinal imaging.13 All measurements in this thesis have been performed 
using HRA 2 or SPECTRALIS™. As the acquisition and technical details of cSLO imaging 
are comparable in both devices, the term HRA will be used for the cSLO imaging machine, 
throughout the manuscript, even though a particular cSLO image was obtained by 
SPECTRALIS™. 
The HRA 2 is a modern, multi-wavelength cSLO designed for fundus imaging in two 
different approaches, reflectance imaging and fluorescence imaging. With this, many different 
imaging techniques like fluorescein angiography, red-free fundus photography, infrared 
imaging and FAF imaging, can be used simultaneously and, if the SPECTRALIS™ device is 
used, these can be combined with high-resolution Fourier-domain OCT.14;15 The maximum 
lateral resolution of the HRA 2 is limited to 5 µm/pixel by the diameter of the laser beam at 
the pupil, the focal length of the eye and the higher order aberrations of the eye.16 The 
longitudinal resolution depends on the wavelength used and varies from 300 µm in blue to 
1200 µm in the near-infrared. Table 2.1 summarizes the technical classifications of the HRA 
2/SPECTRALIS™ device as used for this thesis. 
OPTIMAL CONFOCAL IMAGE ACQUISITION 
The HRA 2 allows for adjustment detector sensitivity to optimize the imaging process. The 
detector sensitivity can only be properly adjusted if the image is adequately focused. The 
focal plane of the SLO should be located on the inner retinal surface, i.e. the inner limiting 
membrane. This can be located by observing the large retinal vessels during slow adjustment 
of the focus knob. The detector sensitivity should be adjusted based on the major reflecting 
regions, which are mainly located at the peripapillary atrophic zone. Here, colored pixels, that 
are indicative for overexposure, should just be hidden. The resulting image yields a maximum 
contrast without over- or underexposure of the structures of interest. 
For fluorescence angiography or FAF imaging, the focus plane should first be explored in the 
blue reflectance mode. Unlike directly reflected light, fluorescent light from the fundus is 
mainly scattered. Consequently, optical edges, i.e. the borders of the vessels, are less defined 
in fluorescent images than in a reflectance image, which makes adequate focusing inherently 
impossible. 
If near-infrared reflectance (NIR) imaging is performed, laser energy can also be adjusted. 
Clinical practice shows that in most cases, 50% of the available laser energy is sufficient for 
good image quality. Due to chromatic aberration, the focusing must be repeated if blue light 
imaging has just been performed.17 One can expect a hyperopic shift of 0.5 to 1.0 diopters 
when switching from blue to infrared imaging. 
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For fundus autofluorescence and OCT imaging, image alignment and mean image calculation 
have been established to increase image detail by improving the signal-to-noise ratio.15;18 This 
has not been investigated for NIR and blue reflectance images and at present, no advice 
concerning post-processing of these imaging techniques can be given. 
Table 2.1 
Technical classifications1 of HRA 2 and SPECTRALIS™ 
 
Element Imaging technique Technical data 
Optically pumped solid state laser Blue light reflectance λ = 488 nm (blue) 
 
Fluorescein angiography 
Fundus autofluorescence 
(short wavelength) 
Barrier filter at λ = 500 nm 
Diode laser 1 
Indocyanine green angiography 
Fundus autofluorescence 
(near infrared; only HRA 2, not SPECTRALIS) 
λ = 790 nm (near infrared) 
Barrier filter at λ = 800 nm 
Diode laser 2 Near infrared reflectance λ = 820 nm 
Diode laser 3 (SPECTRALIS™) Fourier-domain OCT λ = 870 nm 
 
1 http://www.heidelbergengineering.com/, assessed on February 26, 2010 
NEW DEVELOPMENTS 
The fine detail resolution of a cSLO is limited by the higher order monochromatic aberrations 
of the eye’s transparent media. An important advance in ophthalmic imaging was therefore 
the introduction of adaptive optics (AO), a well-known technique used in astronomy to 
compensate for continual atmospheric aberrations.19 In 1995, Miller et al. were the first to 
directly view retinal photoreceptors using an AO fundus camera. Their findings were 
published one year later.20 In 2002, Roorda et al. presented the first AO cSLO, with which 
they could realize a resolution of 2,5 µm laterally and 71 µm axially at 660 nm (red). This 
allowed the direct observation of photoreceptors, retinal nerve fibers and the flow of 
leukocytes within retinal capillaries.21;22 Later on, AO ophthalmoscopy enabled the 
observation of light-induced responses of 
single cones23 and the mapping of cones 
according to their color sensitivity.24 
Recent papers report single-cone 
microperimetry with AO cSLO to 
investigate the coupling between 
photoreceptors and retinal ganglion 
cells.25 
Fig. 2.3 
AO-cSLO images of human retinal photoreceptors (PR) at 1° temporal eccentricity. The single 
frame (A) already provides a good impression of the PR arrangement. Multi-frame averaging 
(B)significantly reduces noise and improves image information. Note the different PR reflectivity at 
630 nm. Adapted from: http://vision.berkeley.edu/roordalab/Movies/STBL.AVI (with permission) 
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THE DIGITAL IMAGE 
About 50 years have passed since the first successful image digitization took place.1 The first 
routine use of digital images in ophthalmology was reported about 20 years later.2 Those 
images still suffered from relatively low resolution and the quality of digital fundus images 
stayed inferior to analog pictures for a long time. Current ophthalmic digital images have on 
the whole replaced analog images due to a huge increase in camera quality, image resolution 
and last not least computer technology. 
Digital imaging makes image storage and distribution much easier and facilitates the 
performance of computerized image analysis. Most digital images are based on raster image 
types, which are matrices of brightness values visualized by an array of colors or gray tones. 
Such an image matrix has a certain number of pixels (picture elements), each of which has its 
own value (Fig. 3.1). When the correct arrangement of pixels is displayed on a computer 
monitor an image is seen. 
Fig. 3.1 
Sample of a 9×9 pixel image. The 
image matrix can be displayed in 
color/gray shades (left) or brightness 
values (right). Values are used for 
image analysis, while shades are 
needed to visualize the image. 
 
Pixels represent image values within a two-dimensional map. If several matrices are layered 
in a tomographic image, three-dimensional information is provided. The corresponding pixels 
are then combined to volume elements (voxels). Both pixels and voxels represent tone values 
at a certain point. To attain perfect resolution, an infinite number of pixels would be needed. 
Therefore, the spaces between limited numbers of pixels are filled using reconstruction filters 
to allow image formation from those discrete entities so that pixels appear as rectangles and 
voxels as cuboids.3 
IMAGE RESOLUTION 
The resolution provides the authenticity of an image concerning the representation of the 
original scene. This is dependent on the optics and aberrations of the imaging system and eye 
(optical resolution) as well as on the size of the matrix used to digitize the image. Increasing 
the number of pixels in a matrix enhances the digital resolution that can be achieved. It should 
be realized that the maximum optical resolution limits the visualization of details within an 
ophthalmic image, and unnecessary increase of the pixel number can lead to artifacts by 
banding, i.e. abrupt changes within one shade without additional image information.4 In 
image analysis it is important to know the particular spatial resolution (pixel size). To 
compare measurements within two different images, the size has to be calibrated by dividing a 
known distance by the number of pixels. This allows fundus structures in different images to 
be compared largely independent of magnification errors by camera optics and refraction of 
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the eye. For example, if an image is normalized to 500 pixels for the distance between fovea 
and the temporal border of the optic nerve head (usually 3000 µm), the resolution will be 6 
µm/pixel.5 
GRAYSCALE VERSUS COLOR SCALE 
Every pixel carries specific brightness information varying from black (minimum) to white 
(maximum). If different wavelengths are discriminated, a color image can be received and the 
information is split into three particular wavelengths, red, green and blue. These images are 
therefore called RGB images. If differentiation into wavelength is not possible or not 
necessary, a grayscale image is created. Then, only general brightness values are received and 
split into a number of gray tones. 
The brightness resolution depends on the number of brightness values allowed in an image. 
The most commonly used value is 8 bits per channel. A bit is a variable that can only have 
two possible values. As a result, an 8-bit gray value image can have 256 (or 28) brightness 
values. Most RGB images have 3 color channels with 8 bits each (24-bit color image), which 
allows for 16,777,216 color variations. This color depth is often called True Color mode.  
Figure 3.2 illustrates the difference in brightness information between a 3-bit and an 8-bit 
gray scale image. In Figure 3.3, a color fundus photograph (24-bit) is split into its RGB 
channels to demonstrate the differences in brightness information between the color channels, 
which results it disparate fundus structure information per channel. 
Fig. 3.3 ◙ 
24-bit color image of a patient with 
cone-rod dystrophy (A). The image 
consists of the blue (B), green (C) 
and red (D) channel. Note that the 
optic nerve head is best visualized in 
blue, macular pathology is best 
visible in green and the red channel 
gives an impression of melanin 
distribution.
 
Fig. 3.2 
Gray scale images of a continuous 
slope from black to white, displayed 
in 3-bit (top) and 8-bit (bottom) 
mode. Less gray values reduce 
brightness information and cause 
banding. 
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SPECIAL IMAGE SCALES 
Standard image data scales are not sufficient to show the results of arithmetical image 
processing. Instead special formats to illustrate continuous, positive and negative pixel values 
and floating points are necessary. Appropriate scaled images are 32-bit images; however, 
these cannot be read from general viewing and office software. If 32-bit images results are to 
be further processed for presentation, conversion to 8-bit is useful. It must be borne in mind 
that transformation from 32-bit to other formats will destroy any useful numerical information 
of the image and replace it with some artificial pixel values. Therefore, all image analysis has 
to be completed on the 32-bit image before conversion. 
IMAGE STORAGE 
The saving of image data is an important issue in digital image processing, as the data format 
used is essential for the amount of image information stored. Images can be stored 
compressed or uncompressed. Compression does not necessarily mean loss of data, but 
compression helps to save volume on a data storage device like a CD-ROM. The compression 
method is responsible if data are saved undestroyed (lossless) or if information is lost (lossy 
formats). If lossy formats are used, compression-related artifacts can occur and images may 
not be used for most analysis purposes any more. 
IMAGE FORMATS 
A digital image is a computer file that contains data on pixel location, number and brightness. 
Furthermore, information about image type (number of bits), color and in some cases, 
technical data of the imaging device, patient and time of recording must be stored. There is 
currently a wealth of image file types and only the most common files in ophthalmic imaging 
can be presented here. 
TAGGED IMAGE FILE FORMAT (TIFF) 
TIFF is the most frequently used lossless format because it is very flexible. It offers the 
possibility of uncompressed data storage, for Lempel–Ziv–Welch (LZW) lossless data 
compression but it may also be used as a container for lossy formats of the Joint Photographic 
Experts Group (JPEG). For scientific imaging TIFF is particularly interesting, as it can handle 
extended data formats like 32-bit images that contain floating rather than binary information 
as well as image sequences. TIFF files are preferred by publishers as the format also preserves 
print color options like CMYK color model: http://partners.adobe.com/public/ 
developer/tiff/index.html (assessed February 26, 2010) 
BITMAP FILE FORMAT (BMP) 
Bitmaps are very simple file formats that can optionally be stored as text files and can be read 
and created by a text editor. A RAW mode exists to save pixel values as binary data. The 
maximum data depth is 32 bits, but in contrast to other formats image metadata or color 
manipulation are not supported. Bitmaps cannot significantly be compressed and are therefore 
very large. This format is particularly useful for value-based image analysis. 
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JOINT PHOTOGRAPHIC EXPERTS GROUP (JPEG) 
Fig. 3.4 
Effect of image compression on file size and data 
content. The original image (A) is TIFF, uncom-
pressed, 75 kilobytes; the LZW compressed TIFF 
image (B) is 22 kilobytes; the JPEG image (C) is 21 
kilobytes. Note the artifacts in (C) with only minor 
advantage of file size reduction according to (B). 
JPEG is currently the most widespread image data format for lossy compression data storage.6 
The degree of compression can be adjusted to allow for a good compromise between file size 
and image quality. Although some JPEG compression may be acceptable for images that do 
not need to offer much clinical detail, this format is not suitable for scientific image 
processing or high-quality image reading due to loss of fine image elements and artifact 
formation (Fig. 3.4). 
 
IMAGE ANALYSIS SOFTWARE 
Special image analysis software is needed to gain access to pixel information of an image, 
measure pixel dimensions and compare two images with each other. This software is different 
from image-editing software like Adobe Photoshop® or the GNU Image Manipulation 
Program (GIMP, www.gimp.org), which are generally used for photo editing inclusive 
labeling and scaling before publication. 
A large variety of proprietary or free programs for medical image analysis are available 
(http://en.wikipedia.org/wiki/List_of_image_analysis_software; assessed March 1, 2010). 
Most programs are specifically designed for radiology or microscopy purposes. Therefore, 
only a few programs may be suitable for ophthalmic image analysis.  
The public domain program ImageJ (http://rsb.info.nih.gov/ij/, official version inclusive user 
manual also available on the CD added to this book) is increasingly used for retinal image 
analysis.7-10 ImageJ was developed at the National Institute of Health and first released in 
1997. Its open source architecture allows for quick bug fixing and the development of 
individual plug-ins for specific image analysis steps. This makes the software flexible and 
adjustable for use in ophthalmic imaging. 
IMAGEJ IN OPHTHALMIC IMAGE PROCESSING 
ImageJ is platform-independent, image-processing software based on Java programming 
language (Sun Microsystems, Santa Clara, CA, USA). It can run on virtually every computer 
system with a Java runtime environment (JRE). The JRE is freely available and can be 
downloaded either separately from Sun Microsystems (http://java.sun.com/) or bundled with 
ImageJ (http://rsbweb.nih.gov/ij/download.html). A large bundle of plug-ins may be 
downloaded. Once saved in the plug-ins folder of ImageJ, these plug-ins can be accessed via 
the program menu like any other item. Major advantages of ImageJ are its support of many 
image formats, and that not only image data but also metadata of an image are imported. After 
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an image has been opened, image type and image data can be changed and adjusted for image 
analysis purposes. 
All image analysis performed to receive the imaging results in this thesis was limited to gray 
value images. Therefore, this introduction is limited to the processing of ophthalmic gray-
value images with ImageJ as color fundus image analysis goes beyond the scope of this thesis.  
Once it has been installed, ImageJ the is started by clicking ImageJ.exe and a small window 
appears including a drop-down menu and a number of buttons (Fig. 3.5). All program 
functions can be accessed via the menus, but some specified functions may quickly be 
effected by the buttons. The Help menu provides online help and access to updates and new 
plug-ins.  
 
Fig. 3.5 
ImageJ main window with drop-down menus and quick access buttons for macros and special 
functions. 
OPENING IMAGES AND MOVIE FILES IN IMAGEJ 
An image may be opened via a standard navigation window by using File | Open. The image 
will then be displayed in its own window, and information about type and file size is 
displayed at the top. By moving the mouse pointer over the image, the individual pixel values 
are displayed together with the x and y coordinates at that individual point. With this, a first 
easy image analysis is possible (Fig. 3.6). 
Importing movie files can be important for early phase of angiographies or tomographic 
images. Movies are series of single images illustrating either a dynamic process or a scan 
Fig. 3.6 
A FAF image opened with ImageJ. The 
image window provides information on 
name, file type, image size in pixels, depth of 
gray-shades and file size (encircled). The 
main window provides the pixel value at the 
mouse pointer position (black arrow). 
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through a large data set. Movies van be opened in Audio Video Interleave (AVI) format and 
are imported by File | Import | AVI. A series of single images can also be stored as one single 
AVI file by File | Save as | AVI if it is opened in a single window (image stack). 
SINGLE IMAGE ANALYSIS 
Digital images include a huge amount of information, some of which is obvious at first sight 
and some of which is obscured. A lot of information can be received and analyzed by human 
observers. However, computerized image analysis can be quicker and may result in a more 
precise analysis.5 All information of an image can be read from the whole image or a selected 
part. For selection of a region of interest (ROI), a number of tools are directly available via 
the buttons on the ImageJ menu bar (Fig. 3.5), including rectangular, elliptical, line and point 
selections. 
IMAGE HISTOGRAM 
The histogram illustrates the distribution of pixel values within an image and can be used as a 
quality measure of fundus image performance. In addition, histograms can be helpful to 
decide on image segmentation and image similarity. The best image contrast and detailed 
information is provided by an image with a well-centered and broadly distributed histogram 
that fills in all existing pixel values. High-contrast images may show two large peaks with few 
values in between.11 By significant under- or overexposure the histogram is shifted to the left 
or the right, respectively, and the profile of the histogram may be reduced (Fig. 3.7). 
However, the shape and distribution of the histogram of an image may be influenced by 
typical changes within the scene of a (fundus) image.6 The image histogram can easily be 
accessed by the ImageJ menu Analyze | Histogram. 
 
 
 
Fig. 3.7 
Histograms of consecutive FAF images of one patient performed at one day. A well balanced 
histogram (A), underexposure (B) and overexposure (C) are displayed. Gray bars indicate 
quality margins for histogram gray values, which should include the black fractions (mean ± 
standard deviation) of the gray value pixel counts of the individual histograms. 
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IMAGE STACKS 
Movies or series of single images can be combined to an image stack. A stack is an image 
series opened within a single window to allow ImageJ to treat it as one image. With this, 
image analysis operations and image manipulations can be performed on a large series of 
images within one single step. In case of noisy image like in FAF imaging, the images within 
a stack can be registered and a mean image can be calculated to improve contrast and improve 
the visibility of image details.  
To combine single images to a stack, all images have to be of the same type (for example, 8-
bit grayscale or RGB) and of the same pixel size. Then, images can be combined by the menu 
Image | Stack | Images to Stack. To keep all image information stacks have to be saved as 
TIFF or AVI files. For stack analysis the menu Image | Stack | Z-project offers a variety of 
analysis tools that are performed pixel by pixel, such as average, median, minimum or 
maximum gray value processing. 
IMAGE REGISTRATION 
In image registration, two images taken at different times by the same technique or received 
by different techniques at the same time are superimposed and aligned. Evaluating fundus 
images pixel by pixel after a follow-up period, is important in studies on the natural course of 
retinal disease and on the therapeutic effects on disease progression.12-14 The comparison of 
different imaging techniques at the same time can also provide valuable new information on 
retinal diseases.15 Image registration is not only important for following changes with one 
specific imaging technique, but it also allows the combination of structural and functional 
imaging with different techniques to generate atlases that portray typical appearances in 
health and disease, to allow the performance of arithmetical operations such as subtraction 
analysis or to render a three-dimensional structure from a tomography stack. 
To judge a lesion within two images, exactly the same region of the fundus has to be 
compared to avoid artificial differences in pixel values. Even if two images have been taken 
immediately after each other, small eye movements (saccades) or changes in head positioning 
may have caused transformations in size and orientation. During registration, digital 
corrections are made for those unwanted image alterations. 
All registration of fundus images follows a stereotypical protocol that can be performed with 
ImageJ. This includes identification of anatomical landmarks that appear in both images 
(feature detection), comparing and identifying these landmarks in both images (feature 
coupling) and finally, calculating and applying a mathematical operation to bring both images 
into perfect correlation (Image alignment). The three main steps of image registration will be 
explained by the use of an ImageJ plug-in, TurboReg.16 
FEATURE DETECTION 
In retinal images, the large retinal vessels and their bifurcations are relative stable and well-
defined features. Depending on the imaging technique, vessels are highly contrasted to their 
surrounding (the retina) and have a characteristic appearance. This makes retinal vessels very 
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useful not only for manual landmark selection but also for automated feature detection, which 
may be superior to manual registration.17;18  
To start with registration, select from the menu Plugins | TurboReg | TurboReg. Registration 
details can be selected from the TurboReg dialog (Fig. 3.8). 
 
 
Fig 3.8 
The TurboReg window allows for choice of 
image source, type of transformation and 
selection of landmarks. It also offers manual 
and automatic registration. 
 
Unregistered image comparison results in significant artifacts that can be visualized by ghost 
vessel appearance (Fig. 3.9). Using image overlay or subtraction, the examiner can rapidly 
ensure the quality of registration by retinal vessel correspondence. 
 
Fig. 3.9 ◙ 
Results of image overlay with and without 
registration of source and target image. 
Note the ghost vessels as a result of bad 
pixel correspondence in the upper row. In 
the color image, yellow and black pixels 
represent good correlation while red and 
green ones stand for bad correspondence. 
 
 
GEOMETRICAL TRANSFORMATIONS FOR IMAGE REGISTRATION 
To align a pair of images, the type of deformation between source and target image has to be 
determined. Images may be misaligned due to rotation, shifting, zoom and warping. Four 
categories of geometrical transformations of an image can be defined derived from these 
alterations. Most transformations need to be iterated several times to gain sufficient similarity 
between source and target image. 
RIGID TRANSFORMATION 
This is the simplest type of image transformation, where rigid anatomy is postulated and the 
image is assumed to move as a whole. A subtype of this transformation is translation, where 
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simply a shift without any other deformation is assumed. Due to the flexibility and softness of 
ocular tissues, rigid transformation is not appropriate for fundus imaging.  
AFFINE TRANSFORMATION 
In the case of affine transformation, straight lines stay straight and parallel lines remain 
parallel, which is very similar to rigid transformation. However, angles between lines can 
change due to image shearing by eye movement. The method of affine measurement has been 
shown to be advantageous for the alignment of multimodal retinal images as used in this 
thesis.16;19 
PROJECTIVE TRANSFORMATION 
When the camera angle of two images of the same scene is different, originally parallel lines 
become converting. This is particularly the case when multiple retinal images from the central 
and peripheral retina are combined to a montage image. Then both affine and projective 
distortion occur and these must be taken into account for correct image alignment.20 
ELASTIC TRANSFORMATION 
Curved or elastic transformations are the most complex geometrical transformation. These are 
most suitable for deformable tissues and have been suggested for use in retinal angiographic 
and autofluorescence image registration.21;22 In TurboReg, elastic registration can be applied 
by selecting the Bilinear transformation mode. 
MATHEMATICAL IMAGE ANALYSIS 
In daily clinical practice retinal images are judged subjectively for changes in their 
appearance, which is a rather inaccurate method and may have a low intra- and inter reader 
reliability if used for fluorescein angiography.23 Although it has not been tested for other 
retinal imaging modalities, subjective image comparison is expected to have relatively low 
agreement between different ophthalmologists. Therefore, an arithmetical approach would 
appear to be suitable, at least, for scientific analysis purposes of retinal images. For instance, 
subtraction analysis has been used to enhance the results of retinal indocyanine green 
angiography24 and reliable quantification of macular pigment was possible from subtraction 
maps of FAF images achieved with two different wavelengths.25 
Arithmetical operations on digital images are numerical steps performed on every single pixel 
value. These operations can be done consistently for the entire image (for example, add a 
constant value to enlighten the image) or individually for each pixel (for example, subtract 
one image from another). In ImageJ these operations can be performed by Process | Image 
Calculator (compare two images) or by Process | Math (constant value operations). Typical 
applications in retinal imaging used in this thesis are longitudinal examinations in macular 
degeneration (Chapter 4) and the assessment of visual and macular pigment (Chapter 5). 
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RETINAL IMAGE SEGMENTATION 
In segmentation, a digital image is apportioned into sets of pixels to describe certain objects. 
This can be useful for objectively following the size of a lesion in retinal disease.26 Images 
may be segmented manually or by (semi-) automatic algorithms. Manual segmentation is 
commonly used. This is very user dependent and time-consuming, and automatic image 
segmentation may reach similar accuracy in a short time,27 which is advantageous for analysis 
of large image series.  
MANUAL SEGMENTATION 
In manual segmentation an expert observer outlines a structure on the computer monitor. In 
ImageJ, this can simply be done by using one of the various buttons on the menu bar (Fig. 
3.5) for open and closed contours. The contour lines have several control points that can be 
assessed and adjusted by right-clicking (Fig. 3.10). The position of the contour can be 
nter and holding the left mouse button. 
 
changed by moving the mouse poi
 
AUTOMATIC SEGMENTATION 
algorithms are available that cover the entire image (i.e. 
HRESHOLDING
f thresholding image value is basically a segmentation of the image 
 
 
 
Fig. 3.10 
Manual segmentation performed with the elliptical 
selection tool of ImageJ. Several white anchor 
points allow for adjusting the contour. 
For automatic segmentation, 
thresholding techniques) or specific areas by predefined changes in pixel values (i.e. edge 
detection methods). A large number of automatic and semiautomatic techniques are available 
for retinal image segmentation. However, current retinal image segmentation is mostly 
performed by hybrid methods based on thresholding and edge detection.28 The following 
techniques have been applied for measurements in this thesis. 
T  
The technique o
histogram. One or more thresholds are defined to set pixels outside the defined range to a 
certain value. In ImageJ thresholds are defined by the menu Image | Adjust | Threshold. Peaks 
and valleys of the histogram are often used to classify a threshold. Defining a suitable 
threshold can be particularly difficult in the case of noisy images then and it may be useful to 
combine thresholding with other image segmentation techniques (Fig. 3.11). 
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Fig. 3.11 
Segmentation of retinal vessels and optic 
nerve head (ONH). The original image (A) 
is first thresholded based on the histogram, 
which results in good ONH definition but 
poor vessel visibility (B). Edge detection 
results in good vessel segmentation but 
invisibility of the ONH (C). Finally, 
combining both segmentation techniques 
gives satisfactory results (D). 
EDGE DETECTION 
Within the same structure of a fundus image, pixel values will not change abruptly but will be 
relatively homogeneous within a certain standard deviation. However, at the border between 
different structures, pixel values may suddenly change and cause so-called edges. Such edges 
can be detected by software through comparing the mean of pixel values within a certain 
region. If a pixel value varies by more than a predefined threshold then the pixel is rejected 
from the region and defined as region border. The operator defines a range of gray levels and 
gives starting points (seeds) from where the algorithm connects all pixels within the threshold 
(region growing). This technique is can be used to measure well-defined regions like atrophic 
areas in FAF images of age-related macular degeneration, a tool that is also implemented in 
the most recent software of the HRA2.  
BEST CURRENT PRACTICE OF RETINAL IMAGING 
Quantitative analysis plays a pivotal role in retinal image processing and the results of this 
may look unusual compared to standard fundus photographs. For reliable results to be 
achieved, the steps taken to perform image analysis must refer to both the imaging acquisition 
technique and the measured parameters. It is also important to set up a precise protocol for 
both the acquisition and processing of an image so that repeatable and reliable results are 
obtained.  
The most important step in studying retinal disease is the choice of one or more appropriate 
imaging techniques. Normally a technique with proven diagnostic value for the disease in 
question will be preferred. When new imaging modalities are considered for scientific 
purposes, the potential of a certain technique to display disease-related changes must carefully 
be evaluated and a stringent imaging protocol should be adhered to. Due to the inconsistency 
of image recordings, retrospective analyses of retinal images are not reliable enough to be 
used for precise quantitative measurements. A detailed image acquisition protocol must be 
provided to allow future repetition of the work. However, even with a prospective approach, 
maintenance of measuring parameters like cornea-camera distance, head positioning, pupil 
width, visual pigment bleach and fixation will be challenging.  
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INTRODUCTION 
When light is put into the eye, a certain fraction will come back to the observer and form 
an image of the ocular fundus. The appearance of the image depends on the reflectivity 
of the single layers of the retina and the underlying tissues. A fundus reflectance image is 
the result of internal tissue reflectivity, light absorbance and scattering at given (spectra 
of) wavelengths. Therefore, fundus reflectance images will have different appearances at 
different  illumination  spectra.1  In  contrast  to  fundus  autofluorescence  (Chapter  5), 
reflectance  imaging  is  characterized  by  the  double‐pass  of  light  though  the  ocular 
tissues,3;4 which may lead to increased optical effects in reflectance images. 
Reflectivity (R) refers to the fraction of light reflected by a surface or tissue layer. It is 
dependent on the wavelength (  of l  and is given by λ) ight
ܴሺఒሻ ൌ
ூೝ
ூ೔
   (1) 
where Ir and Ii are the light intensities of the reflected and incident light, respectively. The 
reflected light will be attenuated by scattering and absorption. These optical effects in fundus 
reflectance imaging may be summarized by light absorbance, which is the wavelength-
dependent optical density (D) of the fundus. Abs c  is given by   orban e
ܦሺఒሻ ൌ െ logଵ଴ሺܫ/ܫ଴ሻ (2) 
and is caused by scattering within the optical media, the retina and the subretinal tissues as 
well as absorption by the lens and absorbing pigments of the fundus. When the absorption 
spectra of certain elements of the optical pathways are known, the source of light absorbance 
at the ocular fundus can be identified.5;6 
In the healthy eye two main absorbers, blood and 
melanin, have been identified in the visible spectrum 
of light.2 The absorption changes dependent on the 
wavelength of light used (Fig. 4.1). Knowledge of 
these specific absorbance spectra assist optical tissue 
analysis from multispectral fundus images.7 It is 
important to recognize that unbleached photopigments 
may increase fundus absorption at their maxima 
(cones at 420, 530 and 560 nm, rods at 495 nm). 
Fig. 4.1 
Absorption of the ocular fundus (y-axis, arbitrary units, logarithmic scale) versus wavelength (x-axis, 
nm) obtained by fundus reflectometry. Main absorbers in the short wavelength spectra are melanin 
(Me) and deoxygenated (Hb) and oxygenated hemoglobin (HbO2). In the near infrared (gray shaded 
part) water (H2o) is an important absorber. The ocular lens (Le) absorbs only in the very short wav-
length spectrum. Macular pigment (maximum absorption about 480 nm) is not shown. 
Adapted from Elsner et al.2(with permission from Elsevier) 
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NEAR-INFRARED FUNDUS REFLECTANCE 
Conventional fundus photography is the result of fundus reflectance within the visible 
spectrum of light, resulting in a multispectral reflectance map from a broad spectrum 
illumination. In general, fundus reflectance increases when the illumination is shifted to the 
red and near-infrared spectrum.1 The main absorbers of the visible spectrum become less 
important and some, like melanin, may even become the source of increased reflectance.8;9 
Therefore, several structures that are invisible in standard fundus photographs may be 
assessed by near-infrared reflectance (NIR) imaging.10;11 With this it becomes possible to 
visualize fundus structures beneath the retina or even in the choroid. This chapter describes 
the use of NIR in choroidal neovascularization and in age-related macular degeneration 
(AMD). It shows that NIR imaging combines information obtained from invasive 
examination techniques like fluorescein angiography and from topographic methods like 
OCT. 
FUNCTIONAL NEAR-INFRARED IMAGING 
NIR imaging is particularly interesting for the observation of retinal responses to visible light, 
as infrared light does not interact with visual pigments. Hence, NIR imaging does not cause 
bleaching and no interaction occurs with any visual stimulus given. Harary et al. (1978) were 
the first to demonstrate light-induced changes of NIR in cane toads (Bufo marinus).12 These 
changes occurred immediately after a given flashlight stimulus and were characterized by a 
quick decrease followed by a slow increase of light transmission. Besides these quick changes 
De Lint et al. (2000) also found slow light-induced changes in the human retina by NIR 
reflectance,13 and Abramoff et al. (2006) were able to map the spatial distribution of stimulus-
induced NIR changes in the human fundus.14 The same group applied pattern stimuli to cat 
retinas and found that positive stimuli were followed by an increase of reflectance and 
negative stimuli caused a decrease of NIR.15 The rate of reflectance change was positively 
correlated with the duration of the stimulus. Pharmacologic investigations finally located 
these NIR alterations in the outer retina and confirmed former theories of light-induced 
photoreceptor changes as being the cause of those modifications in NIR.16  
Latest studies with an AO-SLO have revealed that individual cones cause pattern-stimulated 
alterations of their reflectivity, which may range from 0 to 5% between individuals and may 
reach up to 20% in single photoreceptors.17 These results show that the potential of NIR 
imaging goes beyond anatomical documentation and that it illustrates physiological processes 
within the retinal photoreceptors. The use of multimodal imaging with a cSLO-OCT device 
could also help in studying early stages of common diseases like AMD as well as rare but 
disastrous disorders like Stargardt disease. This could improve our knowledge of 
pathophysiology and improve monitoring of new therapeutic strategies.  
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SYNOPSIS 
Current therapeutic strategies for treatment of choroidal neovascularization require frequent 
monitoring of neovascular activity, which calls for a non-invasive, low risk imaging tech-
nique. 
OCT focuses on static anatomical features like retinal thickening and the presence of sub- and 
intraretinal fluid, whereas fluorescein angiography employs a longer time frame better suited 
to address the dynamic aspect of active fluid leakage. 
Near infrared imaging can be used in the general clinical setting using a commercially availa-
ble confocal scanning laser device (Heidelberg Retinal Angiograph 2).  
Near-infrared reflectance imaging provides information on alterations in the retinal structure, 
subretinal lesions and the accumulation of fluid within and beneath the retina and the retinal 
pigment epithelium. Therefore, near-infrared reflectance summarizes aspects of both fluo-
rescein angiography and OCT in a non-invasive way. 
Increased intra- and subretinal fluid content reduces near-infrared reflectance and causes a 
characteristic dark halo around a lesion. 
A classic choroidal neovascularization typically shows a dark core surrounded by a bright 
corona on near-infrared reflectance imaging. 
The near infrared image of occult neovascular membranes and detachments of the retinal epi-
thelium are less distinctive compared to classic neovascular membranes. An occult lesion 
shows an uneven signal increase; a pigment epithelium detachment typically presents with a 
poorly defined ring-shaped reflex. 
Following successful therapeutic intervention, certain alterations occur in the near infrared 
image of the choroidal neovascular membrane and digital subtraction analysis may be em-
ployed to enhance these alterations to accurately assess treatment efficacy.  
INTRODUCTION 
Choroidal neovascularization (CNV) is the hallmark feature of exudative age-related macular 
degeneration (AMD) and may also complicate other ocular disorders like uveitis, high myopia 
and presumed ocular histoplasmosis. The visual acuity in patients with early AMD remains 
relatively intact until more advanced stages heralded by the arrival of geographic atrophy or 
choroidal neovascularization (CNV). Whereas there are no treatment options in geographic 
atrophy, most cases of wet AMD due to CNV formation are currently being treated with 
intravitreal injection of vascular endothelial growth factor inhibitors (anti-VEGFs).  
To initiate and monitor CNV treatment, careful documentation by serial imaging is necessary. 
This imaging technique should provide information on lesion activity and associated retinal 
damage with as little discomfort to the patient as possible. Currently, the most frequently em-
ployed methods are fluorescein angiography and optical coherence tomography (OCT). The 
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current chapter focuses on a possible alternative imaging method for choroidal neovascular 
membranes originating from the choroid: near-infrared reflectance (NIR). 
HISTOLOGICAL CHARACTERISTICS OF CHOROIDAL NEOVASCULARIZATION 
In CNV, new blood vessels grow from the choroid and invade Bruch’s membrane to enter the 
space under the retinal pigment epithelium (RPE) and/or the sub-neuroretinal space.1-3 Histo-
logical examination of excised membranes revealed the following components:  vascular en-
dothelium, blood, fibrocytes, collagen, fibrin, RPE and retinal photoreceptors.4 The clinical 
appearance of the lesion seems to depend on the localization of the CNV in relation to the 
other retinal layers, notably the RPE. In type 1 the CNV is located inferior to the RPE, and in 
type 2 the CNV has penetrated the RPE layer.5 In type 1 CNV drusen and RPE detachment 
are common, however, only little RPE proliferation will be found. Type 2 CNV represents a 
relative sharply demarcated lesion, surrounded by a subretinal pigmentary nimbus or plaques. 
The histological types of CNV correlate with the angiographic subclasses of classic (type 2) 
and occult (type 1) CNV.6 A distinctive characteristic of neovascular vessels in CNV is the 
lack of tight inter-endothelial junctions, the resulting leakage may lead to serous retinal eleva-
tion and retinal thickening by leakage of blood serum and small molecules.7 The variations in 
anatomical structure, leakage activity and location of the diverse CNV lesions lead to a broad 
variety of optical effects and resulting NIR images. 
CURRENT IMAGING MODALITIES FOR CHOROIDAL NEOVASCULARIZATION 
To visualize active leakage in CNV, fluorescein angiography has firmly been established as 
the gold standard for diagnosing and treatment monitoring in wet AMD. Fluorescein is a rela-
tively small chromophore, which leaks readily through neovascular endothelium and has a 
high quantum yield of fluorescence in the green spectrum after excitation with blue light. 
Therefore, even minor CNV leakage activity may be detected. However, injection of sodium 
fluorescein can cause significant patient discomfort and leads to serious adverse reactions in 
up to 5% of cases.8 The risk increases up to 49% with repeated fluorescein angiography ex-
aminations in patient who previously encountered side effects. In addition, fluorescein angio-
graphy suffers from a low inter- and intra-reader agreement.9 
To better visualize intra-choroidal vessel structures, indocyanine green angiography (ICGA) 
was introduced in retinal imaging.10 Indocyanine green is a relatively large chromophore, 
which does not leak through neovascular endothelium and has a low quantum yield of fluo-
rescence in the infrared spectrum after excitation with infrared light. Therefore, it is suitable 
for neovascular vessel analysis largely independent from visible light absorbers. In contrast to 
fluorescein, indocyanine green has a much lower complication rate of up to 0,34% .11 Howev-
er, interpretation of ICGA images is difficult and requires significant experience. 
The rapidly expanding use of anti-VEGF for treatment of CNV has led to an exponential in-
crease of follow-up control visits with the need for repeated imaging of CNV activity.12 This 
calls for non-invasive imaging techniques to assess CNV activity. In recent years, OCT has 
been suggested as a novel, non-invasive imaging protocol for CNV. OCT provides a pseudo-
histological perspective of pathologic changes within the living retina. It has a high intra- and 
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inter-reader agreement, and with the introduction of the spectral-domain technique three-
dimensional reconstructions of the lesions have been achievable.13;14 OCT and fluorescein 
angiography look at different aspects of intraretinal fluid dynamics, therefore their findings 
often do not concur.15 OCT focuses on static anatomical features like retinal thickening and 
the presence of sub- and intraretinal fluid, whereas fluorescein angiography employs a longer 
time frame better suited to address the dynamic aspect of active fluid leakage. Therefore, no 
clear correlations between lesion type and activity on fluorescein angiography and OCT have 
been established as yet. 
THE BASIC PRINCIPLES OF NEAR INFRARED REFLECTANCE 
IMAGING OF THE RETINA 
The retina is perfectly designed to capture and process the visible spectrum of light, and there-
fore, main absorbance and reflectance occurs at wavelengths between 450 and 780 nm. Light 
of a longer wavelength such a near-infrared is invisible to the naked eye and largely avoids 
absorption and reflection by the layers of the neuroretina and therefore penetrates relatively 
easy tot the level of the RPE and choroid. For that reason, near-infrared light (NIR) is perfect-
ly designed to use in the imaging of sub-retinal structures. Probing the ocular fundus with 
NIR has been suggested as early as 1974 by Dallow,16 but gained little support at the time. In 
1996, Elsner and coworkers17 demonstrated the NIR visibility of subretinal structures in ma-
cular degeneration using a confocal scanning laser ophthalmoscope. Subsequently, this tech-
nique has been extended to polarization-sensitive NIR and only recently, NIR imaging has 
been used to capture the appearance of classic CNV in a small series of AMD patients.18;19  
NEAR-INFRARED REFLECTANCE IMAGE ACQUISITION 
The ocular fundus shows a high reflection of near-infrared light compared to visible light.20 
When a normal fundus camera is employed, these reflections produce poorly contrasted im-
ages unsuitable for further analysis of sub-retinal pathology. Instead, imaging NIR using a 
confocal scanning laser ophthalmoscope (SLO) removes the out-of-focus reflected light, 
which leads to a significant improvement of image quality.21  
The Heidelberg Retina Angiograph 2, which is currently the only available confocal SLO to 
achieve high-contrast NIR images, applies an 830 nm laser source to acquire reflectance im-
ages in the near infrared. The device allows for adjustment of both laser energy and detector 
sensitivity to optimize the imaging process. To achieve high-quality images, an optimal bal-
ance between laser energy and detector sensitivity is necessary. 
Clinical practice has shown that 50% of the available laser energy provides adequate illumi-
nation in the majority of cases. To properly adjust the detector sensitivity the image needs to 
be adequately focused. For CNV imaging the focal plane of the SLO should be located on the 
inner retinal surface. It has been shown that this provides maximum reading contrast of the 
images in the near infrared.22 To achieve this focal plane, the image focus of HRA 2 has to be 
positioned on the large retinal vessels. Then, the detector sensitivity can be adjusted based on 
the major reflecting regions, which are mainly located at the peripapillary atrophic zone. 
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Here, colored pixels, that are indicative for overexposure, should just be hidden. The resulting 
image yields a maximum contrast in the near infrared without over- or underexposure of the 
structures of interest. 
For fundus autofluorescence and OCT imaging, image alignment and mean image calculation 
have been proven to increase image detail by improving the signal-to-noise ratio.23;24 Even 
though this has not been investigated for NIR images, speckle noise appears not to be promi-
nent in NIR and therefore, mean image calculation of an image series is not a promising me-
thod to further enhance image quality.  
NEAR-INFRARED IMAGING OF THE NORMAL RETINA 
To correctly interpret the NIR images and to enable comparison with images in the visible 
spectrum, knowledge of the interactions between light of various wavelengths and the struc-
tures of the retina is essential. In retinal photographic techniques, visible light is highly re-
flected by the cornea and the ever present haze of the ocular media. In fluorescein angiogra-
phy, the light used for excitation has a shorter wavelength than the light emitted by fluoresce-
in. Therefore, reflections and absorptions of media are less important in this technique, and 
image quality therefore often exceeds that of color photography. Confocal scanning laser NIR 
fundus imaging is also largely independent from media reflections, despite the fact that the 
total fundus reflectance is up to 10 times higher than in red-free fundus photographs.25 The 
fact that the healthy retina absorbs near infrared light to a much lower degree allows for a 
marked increase in contrast in the NIR images.26  
 
 
Fig 4.2 ◙ 
Reflecting retinal layers in the near-
infrared. The illuminating beam (red ar-
rows) is reflected by diverse intra- and 
subretinal layers for diverse extents. 
Strongest reflection is provided by the 
sclera (SCL), a smaller amount by the 
retinal photoreceptor layer (PRL) and the 
retinal pigment epithelium (RPE). Small 
amounts of reflections originate from the 
inner limiting membrane (ILM) while the 
retinal nerve fiber layer (RFNL) only gives 
important reflections in the near vicinity of 
the optic nerve. The number and length of 
the blue arrows indicate the degree of near 
infrared reflectance
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In the normal retina, NIR light is reflected by the various tissue layers as well as by sub-
retinal structures (fig. 4.2). The inner limiting membrane demonstrates an age-dependent ref-
lectance that relies on the curvature of the retinal surface as well as on the direction of the 
incoming light.27;28 This can be illustrated at the foveal umbo, which shows an increased NIR 
reflectivity, especially in young individuals (fig. 4.3). The retinal nerve fiber layer shows rela-
tively high reflectivity in the peripapillary region. However, it is very thin at the macula and 
therefore its optical impact on NIR in AMD can safely be neglected.29 The next important 
reflecting layer in NIR is the retinal photoreceptor layer. Even though the reflections of an 
individual photoreceptor are relatively weak, the large number of retinal photoreceptors ampl-
ify the signal to a substantial effect.30 Within the RPE and the choroid, melanin is supposed to 
add to NIR fundus reflectance.31 Finally, the sclera has to be considered as a major contribu-
tor to NIR fundus reflectivity in the healthy human eye.32  
 
Fig. 4.4 ◙ 
Near-infrared reflectors and absorbers in choroidal neovascularization. A multitude of reflecting (ar-
rows point up) and absorbing (arrows point down) elements add to the near-infrared reflectance im-
age of a choroidal neaovascularization (CNV). The length of the arrows indicated the strength of the 
optical effects. Unmasked fibrin (yellow dots) is a strong reflector while fluid appears main the absor-
ber. CL=CNV; CH=choroidea; OC=occult CNV; RE= retina
Fig. 4.3 
Near infrared reflectance of the normal fundus. 
The NIR image of the normal fundus is predomi-
nated by a medium reflectivity originating from 
deep layers, like sclera, photoreceptors and retinal 
pigment epithelium. Even though, these are the 
strongest reflectors in the near infrared, the re-
flected light is diffused by intra-retinal, blood-
related absorbance and scattering. Therefore, the 
superficial peripapillary and perivascular retinal 
nerve fibers (arrowheads) and the prefoveal inner 
limiting membrane (arrow) as superficial reflectors 
in the near infrared, outshine the image. 
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Blood and fluid are the main absorbers in the near infrared spectrum and will therefore look 
dark on NIR imaging. Other CNV components, such as melanin, fibrin and collagen, are 
strong NIR reflectors and will therefore appear bright on the NIR image (fig. 4.4). Similar to 
fluorescein angiography, the anatomical setting of the neovascular membrane, i.e. above or 
below the RPE, is of influence on the NIR image. 
CLINICAL PRACTICE OF NEAR-INFRARED SUBRETINAL IMAGING 
NIR imaging in exudative AMD yields very diverse pictures. This section illustrates the near-
infrared properties of all types of CNVs in exudative AMD and shows additional examples of 
non-AMD related neovascular membranes. The NIR features of neovascular macular degene-
ration (including idiopathic polypoidal choroidal vasculopathy) are summarized in table 4.1. 
 
   NIR appearance   
Lesion type dark halo bright corona dark core 
speckled 
hyper-reflectivity 
diffuse signal 
increase 
large area of 
strong signal 
classic CNV +
 + - - - 
occult CNV + - + - - 
predominant/ 
minimal classic CNV 
+ + +2 - - 
RPE detachment + - +
2 +3 - 
RAP + - + - - 
IPCV + - - +
4 - 
fibrovascular scar ±
1 - - - + 
  
Table 4.1 
Key features of near-infrared reflectance in exudative macular degeneration. CNV=choroidal neo-
vascularization; IPCV=idiopathic polypoidal choroidal vasculopathy; FA=fluorescein angiogra-
phy; RPE=retinal pigment epithelium; RAP=retinal angiomatous proliferation; 1=dependent on 
residual leakage activity; 2=only occult lesion parts; 3=poor defined, ring-like appearance; 
4=vascular, elongated structures; 
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EXUDATIVE AGE-RELATED MACULAR DEGENERATION 
In general, active leakage from a CNV will result in fluid accumulation beneath and within 
the neuroretina.33 Visual function in macular edema, however, depends on the integrity of the 
retinal photoreceptor layer.34 In NIR imaging, the increased fluid content at the posterior pole 
amplifies the near-infrared light absorption and scattering.35 As a result, less light will reach 
the camera detector, causing regions with increased fluid exudation to appear darker on the 
NIR image.36 This reduced photoreceptor reflectivity in NIR in patients with macular edema 
is directly related to the severity of the edema.37 The area of leakage and edema on the fluo-
rescein angiogram corresponds to a dark, poorly defined halo around the CNV lesion on NIR 
imaging (fig. 4.5). We will now discuss the appearance of various types of CNV in AMD on 
the NIR image. The entity of idiopathic polypoidal choroidal vasculopathy will be discussed 
separately. 
Fig. 4.5 
Effect of fluid leakage on the NIR image 
of a CNV. A case of active leaking CNV 
documented by fluorescein angiography 
(A, B). The poorly demarked CNV (A) is 
surrounded by diffuse staining in the 
late phase angiography (B). The digital 
subtraction analysis clearly demarcates 
this fluorescein leakage area (C, ar-
rows), which correlates with the re-
duced near-infrared reflectance around 
the lesion (D, arrows). Note that the 
central part of stronger leakage is as-
sociated with a darker innermost NIR 
area. 
 
CLASSIC CHOROIDAL NEOVASCULARIZATION 
Before the introduction of anti-VEGF treatment of neovascular AMD, only classic CNV cases 
with well-defined borders were applicable for treatment by either focal laser coagulation or 
photodynamic therapy.38;39 Classic cases show high blood flow within the lesion and are sur-
rounded by a characteristic pigmented halo.40;41 These features account for characteristic find-
ings on NIR imaging of classic CNVs.42 
Classic CNVs are typically located anterior to the RPE43 and therefore, only little NIR light 
reflection and absorbance occurs, which accounts for a good visibility of the classic CNV 
lesion in the near infrared. A main attribute of classic CNV lesions in NIR appearance is the 
combination of a central dark core surrounded by a bright corona (fig. 4.6). The ring-shaped 
bright corona may be incomplete in up to one third of cases. The active neovascular process is 
depicted as a dark core due to the blood- and fluid-related light absorption in this area.  
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Fig. 4.6 ◙ 
NIR appearance of classic CNV as com-
pared to fluorescein angiography. This 
case of classic, parafoveal CNV shows a 
ring of increased NIR (upper panel, ar-
rowhead) that is co-located with early 
staining on FA (lower panel, left). The 
leakage zone on FA (lower panel, middle) 
and the dark halo on NIR (upper panel) 
match properly. The increased NIR at the 
fovea (arrow) points to a virtual anatomi-
cal integrity of this area (visual acuity 
20/25). As indicated by the red color on the 
difference map between FA leakage and 
NIR (lower panel, right), fluid accumula-
tion on NIR is only underestimated at hy-
per-reflective areas, however, comparable 
information on leakage is provided at the 
remaining fundus (blue hues). 
It has been shown that neovascular changes due to AMD may not only lead to hypertrophic 
RPE reactions, but also to exudation of fibrin in the area adjacent to the CNV.44;45 More so 
than melanin, fibrin is a relatively strong reflector in the near infrared.46 The bright nimbus 
surrounding classic membranes is only partially co-located with the funduscopically visible 
pigmented halo. For that reason the bright corona in NIR imaging of classic CNV lesions will 
probably reflect not only the hypertrophic RPE reaction but also the fibrin exudation. 
OCCULT CHOROIDAL NEOVASCULARIZATION 
The occult form of CNV is the most frequent neovascular lesion type in AMD.47 On the fluo-
rescein angiogram, occult CNVs are best characterized by the phrase “late leakage of unde-
termined source”. Based on the exact anatomical position of the membrane, light reflection, 
scattering and absorption all add to the near-infrared image.48 Contrary to classic lesions, oc-
cult neovascular membranes are poorly demarked and show overlying scattered NIR increase 
(fig. 4.7). On histology, occult CNV membranes are largely located posterior to the RPE.49;50 
On the surface of the occult CNV disseminated fibrin coagulates have been found, which may 
be related to the spotted NIR increase. Frequently observed alterations of the RPE and small 
drusen in occult CNV cases may also add to their NIR appearance. RPE loss, for instance, 
will cause increased choroidal reflectivity and drusen may decrease NIR focally. 
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Fig. 4.7 
NIR appearance of occult CNV. An eye with 
occult CNV on FA (lower panels) shows cha-
racteristic jagged NIR elevations within an 
area of decreased NIR signal (upper panel). 
Note that the lesion is poorly demarcated on 
NIR as well as on FA. In contrast to the majori-
ty of classic lesions, the dark halo on NIR in 
most occult CNV is less prominent due to only 
mild leakage activity. 
 
 
VASCULARIZED DETACHMENT OF THE RETINAL PIGMENT EPITHELIUM 
If an occult CNV is associated with massive fluid exudation beneath the RPE, a dome shaped 
RPE detachment may occur. Typically, a peripheral hyperfluorescent notch on fluorescein 
angiography suggests the presence of a CNV associated with such an RPE detachment.40 The 
optical appearance of a RPE detachment on NIR is determined by its anatomical contour, me-
lanin content and turbidity of the sub-RPE fluid. In addition, the appearance of the lesion is 
determined for a large part by the focus of the scanning laser ophthalmoscope.51 If the focal 
plane of the image is near the apex of the RPE elevation the lesion appears bright due to the 
light scattered by the pigment epithelium. However, if the image is focused deep to Bruch’s 
membrane, a dark core caused by light absorption within the turbid sub-RPE fluid will domi-
nate the lesion centre. The edges of the RPE elevation will appear bright due to the oblique 
position and associated scattering of the incoming light. This summation of melanin reflec-
tance and light scattering results in a strong NIR signal. Usually, a thin dark halo caused by a 
discrete serous retinal elevation surrounds the RPE detachment (fig. 4.8). In general, an RPE 
detachment will appear as round lesion with a centrally decreased reflectivity by turbid sub-
RPE fluid, delimited by a thin, brighter nimbus and bordered by a dark, irregular halo.52 As in 
occult lesions without RPE detachment, the CNV membrane is poorly defined. 
66 Chapter 4.1 
 
Fig. 4.8 
Vascularized RPE detachment. A case of occult 
CNV with associated serous RPE detachment 
(NIR, upper panel; FA, lower panels). The occult 
lesion has called up a fibrotic reaction with sec-
ondary retinal folds (arrow), leading to increased 
scattering and reflectivity in the near-infrared. The 
edges of the RPE detachment (arrowheads) ap-
pear brighter than the surrounding dark halo 
caused by sub-retinal fluid. The focal plane of the 
cSLO is located deep in the retina. Therefore, the 
turbid sub-RPE fluid causes the center of the RPE 
detachment to appear dark. 
 
MIXED TYPE CHOROIDAL NEOVASCULARIZATION 
In a minority of cases, a non-uniform type of  CNV will occur.53 In fluorescein angiography 
these membranes are classified into minimal classic and predominantly classic CNV lesions. 
In NIR, these mixed types show characteristics of both classic and occult CNVs (fig. 4.9). As 
in fluorescein angiography, the lesion type may be estimated by the area covered by the clas-
sic and occult portion, respectively. 
RETINAL ANGIOMATOUS PROLIFERATION 
Unlike regular exudative AMD, the neovascular membrane in retinal angiomatous prolifera-
tion (RAP) originates from the neuroretina.54 The formation of a CNV in RAP is therefore an 
inherently secondary process. Once the CNV has formed, the differentiation between non-
RAP and RAP lesions on NIR may become impossible. The neovascular membrane in the 
early pre-CNV stages of RAP, on the other hand, may show unique optical properties. In 
these early RAP cases focally increased NIR signals within a darkened, ill-defined area can be 
observed (fig. 4.10). This hyperreflection is most likely associated with the fibrinous material 
located within the edematous swollen retina surrounding the lesion, as demonstrated in histo-
logical preparations of RAP patients. Interestingly, some RAP cases show a much larger zone 
of decreased NIR than is to be expected from the corresponding fluorescein angiogram. This 
may be caused by abnormalities in the Müller cell population, resulting in an increase NIR 
light absorption prior to macroscopic thickening of the neuroretina or leakage on the fluo-
rescein angiogram.55;56 
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Fig. 4.9 
Minimal classic CNV lesion. In partial classic 
CNV cases, NIR (upper panel) shows proper-
ties of classic and occult membranes. Note that 
the area corresponding to the classic compo-
nent on FA (lower panels) appears as incom-
plete bright ring with a dark halo on NIR, 
while the occult parts cause poorly demar-
cated, incomplete NIR elevation within the 
darkened area of sub-retinal fluid (arrow). 
Fig. 4.10 
Retinal angiomatous proliferation. RAP le-
sions are typically best visualized on indocya-
nine green angiography (ICGA, lower panels). 
The new vessels initiate within the neuroretina 
and grow to the RPE and choroid, eventually 
leading to secondary CNV formation. The in-
tra-retinal vascular complex causes jagged 
NIR elevation within the halo of fluid exuda-
tion (upper panel, arrow). The additional RPE 
detachment without signs of CNV on ICGA is 
visible on NIR (upper panel, arrowheads). 
 
IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY 
The term idiopathic polypoidal choroidal vasculopathy (IPCV) stands for a separate clinical 
entity that differs clinically and demographically from AMD.57 ICG and OCT studies re-
vealed that polypoidal vascular lesions of the choroid are associated with serious and hemorr-
hagic RPE detachments.58;59 
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Fig. 4.12 
Fibrovascular scar. After treatment a fibro-
vascular scar remains as leftover of the CNV. 
This formerly classic lesion has partially kept 
the appearance of a bright ring on NIR (upper 
panel). Some parts of the membrane still show 
some perfusion on FA (lower panel), however 
others do not (open arrow). These avascular 
components appear highly reflective on NIR 
due to their increased content of collage fibers 
(arrow). 
Fig. 4.11 
Idiopathic polypoidal choroidal vasculopathy. 
In idiopathic polypoidal choroidal vasculopa-
thy vascular structures may be detected in NIR 
(upper panel, arrow), typically located nasally 
from the macular area. These structures corre-
late with the polypoidal vessel abnormalities 
identified on ICGA in the early phase (lower 
panel, open arrow). A corresponding RPE de-
tachment causes characteristic NIR affections 
comparable to those in figure 4.8. 
The variable presentation of IPCV gives rise to equally variable NIR images. RPE detach-
ments and serous retinal elevations have a similar aspect as vascularized RPE detachments in 
AMD. However, the localization and the source of the underlying subretinal structures sepa-
rate IPCV from a regular AMD-associated RPE detachment on NIR imaging (fig. 4.11).  The 
polypoidal structures can be identified by their increased signal on NIR that collocates with 
their position on indocyanine green angiography. The bright reflex represents the typically 
elongated, large vessel-like structures, as opposed to the adjacent small-sized signals of RPE 
alterations and the large, round reflexes of RPE detachments. 
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FIBROVASCULAR SCAR 
Following treatment or in the later stages of a wet AMD, a degenerative process will lead to 
vessel occlusion and the development of scar tissue within the neovascular lesion. This scar 
consists of dense fibrous tissue, possibly surrounded by fibrinous exudations.60 Higher levels 
of collagen fibers will lead to increased scattering and reflectance within tissue, consequently 
enlarging the NIR signal.61 Therefore, fibrovascular scars can be identified by their excee-
dingly bright appearance on NIR imaging (fig. 4.12). Dependent on residual elevation of the 
overlying retina, a dark halo may be observed in the vicinity of the scar. In addition there may 
be co-existing active parts of a CNV with the typical NIR manifestations as described above. 
CHOROIDAL NEOVASCULARIZATION NOT ASSOCIATED WITH AMD 
A variety of other disorders like high myopia, retinal dystrophies, uveitis, or idiopathic gene-
sis may account for the development of CNV.62-64 The majority of these neovascularizations 
appear to be of the well defined classic type. Coexisting retinal changes associated with un-
derlying disorder, however, may confuse the interpretation of the NIR image. For instance, 
non-neovascular fundus lesions like inflammatory spots may also have increased fluid content 
and cause a locally elevated retina, giving rise to NIR abnormalities not unlike CNVs. 
EVALUATING THERAPEUTIC EFFECTS  
WITH NEAR-INFRARED REFLECTANCE IMAGING 
The evolving new therapeutic strategies in CNV treatment require repeated imaging of the 
fundus to monitor the treatment effects and to aid in the appropriate timing for re-treatment.65 
Besides fluorescein angiography as the gold-standard for the assessment of CNV activity, 
OCT has become a widely accepted non-invasive tool in the evaluation of AMD therapy.66 
However, OCT data are not directly comparable to fluorescein angiography results due to 
their essential differences. Besides the static character of the anatomical OCT image, the huge 
memory capacity needed for modern three-dimensional OCT may be a drawback. Fluorescein 
angiography evaluates the functional aspects of the CNV by dynamic imaging of the amount 
of exudation, but does not provide anatomic information on retinal thickening.  
NIR imaging, on the other hand, will cover both functional (leakage) and anatomical (thicken-
ing) aspects of CNV membranes by non-invasive means. The amount of storage capacity 
needed is minimal compared to 3D OCT (usually between 20 and 800 kilobytes as JPEG and 
TIFF files, respectively). Changes in leakage as well as decrease of retinal thickening both 
will influence the NIR signal. These changes can be assessed by digital subtraction analysis 
and may be used for monitoring the CNV treatment (fig. 4.13). Just as in fluorescein angio-
graphy, an en face image is provided and allows mapping of sub- and intraretinal fluid and 
thickening. Other than OCT volume scan, the rapid image acquisition minimizes artifacts due 
to eye movements. Still, the specificity and sensitivity of NIR in CNV treatment monitoring 
has to be verified by prospective studies. 
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Fig. 4.13 
Follow-up of bevacizumab therapy with NIR. During successful treatment of active CNV leakage 
of fluid will regress and scarring may come up. This example illustrates the accompanying NIR 
changes in a patient with a small, occult lesion. Pre treatment (A) a considerable dark halo is 
present around the CNV. After three sessions of intravitreal bevacizumab, the dark halo has 
largely disappeared (B). In addition, the center of the lesion shows increased NIR due to scar-
ring. The difference in NIR can be illustrated by a subtraction map, which shows increased NIR, 
thus reduced fluid leakage, as white pixels (C). 
 
CONCLUSIONS  
NIR imaging by confocal scanning laser opthalmoscopy offers a rapid and non-invasive way 
to depict sub-retinal changes of the ocular fundus in exudative macular degeneration. As in 
fluorescein angiography, NIR provides information on the area of leakage, which appears as a 
dark halo around a lesion. In addition, data on the nature of the CNV (well-defined or occult) 
could be derived by NIR in a non-invasive way. Retinal thickening, inherently invisible on 
fluorescein angiography, also leads to changes on NIR images and could be correlated to 
OCT findings. Following successful CNV treatment the NIR image changes occur due to re-
duction of leakage and the formation of the fibrinous scar. Even though NIR study results 
seem promising, the clinical significance of NIR imaging in CNV evaluation and treatment 
remains to be proven in large patient samples in a masked, prospective way. The sensitivity 
and specificity of this promising new technique still needs to be compared to established me-
thods of investigation, such as fluorescein angiography and OCT. 
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ABSTRACT 
PURPOSE: To evaluate various types of neovascular age-related macular degeneration 
(AMD) by near-infrared fundus reflectance (NIR) as compared to fundus fluorescein angio-
graphy (FFA) and to test NIR for assessment of leakage due to choroidal neovascularization 
(CNV). 
PATIENTS AND METHODS: Thirty-three patients with neovascular AMD (cases) and 
20 age-matched patients with non-exudative AMD and healthy subjects (controls) were ex-
amined with a confocal scanning laser ophthalmoscope (Heidelberg Retina Angiograph 2). 
NIR images of neovascular AMD were qualitatively compared to the corresponding FFA and 
to age-matched controls. CNV membranes and exudation areas were manually segmented on 
FFA and NIR and analyzed quantitatively. 
RESULTS: Of all cases included, 5 eyes had classic CNV, 6 minimal classic lesions, 15 
occult CNV’s and 7 eyes had retinal angiomatous proliferation (RAP). A dark halo on NIR 
was found in all cases and showed high correspondence to leakage on FFA (r2=0.93; 
p<0,0005). In classic CNV and minimal classic CNV, the classic part of the lesion on FFA 
revealed strong correlation to a dark core surrounded by a bright reflecting ring on NIR 
(r2=0.88; p<0.0005). Occult parts on FFA of minimal classic CNV and occult CNV lesions 
appeared as poorly demarcated, jagged areas of increased NIR. RAP was characterized by 
speckled NIR located at the intraretinal neovascular complex. 
CONCLUSIONS: NIR imaging in neovascular AMD revealed characteristic alterations 
depending on the type of CNV. These changes may reflect histological differences of the le-
sions. Leakage caused local darkening of NIR, presumably originating from increased light-
scattering and absorbance by fluid accumulation and sub-cellular structure alterations. 
INTRODUCTION 
Age-related macular degeneration (AMD) is the most important cause of legal blindness in 
elderly citizens of industrialized countries.1-3 Progression of dry AMD to the neovascular 
form will lead to rapid and severe loss of central vision, and the overall prevalence of ad-
vanced age-related macular degeneration is predicted to grow another 50% by the year 2020.4 
Recent developments of new therapies for neovascular AMD have led to dramatic improve-
ments in visual outcome of patients.3;5 Modern high-quality AMD management, however, 
depends on accurate information about the neovascular activity. Therefore, detection and 
tracking of subretinal fluid caused by choroidal neovascularization (CNV) is crucial for eval-
uation and treatment of neovascular AMD. 
In contrast to normal retina, the pathologic vessels of a CNV in neovascular AMD lack tight 
inter-endothelial junctions and therefore leak.6 As a consequence, the surrounding retina may 
be thickened and serously elevated, a condition that eventually leads to visual impairment. 
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Fundus fluorescein angiography (FFA) has been the leading technique for diagnosis and fol-
low-up of patients with neovascular AMD within the last decennia.  FFA is used to evaluate 
the type of CNV and the presence of fluid leakage in neovascular AMD. However, classifica-
tion of CNV by FFA shows significant intra- and inter-observer variability and therefore, it 
may not always be consistent enough for treatment evaluation.7 In addition, intravenous dye 
application is necessitated for complete FFA, which makes the investigation inherently inva-
sive. 
Optical coherence tomography (OCT) has been suggested as an alternative, non-invasive im-
aging approach for neovascular AMD with relatively high intra- and inter-reader agreement.8 
Even though recent advances in OCT technology have facilitated three-dimensional CNV 
reconstruction,9 data on CNV evaluation by OCT are not directly comparable to FFA and 
there may be extensive disagreement between FFA and OCT in evaluating CNV leakage.10 
This is mainly because FFA and OCT evaluate essentially different aspects of neovascular 
AMD.  FFA assesses fluid leak directly and therefore images the functional aspect of a CNV, 
whereas indirect tissue effects like retinal thickening, elevation and cyst formation can be 
determined by OCT. Because such tissue alterations may also result from other pathological 
conditions in AMD, some OCT changes might not necessarily be the effect of active CNV 
leakage. 
Confocal near-infrared fundus reflectance (NIR) is a non-invasive en face imaging technique 
capable to visualize sub-retinal pathology.11 NIR has been used as rapid, non-invasive tech-
nique for imaging of neovascular AMD without injecting contrast enhancing dyes or pupil 
dilation.12 Recently, specific changes in NIR image contrast and reflectivity have been ob-
served in AMD compared to healthy eyes, and NIR was found superior to standard color fun-
dus photography in screening for neovascular AMD.13 
Several changes of NIR may be expected in neovascular AMD due to light-tissue interactions. 
Even though a variety of different types of neovascular AMD have been examined by NIR in 
the past,11-15 a detailed description of NIR compared to FFA as the gold standard diagnostic 
technique in AMD is lacking. Our present paper aims to provide a qualitative and quantitative 
analysis of NIR alterations and their correlation to FFA changes in different types of neovas-
cular AMD, including assessment of lesion type and leakage. 
MATERIALS AND METHODS 
We performed a prospective, observational study of NIR and FFA in patients with newly di-
agnosed neovascular AMD who presented at our department between June 2007 and January 
2008 and were willing to participate.  Healthy individuals as well as patients with non-
exudative AMD served as controls.  Patients with prior treatment for AMD or questionable 
leakage were excluded. Our investigation was in accordance with the tenets of the Declaration 
of Helsinki and local ethics committee approval was obtained.  
A second generation confocal scanning laser ophthalmoscope (Heidelberg Retina Angiograph 
2, HRA 2, Heidelberg Engineering, Heidelberg, Germany) was used to obtain both FFA and 
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NIR images.  The field of view was 30 × 30 deg and two different laser sources were applied 
to illuminate the ocular fundus for imaging, which is an 830 nm diode laser for NIR and a 
solid-state 488 nm laser with a barrier filter at 500 nm for FFA.  All image processing and 
analysis was carried out using public domain software (ImageJ, v1.41d, available at 
http://rsb.info.nih.gov/ij). For statistical analysis SPSS 16.0 for Windows (SPSS inc., Chica-
go, IL, USA) was used. The Shapiro-Wilk test was used to control quantitative data for nor-
mality. Correlations between FFA and NIR measurements were visualized by scatter plots 
and calculated by Pearson’s correlation coefficient (PCC) at the 0.01 level. To compare mean 
region measurements of FFA and NIR, the paired samples t-test was applied. 
All images were acquired at the high-quality mode of HRA 2, which resulted in an original 
size of 1536 × 1536 pixels. Since no quantitative gray-value analysis was intended, images 
were not standardized for any confounders of image brightness like acquisition sensitivity or 
pupil diameter. Images were checked for eye motion artifacts and centration errors before 
inclusion for analysis. In case of instable fixation vessels may be imaged discontinuously and 
fundus structures may be distorted, which might lead to false measurements. Decentered im-
ages suffer from uneven illumination and may impair segmentation due to reduced local con-
trast. Therefore, images with the above artifacts were excluded. 
For topographic inter-image comparison, images were resized by bi-cubic interpolation. For 
this purpose, the distance from the temporal optic disc margin to the fovea was standardized 
to 500 pixels. This distance has been shown to be a highly reliable anatomic marker of 3000 
microns.16 As a result, all images studied had a standardized retinal dimension of 6 microns 
per pixel independent of acquisition properties and refraction errors. 
FFA images were classified by a highly experienced examiner (CH) into classic , minimal 
classic , occult  or retinal angiomatous proliferation (RAP) lesions. To reduce intra-observer 
variability,7 all FFA images were presented twice within two weeks in a masked, randomized 
fashion. Images of eyes that were not classified identically both times were rejected. Then, 
equally interpreted FFA’s and corresponding NIR images were taken for further analysis. 
As a first step, NIR images were qualitatively weighted against normal subjects and dry 
AMD. For this purpose, a series of age-matched eyes (10 healthy and 10 dry AMD cases on 
FFA) were taken for comparison, and cases were presented to a single observer (TT) in a ran-
domized and masked fashion. In this qualitative image analysis, special attention was paid to 
dissimilarities in NIR patterns between neovascular and dry cases.  
For area measurements, segmentation was performed manually in ImageJ by polygon selec-
tion. All selections were spline fit to minimize the error of linear interpolation between indi-
vidual segmentation points.17 The borders of classic CNVs or classic parts of minimal classic 
CNVs were segmented on early venous phase FFAs, and fluorescein leakage was measured 
on FFA images taken between 7 to 8 minutes after dye injection. To identify active fluoresce-
in leakage, early venous FFA was compared to late-phase FFA of the tested eye. In NIR, a 
central dark core, the surrounding bright halo and a large darkened area were segmented, if 
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identified. To reduce bias, all NIR images were first analyzed and segmented by the masked 
observer (TT) without knowledge of the FFA images. Subsequently, all FFA segmentation 
was done one week later on a randomly changed image sequence. Segmented areas were 
measured and results were statistically analyzed. 
To demonstrate the feasibility for measuring therapeutic effects with NIR, we compared a 
series of NIR and FFA before and after application of intravitreal injection of a vascular endo-
thelial growth factor inhibitor (bevacizumab) in an eye with a RAP lesion. Digital subtraction 
maps allowed objective measurements of reflectance change on NIR parallel to diminished 
leakage on FFA. Measurements were based on images made with dilated pupil as well as 
standardized camera sensitivity, laser power and camera-cornea distance. 
RESULTS 
Figure 4.14 illustrates the NIR appearance of controls and study eyes after qualitative judg-
ment made by one observer looking to all patients and controls in a masked and randomized 
order. After rejection of 1 eye due to intra-observer disagreement in FFA classification and of 
3 images because of bad NIR image quality, data analysis was based on 33 eyes (17 right and 
16 left eyes) with neovascular AMD, including 5 eyes with classic CNV, 6 eyes with minimal 
classic CNV, 15 eyes with occult CNV and 7 eyes with RAP lesions, and 20 controls (10 dry 
AMD and 10 healthy eyes, 5 right and left eyes in each subgroup). 
In normal eyes (figure 4.14A), NIR appeared homogenously dispersed over the posterior pole, 
with a slight decrease of reflectivity at the fovea. Some discrete, plaque-like increase of the 
NIR signal could infrequently be observed at the posterior pole. In contrast, eyes with dry 
AMD did not show a foveal NIR decline, and drusen appeared as disseminated, spotted NIR 
signal decreases (figure 4.14B). As in healthy controls, large areas of NIR reduction were 
missing. 
All neovascular lesions (figure 4.14,C-F) showed a dark halo around the center of the angio-
graphically visible lesion. This darkened area was largely identical with the leakage zone on 
FFA. In all cases of classic CNV and minimal classic CNV, a lesion with a dark core bor-
dered by a highly reflecting ring was visible and collocated to the classic CNV part on FFA 
(figure 4.14,C-D). However, the reflectivity of the bright halo could be partially reduced in 
the minimal classic CNV cases. The occult parts of minimal classic CNV cases as well as 
occult CNV lesions without detachment of the retinal pigment epithelium (RPE) appeared as 
jagged areas of scattered NIR increase without definite borders to the surrounding fundus 
(figure 4.14D-E). In cases of RPE detachment, a sharp bordered, oval structure was observed, 
which showed slightly increased NIR towards its relatively ill-defined boundaries. In RAP 
lesions, the intraretinal vascular complex appeared to cause a speckled focal increase of NIR 
(figure 4.14F), however, this reflectance could not easily be separated from the NIR changes 
by a co-existing occult CNV, if present. 
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Fig. 4.14 
FFA and NIR in controls and AMD 
cases. Illustration of early phase (I) and 
late phase (II) FFAs compared to NIR 
(III). In normal eyes (A) NIR is homo-
geneous with a slight foveal dip (ar-
row). In dry AMD (B), no central dip 
was visible, but drusen caused dissemi-
nated small NIR decreases (arrows). In 
exudative AMD (C-F), a dark halo was 
present around the central lesion, cor-
responding to late leakage on FFA. 
Note the dark core surrounded by a 
bright corona in NIR of classic CNV (C) 
and the classic part of minimal classic 
CNV (D). The dark halo corresponding 
to intraretinal fluid in C contents a 
brighter, halo-like area of “normal” 
NIR, comparable to the surrounding 
fundus. This is probable due to fluid 
separation within the retina around the 
lesion. Occult lesions (E) revealed 
poorly demarcated speckled areas of 
increased NIR (arrows). The intraretin-
al vascular complex in RAP (F) ap-
peared as small, focal NIR increase. 
The area of leakage on FFA is smalle 
than the dark halo on NIR (arrows). 
The plaque of high NIR under the lea-
kage zone corresponds to a clinically 
visible choroidal nevus. Images were 
contrast enhanced for improved feature 
visibility. 
Table 4.2 specifies detailed results on NIR and FFA measurements of the study eyes with the 
linear regressions shown in figure 4.15. On NIR, precise segmentation of occult lesions, RAP 
and RPE detachments was not possible in most cases, and therefore, quantitative analysis was 
restricted to leakage areas in these patients. 
All quantitative results were normally distributed and analyzed by the paired-samples t-test. 
In general, NIR tended to underestimate CNV size when only the dark lesion core was com-
pared to FFA. This was statistical significant only for minimal classic lesion parts p=0.004). 
On the other hand, CNV assessment by NIR resulted in significant overestimation as com-
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pared to FFA when the bright halo was included in classic lesions (p=0.001). Leakage zones 
on FFA tended to be smaller than the darkened perilesional halo on NIR in all CNV types, 
however, this was only statistically significant in occult lesions and RAP (p<0.005 in both 
groups). There was strong correlation between the areas of angiographically visible classic 
CNV and the classic part of minimal classic CNV lesions on the one hand and the dark core 
lesions surrounded by bright halos evident on NIR (r2=0.62; p=0.007) on the other. The corre-
lation appeared to be even better if the bright rings were included into the measurements 
(r2=0.88; p<0.0005). High correlation was observed between the large, darkened areas sur-
rounding the neovascular lesions in NIR if weighted against the zones of late leakage on FFA 
(r2=0.93; p<0.0005). Digital subtraction analysis of NIR images of a RAP lesion before and 
after bevacizumab treatment showed reflectance elevation on NIR parallel to leakage decrease 
in FFA (figure 4.16). 
 
FFA classifi-
cation 
CNV size 
[FFA] 
(95% CI)* 
DC [NIR] 
(95% CI)* P† 
DCC [NIR] 
(95% CI)* P† 
Leakage [FFA] 
(95% CI)* 
DH [NIR] 
(95% CI)* P† 
CL 
0.87     
(0.02-1.71) 
0.61 (0.09-
1.14) 
0.11 
(0.25) 
1.10 (0.34-
1.85) 
0.001       
(-0.23) 
4.88         
(3.60-6.16) 
5.28      
(4.24-6.33) 
0.51      
(-0.41) 
MC 
0.86     
(0.46-1.26) 
0.38 (0.26-
0.50) 
0.004 
(0.49) 
0.90 (0.62-
1.17) 
0.82        
(-0.03) 
10.22       
(6.12-14.32) 
10.68    
(7.37-
13.99) 
0.51      
(-0.46) 
OC NA NA NA NA NA 
12.78     
(11.06-14.51) 
14.00  
(12.12-
15.88) 
< 0.0005   
(-1.22) 
RAP NA NA NA NA NA 
4.25         
(3.43-5.06) 
7.75      
(6.34-9.17) 
< 0.0005   
(-3.50) 
Table 4.2  
Area measurements in exudative AMD. * = means of areas (mm²) are presented together with their 95% confi-
dence intervals; † = p-values (and magnitude) of paired differences between NIR imaging and FFA; CL = clas-
sic lesion; DC = dark core measured without bright corona; DCC = dark core measured with bright corona; 
DH = dark halo around lesion; MC = minimal classic lesion; NA = not appropriate; OC = occult lesion; RAP = 
retinal angiomatous proliferation 
DISCUSSION 
The ocular fundus includes a variety of absorbing, reflecting and scattering structures, which 
contribute to NIR and may vary considerably between individuals.18;19 In contrast to visible 
wavelength illumination, fundus reflectance may be up to ten times higher in the near infrared 
and is then largely independent of melanin content, which advances the visibility of deep fun-
dus structures.11;20 In the present study, NIR images of patients with neovascular AMD were 
analyzed and compared to lesion features on FFA. 
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A characteristic of neovascular membranes in AMD is intra- and subretinal fluid leak from 
the CNV vessels, which may be observed as fluorescein extravasations on FFA. In our present 
study, darkened, ill-defined areas on NIR surrounding the angiographically visible CNV 
showed high correlation with the late leakage zone on FFA. This area of reduced NIR may 
also overlap the CNV in cases of occult lesions. Increased contents of fluid or blood will ab-
sorb near-infrared light.11 In addition, leakage through fenestrated endothelia, as present in 
CNV membranes, will result in protein-rich fluid accumulation and for that reason, light-
scattering will add to NIR decrease in the surrounding of an actively leaking CNV.14  
The halo of reduced NIR by CNV related fluid leakage may show areas of NIR near to nor-
mal in single cases, which may be related to various reasons. First, a reactive proliferation of 
the underlying RPE may lead to increased NIR and may compete NIR attenuation by fluid. 
Second, irregular fluid accumulation may result in unequal distribution of light absorption and 
scattering within the retina, thus leading to irregular shaped NIR reduction. Summation of 
several optical effects may occasionally complicate the detection of fluid related halos on 
NIR. 
Fig. 4.15 
Linear regression curves of CNV and leakage areas on FFA and NIR images. Illustration of lesion 
areas measured on FFA as compared to NIR. Panels A and B show data on the measures of classic 
neovascular membranes only without the corresponding leakage zones. There is good correlation 
between NIR and FFA when the size of the central dark core is compared to FFA lesion size (A). 
However, the correlation between FFA and NIR improves when the bright corona on NIR is added 
to the area measurements (B). In all cases, high correlation was observed between leakage area 
on FFA and the dark halo on NIR surrounding the lesion (C). 
In our series, the halo of reduced NIR was significantly larger than the leakage zone on FFA 
in occult CNV and even more in RAP lesions. This may be caused by several reasons. Occult 
membranes are located within the choroicapillary layer and RPE on OCT.21 Typically, the 
retina appears less thickened and flatter in occult CNV than in other types of neovascular 
AMD,22 which points to only mild membrane activity and leakage in most cases. FFA is ca-
pable to report relatively high leakage activity within several minutes; however, it will proba-
bly miss slow fluid accumulation in the surrounding. On the other hand, NIR may detect opti-
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cal changes associated with increased fluid content and therefore, affected areas of chronic 
leakage may appear larger than on FFA, especially in slow leaking occult lesions. 
In cases with RAP, reactive, sub-cellular changes within the Müller cells may occur.23 Such 
microscopic changes may increase scattering and light absorption within the inner retina prior 
to macroscopic thickening of the retina24;25 and thus, lead to darkened areas on NIR that may 
appear larger than the leakage zones detected on FFA. 
within the retinal glia cells may add to reduced NIR by increase of intra-cellular light scat-
te
In  
by i-
ca
The total reflection of light by the ocular fundus can be divided into a directional and a non-
directional part, each of which contribute to the total fundus reflectance by roughly the half.26 
Lessening of directional retinal light reflection possibly contributes to focal NIR decrease in 
neovascular AMD, as macular edema will confuse retinal symmetry and therefore, total retin-
al NIR may be even more decreased in such fundus regions. In addition, edematous changes 
Fig. 4.16 ◙ 
Follow-up during intravitreal anti-VEGF therapy of a RAP lesion. The left image faction shows 
early (left column) and late phase FFA (middle column) as well as NIR (right column) before (A-
C) and after three (D-F) and six (G-I) intravitreal applications of bevacizumab. Late leakage on 
FFA becomes markedly reduced (B,E,H) whilst the initial dark halo on NIR disappears (C,F,I) 
during treatment. Digital subtraction analysis of the standardized NIR images illustrates the in-
crease of NIR around the RAP lesion after the first treatment series (J, yellow-red spots). Some 
foci of extreme NIR elevation, which appear as lipid exudates on funduscopy (L-M), disappear in 
the due course (K, blue spots). Images were contrast enhanced for improved visualization. 
r.24  
 accordance with previous studies, all classic parts of the CNV lesions were characterized
 a dark core surrounded by a bright reflecting, ring-shaped halo in NIR.11;14;27;28 Histolog
l analysis of excised neovascular membranes has revealed ultrastructural differences be-
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 increased NIR (figure 4.17). This gives the im-
pression that melanin may not contribute significantly to NIR in classic CNV. Therefore, we 
believe that fibrin, and not melanin, should be considered the most important reflector to 
cause the bright CNV halo of NIR images. 
 
IR elevation was observed at the borders of the RPE detachment (figure 
tween classic and occult cases in AMD.29 In detail, classic lesions were fibrovascular com-
plexes located predominantly anterior to the RPE, and appeared to be surrounded by fibrin 
and hyperplastic, melanin-consisting RPE. The blood-rich center of such a lesion will absorb 
near-infrared light and therefore, will appear darker. Fibrin and melanin, on the other hand, 
are considered potent reflectors in the near-infrared,30 and may therefore be represented by the 
bright corona of the classic CNV lesions. We compared the color fundus photographs of the 
classic CNV cases to the corresponding NIR images, and we found only poor co-localization 
of dark pigmented lesion components with
 
 
In contrast to classic CNV cases, occult CNVs appeared as poorly demarcated areas of scat-
tered NIR increase. In histology, occult lesions turned out to be essentially located beneath the 
RPE, and fibrinous material was spread diffusely over the entire surfaces of the fibrovascular 
membranes.29 Assuming fibrin as the major reflecting substance in NIR of neovascular AMD, 
the scattered pattern of increased NIR observed in the occult CNV cases here reflects the ear-
lier reported ex vivo observations. In those cases that RPE detachment was present, only a 
slight, diffuse N
Fig. 4.17 ◙ 
Illustrated co-localization analysis of melanin and increased NIR in CNV. In a classic CNV 
case, regions with increased pigmentation on color fundus photograph (A) and areas of in-
creased NIR (C) were segmented by thresholding and superimposed after image alignment (B). 
Total areas summed up to 0.44 mm², where 0.32 mm² accounted to melanin and 0.25 mm² to 
NIR increase. Both areas shared 0.14 mm², which resulted in a co-localization of 32%.  Images 
were contrast enhanced for better performance.  Segmented layers (B): green = melanin, red = 
NIR increase, yellow = shared pixels of melanin and NIR increase 
4.18). A possible explanation may be that the RPE will be observed more oblique at the bor-
ders of its detachment and therefore, any reflections from this area will sum up and increase 
the NIR signal. 
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Cases of RAP showed speckled NIR increase at the intraretinal part of the lesion. Histology of 
such eyes revealed fibrinous material around the neovascular complex within the retina.31 
Like in other cases, this supports fibrin as a main contributor to increased NIR at or around 
low ng more infrared light to return to the camera. 
Other than FFA, NIR does not suffer from non-leakage staining, which may be a confounder 
dy, to investigate whether NIR could help to detect leakage activity 
and to distinguish between several types of neovascular AMD. Still, the usefulness of NIR for 
neovascular AMD evaluation in daily practice remains to be determined by sensitivity and 
specificity assessment. 
neovascular AMD lesions. Because most RAP cases were associated with occult CNV, a pre-
cise localization of intraretinal NIR increase was impossible due to jagged NIR enhancement 
of the sub-RPE part of the membrane. 
Reduction of leakage due to bevacizumab treatment of neovascular AMD could be demon-
strated by digital subtraction analysis of NIR achieved before and after treatment. In detail, 
previously reduced NIR collocated with the leakage zone on FFA increased and documented 
the therapeutic effect in a non-invasive way. Reduced fluid content and retinal thickening led 
to less absorption and scattering thus al i
in FFA interpretation after CNV treatment.32 Therefore, NIR appears a good candidate for 
follow-up of neovascular AMD therapy.  
Various limitations of the present study have to be addressed. First of all, the yet incomplete 
understanding of CNV reflectivity in the near infrared limits the interpretation of our results. 
Like in previous investigations, the interpretation of our NIR results relied on funduscopy and 
FFA,11;15;27;30 but not on direct comparison with histology. Future studies have to address the 
topographically oriented spectral properties of NIR in neovascular AMD in comparison to ex 
vivo histology and basic optical research on reflecting substances. Secondly, the optic proper-
ties of candidate reflectors like fibrin and melanin were hitherto not compared directly. Misin-
terpretation of foci of increased NIR is therefore possible. However, this does not conflict 
with the goal of this stu
Fig. 4.18 
Dome shaped RPE detachment on NIR and 
OCT. The RPE detachment is visible as a slight, 
diffuse NIR elevation with a dark center, corres-
ponding to a dome shaped elevation of the RPE 
on OCT. The tip of the RPE detachment shows 
increased NIR due to focal light reflection. The 
lesion is surrounded by a dark halo, corres-
ponding to subretinal fluid on OCT. The black 
line indicates the location of the OCT scan. 
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In conclusion, NIR revealed characteristic optical changes of the fundus in neovascular AMD. 
By this, NIR allowed to detect leakage from active CNVs. Furthermore, distinction between 
different types of neovascular AMD was possible and good spatial correlation to FFA was 
given in cases with classic or minimal classic CNV. It appears likely, that fibrin is the main 
contributor to NIR increase associated with neovascular AMD. A halo of reduced NIR around 
the CNV may origin from light scattering and absorption within and beneath the retina due to 
fluid accumulation and structural tissue disorder. Masked and longitudinal studies should test 
NIR as additional, non-invasive imaging technique for therapeutic studies of neovascular 
AMD with the potential of refined phenotyping by imaging of sub- and intra-retinal changes. 
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INTRODUCTION 
Fluorescence is a fascinating optical property of materials caused by light of a certain 
wavelength (excitation light) and characterized by the emission of light of a different 
wavelength. Physically, fluorescence occurs when electrons of a molecule absorb energy from 
excited light photons and in so doing are moved from their ground state to a higher level 
(excited state), which is less stable. The duration of the excited state, called fluorescence 
lifetime, is usually very short and seldom lasts longer than a few nanoseconds. The electron 
returns to its ground state under emission of light (fluorescence) and oscillation (heat). As 
only part of the original light energy is emitted, the fluorescence light is normally of longer 
wavelength (lower energy) than the exciting light. Excitation and fluorescence are defined by 
Equations 3 and 4, respectively, where S0 is the ground state, S1 is the excited state, Eex is the 
exciting and Eem the emitted photon energy (dependent on wavelength) and Eosc the 
oscillatory energy. 
ܵ଴ ൅  ܧ௘௫ ՜  ܵ  
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The difference between the energy maxima of the absorbed and emitted light is called Stokes-
shift. Typically one photon per molecule is absorbed. In this case the wavelength of the 
emitted photon is longer than that of the absorbed photon (Fig. 5.1). When two photons at a 
time are absorbed, one photon is destroyed and the emitted light has a shorter wavelength than 
the exciting light (anti-Stokes-shift). This effect is used in microscopy for so-called two-
photon excited autofluorescence.1 
 
Fig. 5.1 
Diagram to illustrate the Stokes shift of a 
given fluorescent sample with one absorbed 
photon per molecule.  
The emitted light is usually of lower brightness than the reflected light and the fluorescence 
signal is dominated by the reflected light. Therefore, fluorescence can only be observed by the 
use of filters that block reflected light (i.e. light of the exciting spectrum).  
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SOURCES OF OCULAR FUNDUS AUTOFLUORESCENCE 
The spontaneous fluorescence of substances in biological tissues is called autofluorescence. A 
lot of pathologic and physiologic substances, called fluorophores, may elicit autofluorescence. 
Autofluorescence of the ocular tissues was first detected with microscopy by viewing a 
specimen with a blue-light filter.2 Fundus autofluorescence (FAF), i.e. en face viewing of the 
autofluorescence phenomenon in the living eye, was first observed in the short wavelength 
spectrum when fluorescein angiography was used for diseases with large amounts of ocular 
fluorophores.3 Later FAF was also observed in the near-infrared spectrum of light when 
Indocyanine green angiography was used.4 However, due to the weak signal of FAF, 
clinically useful images could only be obtained after the invention of the SLO. 
In general, short-wavelength induced FAF (SW-FAF) and near-infrared FAF (NIR-FAF) can 
be applied. Best results are achieved with a cSLO, and the HRA 2 is typically used for FAF 
imaging. Alternatively, a modified fundus camera may be used. However, due to the 
dissimilar imaging modalities and the differences between exciting and emission spectra the 
results of both imaging techniques may not be directly compared. The technical parameters of 
both methods have been extensively described elsewhere.5 
LIPOFUSCIN 
Lipofuscin is a yellow-brown pigment stored as cell senescence product. In the eye, lipofuscin 
is accumulated within the lysosomes of the retinal pigment epithelium (RPE) as a non-
degradable end product of photoreceptor metabolism.6 Degradation and shredding of 
photoreceptor outer segments (POS) with subsequent phagocytosis by the RPE is a lifelong 
process, and billions of POS may be phagocytozed per RPE cell.7 Therefore, lipofuscin 
accumulates during a lifetime within the RPE as a physiological ageing process. However, 
lysosomal dysfunction, autophagy and cellular stress may increase the accumulation of 
lipofuscin and finally cause retinal dysfunction.6 
RPE lipofuscin biosynthesis is part of the visual cycle on the POS and is therefore enhanced 
by light and vitamin A. Photooxidation of lipofuscin can lead to increased photoreactivity and 
finally to retinal damage.8 The biochemical composition of RPE lipofuscin is still largely 
unknown; however, A2E (C43H58NO) was identified as the main fluorophore of RPE 
lipofuscin.9;10 A2E absorbs light of the ultraviolet and blue spectrum and emits a relatively 
strong yellow-orange fluorescence.11 However, it has been suggested that as yet unknown 
fluorophores other than A2E may significantly contribute to lipofuscin autofluorescence.12 
The emission spectrum of RPE lipofuscin depends on age and shows an increase of 
fluorescence and a right-shift during life.13 These in vitro observations were paralleled by 
investigations by Delori et al., who found increase of FAF during lifetime.14 However, 
excitation and emission spectra were slightly right-shifted in vivo. The latter results suggest 
lipofuscin to be the major fluorophore responsible for the physiologic appearance of SW-
FAF. 
There is evidence that FAF, at least under pathological circumstances, may not only be based 
on lipofuscin fluorescence from the RPE.15 Multispectral FAF revealed a number of 
additional fluorophores that contribute to FAF appearance and these should be considered for 
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FAF interpretation.16 This study showed a green fluorescence of Bruch´s membrane, outer 
retina and Drusen as well as from the choroid, which was observed besides the yellow-orange 
emission of the RPE. The green autofluorescence appeared weaker than the RPE 
autofluorescence and its distribution was comparable to lipofuscin distribution in healthy eyes 
but could be very dissimilar in retinal diseases. Further studies could discriminate oxidized 
flavin adenine dinucleotide (FAD), advanced glycolation end-products (AGEs), collagens and 
elastin within the short emission spectrum.17 While imaging with the HRA 2 will include all 
autofluorescent materials of the fundus (filter at 500 nm), FAF imaging using the modified 
fundus camera (filters at 675 nm and 615 nm, respectively) will only allow the observation of 
lipofuscin autofluorescence.18 Apart from optical differences between a conventional fundus 
camera and a cSLO, the contribution of non-lipofuscin fluorophores could be a major reason 
for differences in imaging results between both systems. 
MELANIN 
Melanin is a cell-pigment located in organelles (melanosomes) of the anterior parts of the 
RPE cells. It plays a role in light absorption and absorption of free radicals at the ocular 
fundus. Melanosomes undergo changes during lifetime and are degraded and incorporated 
into lysosomes, finally forming melanolipofuscin. Even though, lipofuscin is the main 
contributor to retinal phototoxic damage,19 aged melanosomes can lose their photoprotective 
property and add also to phototoxicity under irradiation with blue light.20 
Whereas melanin does not show any recordable fluorescence within the visible spectrum of 
light,17 recent studies have shown that excitation in the near-infrared spectrum can elicit near-
infrared melanin-related autofluorescence.21;22 Currently, useful NIR-FAF images can only be 
obtained by the HRA 2 with an excitation wavelength of 787 nm and a fluorescence filter at 
800 nm. NIR-FAF images are much noisier than SW-FAF ones because the infrared fundus 
autofluorescence signal may be up to 100 times less intense that that of conventional FAF.22 
DISTRIBUTION OF FUNDUS AUTOFLUORESCENCE 
In the healthy typical patterns of FAF can be observed, which differ significantly between 
SW-FAF and NIR-FAF (Fig. 5.2). According to the distribution of ocular lipofuscin,23 SW-
FAF shows a ring-shaped increased signal with a maximum about 10° from the fovea at the 
temporal side. Due to the lower concentration of lipofuscin and, in addition, the blue-light 
absorption by macular pigment and melanin, a relative minimum of SW-FAF is present at the 
macula. Due to absence of lipofuscin or other strong fluorophores, or due to the absorption of 
exciting light, virtually no SW-FAF is visible at the large retinal vessels and the optic nerve 
head. 
Fig. 5.2 
Fundus autofluorescence images of a 
healthy individual received by the HRA 2 
with excitation and emission spectra at 
488/500nm (left) and 787/800 nm (right), 
respectively. Note the major difference of 
FAF at the macula, showing a minimum 
in SW-FAF and a maximum in NIR-FAF. 
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In NIR-FAF, the optic nerve had and retinal vessels also appear dark. However, consistent 
with the melanin distribution in the RPE,24 a nasally-shifted maximum of NIR-FAF signal is 
visible in the macular area, sometimes associated with a small dip at the fovea. Typically, 
there is less contrast in NIR-FAF than in SW-FAF due to the relative low signal-to-noise 
ratio.22 
CONFOUNDERS OF FUNDUS AUTOFLUORESCENCE INTENSITY 
The appearance of FAF may be affected by a change in the exciting light reaching fundus 
fluorophores, or by reduction of emitted light, or both. These effects are independent of the 
absolute quantity of fluorophores of the quantum yield of a FAF investigation. The next 
paragraphs provide an overview of two factors, visual and macular pigment, influencing FAF 
appearance in the healthy and diseased eye. Both will be the subject of clinical studies 
presented in the following subchapters. As near-infrared light is not absorbed by visual or 
macular pigment, only the results of SW-FAF and not of NIR-FAF imaging are influenced by 
changes in these substances. 
Fig. 5.3 
Correlation between FAF and OCT in a patient with retinitis pigmentosa (A, B) and cone-rod 
dystrophy (C, D). The bright rings on FAF (black bars) co-locate with loss of the POS (white 
arrow, B) on OCT. The black ring on FAF (C) goes with combined loss of photoreceptors and 
RPE (white bars). The horizontal white arrows indicate the positions of the OCT scans. 
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VISUAL PIGMENT 
In healthy eyes, dynamic FAF alterations may be caused by bleaching of visual pigment.25 
Therefore, complete bleaching of visual pigments should be performed before recording SW-
FAF images. The dynamics of visual pigment bleaching were topographically analyzed by 
FAF and will be described in Chapter 5.1 of this thesis. 
Absence of the POS under pathological conditions may affect the appearance of SW-FAF as 
well. In patients with long-lasting but resolved neuroretinal detachments, photoreceptor loss 
resulted in increased SW-FAF of the affected areas.26 This effect was more evident in the 
unbleached (dark-adapted) than in the bleached state. Similar observations could be made in 
patients with retinitis pigmentosa and for cone dystrophy (Fig. 5.3). Typically, the border 
between healthy and diseased areas in these patients shows a ring of increased SW-FAF, 
caused by the absence of POS and thus the blue-light absorbing visual pigment.27 
MACULAR PIGMENT 
Macular pigment in the human retina was first extensively described by Schultze (1866), who 
detected the absorbance of blue light by macular pigment and speculated whether this could 
be protective for the retina.28 About 20 years later, Hering detected that macular pigment 
showed significant variations between individuals and that green light was absorbed less than 
blue light.29 Interestingly, both Schultze and Hering had the impression that newborn infants 
had less or no macular pigment. 
Th ar pigment consists of two hydroxyl carotenoids, lutein and zeaxanthin. The 
topographic distribution of the components of macular pigment differs significantly. While 
ze d 
ha ht 
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The peak of light absorption by macular pigment is at 460 nm with a broad filter spectrum, 
protecting the central retina from phototoxic effects and improving retinal optical quality by 
absorbing stray light.31;32 Due to the different amounts of absorption within the blue and green 
spectra, the quantity of macular pigment may be calculated by subtraction analysis from 
consecutive images in both spectra. This has successfully been performed with reflectometry 
and by FAF imaging.33 As macular pigment predominantly affects macular FAF imaging in 
e macul
axanthin distribution shows a high peak at the fovea, lutein dominates in the periphery an
s only a slight increase at the macula (Fig. 5.4).30 Thus, the main part of blue lig
sorption by macular pigment will be caused by zeaxanthin. 
Fig. 5.4 
Illustration of the optical density of lutein 
(L, solid line) and zeaxanthin (Z, dashed 
line). AT the fovea, macular pigment 
consists mainly of Z, while in the periphery 
L is the primary carotenoid. 
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the blue spectrum, FAF images performed with the HRA 2 at 488 nm will be influenced by 
ng macular pigment loss at least in 
some acquired cases.  In Chapter 5.2, FAF imaging will be applied next to fundus 
38 They 
iagnosing and staging of macular holes, which was groundbreaking 
non-infectious ocular inflammations, central serous 
A huge advantage of FAF imaging is the straightforward and non-invasive nature of the 
technique. Still, interpretation of FAF images remains difficult in a lot of diseases. In recent 
years, the combination of FAF with Fourier-domain OCT (multimodal imaging) has assisted 
the recognition of many FAF affections that were poorly understood in the past.63  
R
1. l. Two-photon excited autofluorescence imaging of human 
006;11:010501. 
2. orescence of hyalocytes and pigment epithelium and the 
bstance from these tissues. Exp Eye Res 1973;17:313-20. 
, and fundus flavimaculatus. Br J 
.  Piccolino FC, Borgia L, Zinicola E, et al. Pre-injection fluorescence in indocyanine green angiography. 
Ophthalmology 1996;103:1837-45. 
changes in the density or quantity of macular pigments. The impact of macular pigment on 
FAF images became obvious by studying patients with congenital or acquired loss of macular 
pigments.34;35 However, due to additional blue-light absorbers like melanin, blue light 
reflectance imaging appeared favorable in demonstrati
36
reflectometry to identify the first known genetically driven maculopathy with virtually total 
absence of macular pigment.  
FUNDUS AUTOFLUORESCENCE AS DIAGNOSTIC TOOL 
More than thirty years ago, fundus autofluorescence was initially described as a phenomenon 
in the living eye.3 Nearly 20 years later von Rückmann et al. performed pioneering FAF 
examinations with a cSLO on normal eyes37 and on patients with macular dystrophies.
also suggested FAF for d
in the pre-OCT era, when that diagnosis was mostly confirmed by fluorescein angiography.39 
Within the last decade, a continuous growth of FAF research has taken place with a total of 
351 publications and 3585 citations between 2000 and 2010 (ISI web of knowledge, assessed 
on March 12, 2010 at http://apps.isiknowledge.com.proxy.ubn.ru.nl:8080). Currently, FAF is 
applied to a broad variety of diseases like inherited retinal diseases, age-related macular 
degeneration, infectious and 
chorioretinopathy, toxic retinopathy, benignant and malignant tumors and many more.40-62 In 
Chapter 5.3, the FAF appearance of genetically confirmed retinal dystrophies will be 
described. Chapter 5.4 compares the different appearances of inherited retinal diseases in SW-
FAF and NIR-FAF. 
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Ophthalmol 1978;62:256-60. 
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ABSTRACT 
This study investigated changes of short wavelength fundus autofluorescence (SW-AF) by 
retinal bleaching effects. All measurements were performed with the Heidelberg Retina Angi-
ograph (HRA) 2. Initially, experimental imaging was done on a healthy eye after dark adapta-
tion.  Photopigment was bleached within the central 30 degree of the fundus by the HRA exci-
tation light. Then, SW-AF imaging of this region was performed, and SW-AF of the sur-
rounding, unbleached 25-degree fundus region was subsequently studied by a wide field lens. 
Next, another 30 degree SW-AF image of the posterior pole was obtained after complete dark 
adaptation. Then, an extra SW-AF examination was performed with 15 degrees temporal ec-
centricity, overlapping the original examination area. Finally, a successive image series was 
carried out on the dark-adapted eye to test for bleaching kinetics. The second and third expe-
riment was also performed on eyes with macular dystrophies. Distinct regions of increased 
SW-AF were observed after strong illumination with the blue excitation light in all eyes stu-
died. During light adaptation mean gray levels showed a saturation plateau after an initial 
steep increase. The resulting gray-value maps showed significant differences of pixel intensi-
ties between bleached and unbleached parts of the fundus. Two-dimensional density differ-
ence maps allowed analysis of visual pigment distribution and density in both healthy eyes 
and eyes with macular dystrophies. Our observations highlight the viability of objective, non-
invasive evaluation of visual pigment in the healthy and diseased human retina by means of 
confocal fundus autofluorescence. 
INTRODUCTION 
Vision begins with the absorption of photons by the photopigment in the rods and cones. The 
process of photobleaching within the outer segments involves the dissociation of rhodopsin 
into opsin and 11-cis-retinal, which then isomerizes to all-trans-retinal. By photo-
isomerization, retinal photopigments loose their original absorption properties and conse-
quently the optical density of the photoreceptors is altered.1 The magnitude of this photob-
leaching process strongly depends on the number of photons absorbed, whereas the duration 
of photobleaching is maintained by the regeneratory potential of the visual pigment.2 Several 
photoreceptor dystrophies may initially result in subtle changes of dark adaptation and color 
vision3;4 and need to be evaluated by psychophysical diagnostic tests, which are inherently 
subjective. Measuring photobleaching in such cases could serve as an objective test modality 
and therefore may add valuable and reliable information on the phenotype. 
Illumination of the ocular fundus with blue (short wavelength, SW) or near-infrared (NIR) 
light induces autofluorescence (AF) of fluorophores within the retinal pigment epithelium 
(RPE).5;6 In case of excitation with light of the blue-green portion of the spectrum, the result-
ing SW-AF originates predominantly in the lipofuscin granules of the RPE.7 In NIR-AF, me-
lanin or related fluorophores have been suggested as major contributors to the resulting AF 
pattern.5 
Regardless of the type of fluorophore in the RPE, the exciting light first has to pass through 
the photoreceptor layer, inevitably leading to reflectance, scattering and absorbance. The lat-
ter occurs mainly in the outer segments and strongly depends in the wavelength of the trans-
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mitted light.8 Irradiation with SW visible light will bleach visual pigments in the outer seg-
ments of short-wavelength-sensitive (SWS) and middle-wavelength-sensitive (MWS) cones, 
but also rods and long-wavelength-sensitive (LWS) cones will be bleached to a certain ex-
tend.9-11 On the other hand, if NIR light is used to excite AF there will virtually be no absor-
bance by visual pigments within the photoreceptors. Therefore, no change of NIR induced AF 
will take place.8 
In this paper, we illustrate a topographically defined increase of SW-AF as a function of pho-
topigment density loss due to illumination with blue light. 
MATERIAL AND METHODS 
The study was divided into two parts. In the first leg, three well-defined AF experiments were 
performed on the healthy eye to evaluate our measurement strategy. In the second leg, specif-
ic elements of these tests were repeated on eyes with macular diseases. Our study was per-
formed in accordance with the tenets of the Declaration of Helsinki 1975 (1983 revision). 
Local Ethics Committee approval was obtained and informed consent to participate in this 
study was acquired for all subjects. 
The first experiment involved central AF measurement on the healthy left eye of one of the 
authors (TT) with a confocal scanning-laser ophthalmoscope (cSLO, Heidelberg Retina Angi-
ograph 2, Heidelberg Engineering, Dossenheim, Germany) after dark adaptation for 20 mi-
nutes. The power output at the cornea was approximately 300 µW, which resulted in an 
equivalent retinal irradiance of approximately 315 µW/cm².12  A pupillary diameter of more 
than 6 mm was achieved with 1 drop of tropicamide and 1 drop of phenylephrine. Images 
were acquired digitally with a resolution of 1536 × 1536 pixels and 8 bits of gray scale. First, 
the cSLO was focused on the central retina using a reflectance image under illumination with 
a NIR laser spot at 787 nm. Then, a 30° confocal SW-AF measurement (excitation wave-
length 488 nm, emission filter >520 nm) was performed with the subject looking at a central 
fixation spot within the cSLO camera. Before the start of the first measurement the central 
area was illuminated with the excitation light source for about 60 seconds to achieve light 
adaptation of this area. A total of 9 frames were then recorded within 2 seconds to allow noise 
reduction by calculating of a mean image after frame alignment. The examined eye was sub-
sequently covered, and the camera optic was changed to a 55° wide angle lens. Next, the 
cSLO was focused again under NIR light, and a second series of 9 frames was immediately 
recorded without light adaptation of the peripheral area, again using a SW excitation wave-
length of 488 nm. The time between the first and second frame series was approximately 10 
seconds. The resulting image showed two distinct fundus parts, namely a central 30° area of 
AF after light adaptation and a peripheral area of AF at the dark adapted state. 
The second experiment was performed on the same eye under the same conditions as the first 
experiment. First, a central 30° SW-AF image was achieved as described before. Then, a 
second 30° SW-AF image was performed with 15° temporal eccentricity of fixation. This 
resulted in a second frame series covering half the previously examined fundus area. This 
experiment was repeated for NIR-AF (excitation wavelength 787 nm, emission wavelength 
filter >820 nm). 
Analysis of visual pigment by fundus autofluorescence 107 
 
In the third experiment, a series of 30 single shot images was recorded by video-mode (5 
frames per second) following dark adaptation. We repeated the second and third experiment 
in selected patients with macular dystrophies, such as Stargardt disease (STGD1), cone rod 
dystrophy, and choroideremia. 
All digital image processing and analysis was performed using ImageJ (version 1.37f; availa-
ble at http://rsb.info.nih.gov/ij), a public domain digital image-processing program.13 Density 
variations and changes during photopigment bleaching were calculated and displayed using 
Origin 7.5 for Windows (OriginLab Corporation, Northampton, MA, USA). For any image 
analysis, AF maps were analyzed as is and were not manipulated by zero-level correction of 
histogram stretching. 
For standardization of gray value investigation, all AF images were resized with bicubic in-
terpolation so that the distance from the temporal edge of the optic disc to the fovea was 500 
pixels. The optic disc-fovea distance is a highly reliable anatomic marker of 3000 microns, 
which was shown to be a better constant than optic disc diameter or resizing based on camera 
magnification values.14 The resulting images were smaller than the originals and had a stan-
dard pixel size of 6 microns per pixel. 
The mean gray values of the resulting AF within the initially and subsequently illuminated 
areas of experiment one and two were compared. To perform gray value analysis, equal qua-
drangle regions of interest were chosen within the lighter central area and the darker peripher-
al area. The density changes (∆d ) of visual pigment were calculated as differences in log ex-
posure 
∆d = logpre – logpost      (5) 
Fig. 5.5 
SW-AF examination by Heidelberg Retina Angiograph 
(HRA 2, 55º exam), taken immediately after an initial 
30º exam with the same illumination settings. The site 
of the previous AF examination is outlined as a bright 
area with the shape of the internal mirror of the HRA 
camera. After quantitative measurements the image 
was histogram stretched to enhance contrast. 
within appropriate sections of the bitmaps. Before optical density analysis, standardized im-
ages and subtraction results were blurred (Gaussian blur, 60 µm full width half maximum) to 
reduce noise. To create density difference maps, we computed log images from the initial and 
the bleached SW-AF measures and performed image subtraction according formula (5), and 
the results were displayed using 32-bit gray scale bitmaps. 
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RESULTS 
The first experiment demonstrated a region of increased AF in the shape of the internal mirror 
of the cSLO camera (fig.5.5). We calculated the mean gray values (G1 and G2) of the 8-bit 
grayscale from four representative 100 × 100 pixel areas, respectively, from the central 30º 
area (G1 = 182,5 ± 11,5)  and the 30º -55º area (G2 = 153,5 ± 9,75). The area of macular pig-
ment, where SW-AF was inherently reduced, was excluded from the calculation of G1. The 
resulting change of visual pigment optical density within the primarily examined region of the 
fundus according to equation (5) was log G1 – log G2 = 0,075. 
Fig. 5.6 ◙ 
SW-AF (panel A) and NIR-AF (panel B) taken with 15º temporal eccentricity immediately after a 
previous central measurement with unchanged settings. An increased area of focal AF (panel A; 
arrow) was present in blue light induced AF but not in NIR-AF. This dissimilarity is also demon-
strated on the plotted mean gray values (panels C and D) of two equivalent regions (red boxes) in 
SW-AF and NIR-AF. The gray value slope between bleached and unbleached area (panel C; arrow) 
is a result of optical vignetting effects. The asterisks sign a retinal blood vessel (panel A) and the 
resultant depression in the mean gray value plot of blue light induced AF (panel C). 
 
The result of the second experiment matched that of the first experiment. Again, an area of 
considerably increased SW- AF could be observed within the primarily examined fundus re-
gion, adjacent to a region of lower AF in the secondary region (fig.5.6). The mean gray values 
in eight characteristic subregions (100 × 100 pixels) within the initially and subsequently ex-
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amined regions were then measured for SW-AF and NIR-AF (table 5.1). As previously ex-
pected, we only observed a significant change of pixel intensities in SW- AF but not in NIR-
AF. The ensuing alteration of visual pigment optical density after bleaching and excitation 
with 488 nm was 0,11. 
Assessment  Mean  SD  SE  Mean difference 
(sub vs. ini) 
95% CI of difference 
(lower / upper) 
Blue AF   ini 110,25  9,11  4,55     
Blue AF   sub 85,75  4,99  2,49  ‐ 14,25 a  ‐22,19 / ‐6,31 
NIR AF ini  59,25  2,87  1,43     
NIR AF sub  60,25  2,50  1,25  0,25 b  ‐3,73 / 4,23 
The topographically defined kinetics of SW-AF in a healthy eye in the third experiment and 
the resulting mean gray value plot are depicted in figure 5.7. An exponential increase of the 
mean gray values during SW-AF recording could be observed. The image series of the expe-
riment demonstrates that the intensification of SW-AF during bleaching is best appreciated in 
a broad circular area around the fovea with an inner eccentricity of 11°. This region of pro-
nounced SW-AF increase was located clearly outside the area obscured by macular pigment. 
Table 5.1 
Measures of short-wavelength and near-infrared autofluorescence on 8-bit gray value fundus maps. 
CI=confidence interval, SD=standard deviation, SE=standard error, ini=initial central measure-
ment after dark adaptation, sub = subsequent measurement 15º temporal immediately after initial 
measurement, a=statistically significant difference (one sample t-test, p=0,01), b=not statistically 
significant 
To assess the bleaching process topographically, we calculated a density difference map from 
the unbleached and bleached SW-AF images (fig.5.8). Even though bleaching occurred in all 
fundus areas, plotted gray levels illustrate that bleaching with SW light was minimal at the 
fovea and reached maxima approximately 12° away from the fovea in the horizontal and ver-
tical meridians. Bleaching levels fitted Gaussian relative to the distance from the macula with 
an exaggerated progression in the horizontal meridian. To further elucidate the topographical 
distribution of visual pigment distribution, as measured by SW-AF, we analyzed the density 
difference map outside the macular pigment area along a circle with a radius of 9° centered on 
the fovea (fig.5.9). We discovered that density peaked on the temporal and nasal horizontal 
meridian with the highest densities of visual pigment on the temporal side. The latter calcula-
tions were reproducible on the same eye in repeated measures. 
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To estimate the kinetics of visual pigment density change during bleaching the first nine im-
ages after dark adaptation were used and a linear fit was applied. With strong illumination, the 
visual pigments within the photoreceptor cells will bleach according to the Lambert-Beer-
law15 
A(λ) = 1-exp(-α(λ)cl)    (6) 
where A(λ)  is the proportion of light absorbed by photopigments, α(λ) is the extinction coeffi-
cient of visual pigment, c is the concentration of visual pigment within the retina, and l is the 
path length of light through the retina. The Lambert-Beer-law implies an inverse logarhythmic 
correlation between the concentration of an evaluated substance and the transmitted light. 
Accordingly, visual pigment optical density showed exponential kinetics during strong illu-
mination, beginning at low SW-AF levels (higher initial photopigment density) with a steep, 
almost linear slope in the beginning, which flattened asymptotically during the bleaching 
process. 
In experiment 3 the slopes of linear regressions within the early bleaching process were less 
steep for patients with cone rod dystrophy, STGD1 and choroideremia than for a normal sub-
ject, and patients with large atrophies showed less slope than subjects with preserved RPE 
(fig. 5.10). In a topographic case model of STGD1 we found focally decreased optical densi-
ties in atrophic, dark areas on fundus AF images. Interestingly, density measures on areas 
with increased AF due to lipofuscin accumulation did not appear to be altered (fig. 5.11). 
The aim of this study was the evaluation of the principle of a new technique of visual pigment 
densitometry. The experiments therefore made use of individuals, rather than of large, repre-
sentative study groups. For that reason the study results were not statistically analyzed. 
 DISCUSSION 
The experiments in our present study demonstrate that bleaching with exciting SW light of 
488 nm increasingly expands the level of AF in subsequent images. Presumably, this is 
caused by reduced absorption of light by the bleached photoreceptor pigments. Since NIR 
light does not bleach visual pigments, this phenomenon did not occur when NIR light was 
used instead of SW light. Furthermore, we were able to demonstrate the asymptotical, illumi-
nation-dependent kinetics of mean SW-AF, and accordingly photopigment bleaching, to a 
maximum level (fig. 5.7). In a normal subject, the loss of optical density following exposure 
to SW light was minimal in the macular area, increasing in a circular area beginning at 11° 
from the fovea, with maximal decrease of visual pigment density in the temporal periphery 
and the lowest optical density decrease superiorly. In retinal dystrophies, optical density ki-
netics as result of bleaching with SW light appeared to be less than in the normal eye. In 
STGD1 atrophic areas with pronounced photoreceptor loss showed decreased visual pigment 
densities. By contrast, in fundus areas with increased lipofuscin AF and a relative intact pho-
toreceptor layer the visual pigment density was unaltered. 
Recently Prieto and coworkers demonstrated that short-wavelength induced fundus AF may 
be useful to measure the optical density of the photoreceptor layer.10 Their measurements 
were performed on the pupillary plane integrating AF from the ocular fundus. In our present 
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study, we employed confocal retinal AF imaging, which allowed a topographical localization 
of the central fundus AF. The current technique enabled us to localize and analyze focal alte-
rations of AF and the visual pigment distribution after photopigment bleaching and to perform 
quantifications of visual pigment density on definite fundus sites. In the majority of retinal 
dystrophies, the structural retinal damage differs greatly depending on the anatomical loca-
tion. When fully developed, the currently described technique might be suited to objectively 
analyze the visual pigment density as well as regeneration in retinal areas with SW-AF altera-
tions.  
 
 
Fig. 5.7 ◙ 
Image series from a video mode SW-AF measurement (panel A, 5 frames per second, plotted left to 
right and top to bottom) and the mean gray values of the images (panel B), demonstrating bleach-
ing kinetics. During SW light illumination, AF increase (panel A; false colors specify AF intensity) 
occurred largely within a circular area of 11° eccentricity centered to the fovea. The total increase 
of SW-AF during photopigment bleaching, which is 20.6 per cent of baseline, fits asymptotic kinet-
ics (panel B; black curve). The resulting change of photopigment density during this measurement 
is 0.08. 
We have measured diverse optical densities in the same eye in the first and second experi-
ment. The AF based method used here depends on reference areas outside the bleached fun-
dus sites, which were different in both experiments. The amount of fluorophores referred to 
may have been unequal, consequently leading to different degrees of SW-AF. Therefore, opti-
cal densities may have been calculated lower if referred to areas with more fundus AF. Never-
theless, in both experiments the photopigment densities were lower than previously re-
ported.10;16 This is independent on reference areas as discussed above and may be attributed to 
differences in the experimental setups. 
Dependent on the experimental setup of either a double-pass (reflectrometry) or a single-pass 
(AF method) measurement, differences in optical densities results may occur. This may espe-
cially be true for high angles of incidence.10 Accordingly, we found lower optical densities by 
the AF method than reported earlier by fundus reflectrometry. 
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Fig. 5.8 ◙ 
Density difference map calculated 
from SW-AF of a healthy eye (32-
bit gray values) and plotted densi-
ty values on the horizontal and 
vertical meridian through the fo-
vea. Lower (darker) gray values 
indicate increased photopigment 
bleaching. Gaussian fit of optical 
density had a minimum at the fo-
vea, and differences between fovea 
and periphery were largest in the 
horizontal plane. 
In addition, the optical spectrum used in different studies may result in diverse optical densi-
ties, as some wavelengths may not bleach all rods and cones. Van Norren and van de Kraats 
employed a scanning laser ophthalmoscope for comparison of fully bleached reflectance maps 
with dark adapted reflectance maps, using a wavelength of 514 nm (green) for excitation and 
bleaching.16 They found optical densities varying from 0.15 in the periphery to 0.45 in the 
fovea, focally determined on the retinal plane. Prieto and coworkers bleached with light of 
592 nm (orange) and excited with 543 nm (yellow-green).10 They observed visual pigment 
density changes between the dark adapted and bleached state of 0.204 to 0.228, measured in 
the pupillary plane. However, Tornow et al. demonstrated that the use of a He-Ne-laser of 
long wavelength (633 nm) could reduce reliability of optical density measures by significant 
variations of laser intensity with time.17 With the more stable argon laser (514 nm, a wave-
length that can be absorbed by both rod and cone photopigments) they measured a central 
density peak of 0.4 and peripheral densities from 0.11 nasally and 0.23 temporally. 
In our present study, we applied light of short wavelength (488 nm) to simultaneously bleach 
the visual pigment and excite AF. Therefore, at the central fundus a significant amount of 
bleaching light may have been absorbed by macular pigment.9 Accordingly, we measured 
decreased optical densities in the fovea, where macular pigment density is strongest (fig. 5.8). 
This is in contrast to earlier densitometry results by cSLO fundus reflectance, where optical 
density peaked at the fovea when measured and bleached with longer wavelengths.16;17 
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As the SW light of 488 nm, which we have used in the present study, is essentially absorbed 
by macular pigment, visual pigment in the fovea may have been bleached incompletely and, 
consequently, optical density calculations of photopigments may have been underestimated in 
the fovea. The use of an increased excitation wavelength of 532 nm would reduce macular 
pigment absorption to a minimum,18 whilst lipofuscin AF would not change significantly.19 
Doing so, the accuracy of foveal visual pigment calculations may accordingly be improved. 
Fig. 5.9 ◙ 
Topographic analysis of visual pigment density difference map by SW-AF in a healthy subject. 
The red graph (panel A) depicts the multiple peak Gaussian fit of the plotted gray values within 
360 pixels radius around the fovea (panel B; red circle). While the density difference between 
dark adapted and bleached state peaked temporally and nasally it declined superiorly and infe-
riorly. Two-dimensional distribution of differences in optical density are better noticeable in the 
false color coded density map (panel C); according to the color level definition in panel A, war-
mer colors indicate increased optical density. S=superior, T=temporal, I=inferior, N=nasal 
Even though our initial AF measurements were done after complete dark adaptation, a series 
of 9 frames was used in the first two experiments to attain sufficient noise reduction for high-
quality fundus images. This caused progressive bleaching during measurement, as demon-
strated in fig. 5.7. Therefore, the last frames of the series display higher mean gray values 
than the first ones. As a result, the mean gray value of the aligned mean image of the series 
was artificially increased and did not resemble a totally dark adapted state of all photoreceptor 
elements. Because the second series of frames overlapped the initial area of AF images, opti-
cal vignetting may have changed the dark adapted state of the not illuminated retinal parts in 
the near vicinity if the initially bleached retina, as depicted in figure 2. Therefore, all mea-
surements of optical density based on SW-AF have been done at least 1° away from the 
boundary between bleached and unbleached retina. The use of single images for density cal-
culation may help to improve accuracy of quantitative measurements, but image quality will 
decrease and therefore, topographic localization of visual pigment density may be less pre-
cise.  
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Visual pigment density measurement by the AF method may essentially be a single pass mea-
surement10 due to the spectrum of the emitted light, which peaks around 620 nm. This is for a 
major part outside the absorption maximum of the rods and short wavelength cones. There-
fore, the total absorbance by the dark-adapted retina may be reduced and visual pigment den-
sity measurements might be considerably lower than by the reflectometry method. 
SW-AF is for the most part based on the lipofuscin content of the RPE, and SW-AF may 
show long-term changes.20 In addition, metabolic changes may have influence on the fluores-
cence lifetime at the fundus.21 However, Laemmer et al. demonstrated high short-term repro-
ducibility of SW-AF levels and patterns.22 This is in accordance with the results of lipofusci-
nogenesis research, which show that lipofuscin formation is an age-related process over many 
years.23 Therefore, major short-term changes, which may have impact on SW-AF and thus, on 
the resulting single-pass density measurements, may not be expected. 
  
Fig. 5.10 
Plotted data of optical density kinetics (symbols) and corresponding linear fits (lines) of eyes with a 
healthy retina, STGD1 with preserved central retina, STGD1 with a large area of central atrophy, 
cone-rod dystrophy, and choroideremia with subtotal atrophy. Data were normalized to clarify 
relationships between regression slopes. The slopes of the linear regressions in macular dystro-
phies were flatter than in a healthy subject.  =healthy retina,  = STGD1 with preserved cen-
tral retina, =STGD1 with central atrophy,  =cone-rod dystrophy,  =choroideremia  
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The preliminary results of our study suggest some topographic variations of photopigment 
optical density in the normal retina, as depicted in figures 5.8 and 5.9. In detail, visual pig-
ment densities were higher temporally than nasally, and lowest densities were measured supe-
riorly and inferiorly. Our results of the horizontal extrafoveal topography of photopigment 
density are in accordance with earlier published data.17;24 Measurements of a large group of 
normal subjects are needed to calculate normal density maps, which may help with the inter-
pretation of visual pigment density maps in retinal pathologies.  
 
Fig. 5.11 ◙ 
Comparison between SW-AF (panel A; lighter areas indicate in-
creased lipofuscin) and optical density difference map (panel B; 
lighter areas indicate less optical density) of the macular area in a 
patient with STGD1, both Gaussians blurred (full width at half 
maximum 60 µm). The images were superimposed to demonstrate 
dissimilarities between optical density and SW-AF topography 
(panel C; green = SW-AF, red = density difference). In areas with 
decreased AF (e.g. areas of retinal pigment epithelium deteriora-
tion) optical density was low. Increased AF levels, however, did 
not necessarily correlate with changes in the optical density map. 
As demonstrated in figures 5.10 and 5.11, some changes in 
visual pigment density kinetics and topography may be ex-
pected in macular dystrophies. However, the interpretation of 
the density map results can be challenging in areas of RPE 
atrophy, where SW-AF will be significantly altered. In that 
case, accurate density calculations from SW-AF will be im-
possible. Therefore, the use of fundus reflectance images may 
reveal improved results in eyes with large atrophic areas.24 In 
contrast, increased SW-AF is unlikely to affect the assess-
ment of photopigment density, as demonstrated in figure 5.11. 
Our observations suggest that short-wavelength AF may be 
useful to measure the topographical distribution of visual 
pigments in the retina. However, some modifications of our 
experimental setup could improve the precision of photopigment density measures. First, a 
single-flash image could be used to determine the fundus AF under dark-adapted conditions to 
avoid artificial bleaching.1 Hereafter the region of interest should be bleached, which may be 
achieved with a bright light source. A 6-log-Troland will bleach approximately 96% of all the 
visual pigment.25 Stepwise bleaching with defined luminance may allow focal analysis of vis-
ual pigment kinetics, which may fit a cumulative Gaussian curve in the healthy.26 
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In general, fundus AF consists of diffusely emitted light and therefore, a certain amount of 
this light may not be guided by photoreceptors. As a result, photopigment density measured 
by AF may basically be lower than assessed by reflectance methods.  Pupillary alignment has 
been shown to be critical for cone densitometry.27;28 Even though the importance of pupil 
alignment is yet not specifically investigated in fundus AF imaging, it is most probably essen-
tial for equal illumination, and therefore, for exact AF measurement. The position and rotation 
of the eye relatively to an optical instrument may affect image quality by optical vignetting 
unless sufficient pupil size.29;30 Vignetting effects will produce an unequal AF topography and 
therefore may severely change visual pigment density measurements. A pupil monitoring sys-
tem together with a bite board should therefore be used to control the position of the pro-
band’s pupil and head relatively to the camera to avoid any systematic optical affections. 
In conclusion, we were able to demonstrate that multifaceted analysis of retinal photopigment 
bleaching with the commercially available Heidelberg Retina Angiograph 2 is possible. How-
ever, a custom-made system could improve the accuracy of the visual pigment density mea-
surements by standardizing the bleaching process in AF assessment. Such a standardized test 
based on reliable values of healthy subjects should allow to objectively investigate visual 
pigment regeneration, which is fundamental for early diagnosis and improved understanding 
of the underlying pathomechanisms in retinal dystrophies.  
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ABSTRACT 
PURPOSE: Sjögren-Larsson Syndrome (SLS), an autosomal recessive hereditary disorder 
with congenital ichthyosis, spastic di- or tetraplegia, and mental retardation, reveals a charac-
teristic macular dystrophy with intra-retinal crystals and foveal pseudocysts.  Ophthalmic 
symptoms in SLS are reduced visual acuity and photophobia. Here we report deficiency of 
macular pigment as a novel finding in this peculiar, congenital maculopathy. 
DESIGN: Cross-sectional, observational case study.  
PARTICIPANTS: Patients with clinically and genetically proven SLS were included. 
METHODS: Besides general ophthalmologic examination, we used two different modali-
ties, fundus autofluorescence (FAF) and fundus reflectometry with the macular pigment ref-
lectometer (MPR), for measuring macular pigment (MP). 
MAIN OUTCOME MEASURES: Distribution profiles and quantity of MP in eyes of 
SLS patients. 
RESULTS: We included 28 eyes of 14 patients. The technique to measure MP depended on 
the ability of the mentally handicapped patients to cooperate. FAF images providing qualita-
tive estimates could be obtained in 9 eyes of 5 patients, and MPR measures providing quantit-
ative estimates could be performed in 19 eyes of 10 patients. FAF images of SLS patients 
lacked the typical attenuation of macular FAF signal expected in normal eyes. Mean foveal 
MP levels measured by MPR showed significantly lower values in SLS patients (0.10 ± 0.07) 
than in healthy individuals (0.69 ± 0.17; Student’s t-test, p < 0.001).  
CONCLUSIONS: The group of SLS patients studied here had significantly reduced levels 
of foveal MP. The crystalline macular dystrophy in SLS appears the first known disease with 
genetically caused deficiency of MP. 
INTRODUCTION 
Sjögren-Larsson Syndrome (SLS), as first described by Sjögren and Larsson in 19571, is an 
autosomal recessively inherited disorder, characterized by mental retardation, spastic diplegia, 
and congenital ichthyosis. The disease is caused by an enzymatic defect in lipid metabolism, 
namely microsomal fatty aldehyde dehydrogenase (FALDH) deficiency. FALDH catalyzes 
the oxidation of many different medium- and long-chain fatty aldehydes into fatty acids. 
FALDH deficiency results in the accumulation of fatty aldehydes and fatty alcohols in body 
tissues, which is considered the principal causative mechanism leading to the clinical symp-
toms of SLS. 
Besides the neurocutaneous features, patients with SLS exhibit a typical crystalline juvenile 
macular dystrophy with onset in childhood, which is characterized clinically by reduced visu-
al acuity and photophobia.2 In addition to the crystalline deposits located at the inner retinal 
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layers, we were able to detect a cystoid foveal atrophy, possibly based on an underlying 
Müller cell disorder, by optical coherence tomography (OCT).3 
Macular pigment (MP) is a mixture of two carotenoids, lutein and zeaxanthin. The concentra-
tion4 and spatial distribution5-7 of lutein and zeaxanthin varies greatly among individuals. In 
humans, carotenoids are only acquired through dietary intake. Peak concentration of MP de-
pends on many factors, such as geographic location and lifestyle, i.e., nutritional habits, 
smoking and supplemental intake.8-11 Regardless of the wide ranges of MP concentrations 
under physiological circumstances, MP is not totally absent in a healthy individual and optical 
density levels of MP below 0.2 are extremely rare.12,13 MP is predominantly located in the 
photoreceptor axon layer and the inner plexiform layer of the macula,14 where it probably 
plays a role in photoreceptor protection by neutralizing free oxygen radicals and by absorbing 
potentially phototoxic, high-energetic blue light (400-530nm).15,16 
The macula of SLS patients lacks the normal dark-yellowish appearance, a feature that had 
not been fully appreciated previously.2,3 This is probably because the phenomenon could easi-
ly be overlooked by the considerable number of bright glistening crystals at the macula. To 
decide, whether an altered distribution or concentration of MP could be responsible for the 
changed macular shades, we extended our previous ophthalmologic studies on SLS patients 
with fundus autofluorescence (FAF) and spectral fundus reflectometry to compare the levels 
of lutein and zeaxanthin in the eyes of SLS patients to healthy controls.17,18  
METHODS 
We performed a cross-sectional, observational study on patients from an earlier investigated 
population with clinically and genetically proven SLS,3 treated at the Departments of Oph-
thalmology and Pediatric Neurology, Radboud University Nijmegen Medical Centre. The 
study was performed in accordance with the tenets of the Declaration of Helsinki 1975 (1983 
revision). Local Ethics Committee approval was obtained and informed consent to participate 
in this study was acquired for all subjects. Because of the mental retardation in SLS, informed 
consent for study participation was also received from the patient’s parents or legal guardian. 
Limited cognitive capacities, photophobia, and inability for stable fixation due to spasticity 
complicated the clinical exams, especially the acquisition of autofluorescence images and 
fundus reflectometry. Therefore data using these modalities could only be obtained in a subset 
of patients. The diagnosis of SLS was proven in all patients by deficient FALDH activity in 
leukocytes or cultured skin fibroblasts and mutation analysis of the FALDH gene.19  
Besides general ophthalmic examination, including best corrected visual acuity, slit lamp 
biomicroscopy, binocular ophthalmoscopy, digital color fundus photographs (Imagenet, Top-
con Corporation, Tokyo, Japan) were obtained. In addition, OCT scans (trans macular line 
scans) and FAF images were performed by a hybrid OCT - confocal scanning laser ophthal-
moscope (SPECTRALIS®, Heidelberg Engineering, Heidelberg, Germany).  
The protocol to derive FAF images was applied as described elsewhere.20 In the presence of 
MP, decreased levels of autofluorescence are usually visible in the macular area due to the 
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blue light absorbing properties of MP. To quantify MP, a two-wavelength method (blue λ ~ 
460nm, green λ ~ 530nm) should be used, which is technically impossible with SPECTRA-
LIS®, therefore, only a qualitative estimation on the presence of MP was realizable in this 
study arm. 
To objectively show a possible loss of MP we measured the optical density of macular pig-
ment (MPOD) by fundus reflectance spectroscopy using the Macular Pigment Reflectometer 
(MPR). Details of this setup and the spectral analysis employed are described by de Kraats et 
al. (2006)17 and Berendschot et al.23,24 respectively. To determine MPOD values at different 
eccentricities we modified the MPR by adding 5 fixation points at 1, 2, 4, 6 and 8 degrees 
next to the central measurement field of 1 degree.18, 25 Due to a fixed location of the eccentric 
fixation points in the MPR, they are always presented on the right side of the central white 
light (i.e., temporally for the right eye and nasally for the left eye). A single measurement on 
the MPR takes one second. We used the mean of 5 measurements. For comparison with nor-
mals, MPOD spatial profiles were taken from Van de Kraats et al., who measured 23 healthy 
subjects (aged 24.3 ± 2.7 years) at 0, 1, 2, 4 and 8 degrees using a similar device for determi-
nation of MPOD.18  
RESULTS 
We included 28 eyes of 14 patients with SLS (7 male, 7 female; mean age 20±9 years). Pa-
tient demographics, best corrected visual acuity, FAF data and MPOD measurements are 
summarized in Table 1. All patients showed the characteristic crystalline macular dystrophy 
on ophthalmoscopy and OCT. In contrast to normal fundus appearance, a relatively homo-
genous orange background reflectance was observed beneath the area of the obvious glisten-
ing white crystals (fig. 5.12).  
Fig. 5.12 ◙ 
Fundus appearance of the macula in Sjögren-Larsson syndrome. Color fundus photographs 
of a patient with Sjögren-Larsson syndrome (A) and a normal control (B). The brightness of 
macular background is relatively homogenous in the patient, while a considerable central 
darkening due to macular pigment is present in the healthy control. Note the huge amount 
of intraretinal crystals in the Sjögren-Larsson patient. 
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CONFOCAL FUNDUS AUTOFLUORESCENCE IMAGING 
FAF images could be obtained in 9 eyes of 5 patients, mean age 23.2 ± 9.1 years, and re-
vealed important differences as compared to 20 eyes of 10 healthy controls, mean age 24 ± 3 
years (fig. 5.13). In all patients the typical FAF attenuation in the fovea seen in healthy eyes 
was absent. Instead, the background FAF as seen in the periphery was continued within the 
macular region. In addition, focal FAF increase could be observed at the foveal centre in 7 of 
9 eyes examined. Occasionally, spots of decreased FAF could be observed perifoveally, 
which were not co-located with intra-retinal crystals or pseudocysts. No FAF abnormalities 
were discerned outside the macular region. 
Fig. 5.13 
Fundus autofluorescence (FAF) characteristics in Sjögren-Larsson syndrome. Fundus au-
tofluorescence sample images and profiles of mean (error bars indicate standard deviation 
of mean) in patients with Sjögren-Larsson syndrome (A) and in healthy, age-matched con-
trols (B). Study subjects show an autofluorescence maximum within 1 degree eccentricity, 
which is roughly 25% above the peripheral levels. Instead, healthy individuals show central 
attenuation of autofluorescence of approximately 50% and highest values in the periphery. 
FUNDUS REFLECTANCE SPECTROSCOPY 
Fundus reflectometry was successfully performed with central fixation in 19 eyes of 10 pa-
tients (mean age 17.4 ± 10.5; median, 16.5; range, 5 to 38 years). Even though the mean age 
of SLS patients differed significantly from the mean age of the control subjects for MPR mea-
surements (mean age 24.2 ± 2.7; median, 23.9; range, 20 to 32 years; p = 0.005) we consi-
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Fig. 5.14 
Macular pigment optical density measure-
ments in Sjögren-Larsson syndrome. Macu-
lar pigment optical density (MPOD) is ex-
pressed on the vertical axis, against foveal 
eccentricity in degrees on the horizontal 
axis. Data of patients with Sjögren-Larsson 
syndrome (SLS), obtained from 9 right eyes 
(OD) and 10 left eyes (OS) (see Table 1), 
had significantly lower foveal MPOD values 
compared to healthy controls (Student’s t-
test, p < 0.001). Error bars indicate the 
standardized deviation. Line is drawn as a 
guide to the eye. At 1 degree only one mea-
surement was available in the SLS cohort 
and at 2 degrees only two. Therefore, no 
error bars were placed here. 
ermore, MP has also been perceived in otherwise 
healthy premature infants and children.9, 27 
 plus 
zeaxanthin) was 0.14, compared to 0.24 in healthy controls (Student’s t-test, p < 0.001). 
8 
degrees eccentricity, lacking the well known profile of MPOD observed in healthy subjects. 
dered data comparison appropriate. The small but significant age difference between cases 
and controls is unlikely to have impact on MP density, because the relationship between 
MPOD and age, if any, is marginal.26 Furth
Peripheral fixation proved to be difficult for these subjects, resulting in less peripheral data. 
The spatial profile of MPOD from SLS patients showed very low values at all eccentricities 
and lacked the central peak present in healthy eyes (fig. 5.14). Mean MPOD values at 0, 4, 6 
and 8 degrees eccentricity were always below 0.13. At the fovea, mean MPOD (0.10 ± 0.07) 
was significantly decreased compared to control subjects (0.69 ± 0.17; Student’s t-test, p < 
0.001). Spectral sub-analysis revealed that MP in SLS almost solely constituted of lutein, and 
zeaxanthin was virtually absent. Average foveal zeaxanthin fraction (zeaxanthin / lutein
DISCUSSION 
In our present paper we report on the lack of macular pigment in patients with juvenile, crys-
talline macular dystrophy due to SLS. This was indicated by the absent yellowish reflex of 
macular pigment on funduscopy and the missing macular FAF attenuation in SLS patients. 
Quantitative analysis by MPR revealed virtually complete absence of carotenoids, especially 
zeaxanthin, within the central retina of SLS patients. Recently, acquired partial MP loss has 
been reported in patients with Macular Telangiectasia type 2,25 however, we are not aware of 
any earlier description of virtually complete absence of MP due to a genetic disorder. Normal-
ly the MPOD peaks at, or near, the foveal centre and then decreases rapidly with eccentrici-
ty.5, 7 The shape of MPOD distribution in SLS, however, appears to be flat over the central 
126 Chapter 5.2 
 
The findings of our present study correspond with the ophthalmic symptoms observed in SLS 
patients. Short wavelength light, which is filtered by MP for a large part, has been shown to 
induce more intraocular straylight than light of longer wavelengths.28 Reduction or absence of 
MP may therefore lead to increased intraretinal straylight and hence, photophobia. Further-
more, it has been demonstrated that the amount of MP, at 30’ eccentricity, clearly reduces the 
deleterious effects of glare, an effect that was supposed to be mainly based on filtering.29 In 
addition the central levels of MP appear to contribute to improved visual performance, mainly 
in the short-wavelength spectrum (Snodderly DM et al. IOVS 2009;Volume: ARVO E-
Abstract 1702). Besides retinal thinning and pseudocyst formation, the absence of macular 
pigment together with the presence of highly refractive intra-retinal crystals may induce in-
creased amounts of straylight at the fovea and hence, play an important role in the ophthalmic 
symptoms of SLS patients, such as reduced visual acuity and photophobia. The lacking MP 
related protection from high-energetic photons may also add to the degenerative processes 
leading to macular thinning and pseudocyst formation. 
OCT-imaging in SLS patients displayed intraretinal crystals within the central 8 degrees fo-
veal eccentricity.3 These crystalline deposits seemed to be mainly located in the ganglion cell 
layers (GCL) and inner plexiform layer (IPL). Thus far, the biochemical nature of the glisten-
ing dots remains unknown, however, the site of their location on OCT corresponds with the 
histological position of MP in the normal retina.14 This co-localization suggests a relationship 
of the formation of intraretinal crystals and the absence of MP. 
The human body is unable to synthesize any carotenoids and therefore is completely depen-
dent on dietary carotenoids, including lutein and zeaxanthin. Lutein and zeaxanthin are ab-
sorbed by intestinal mucosal cells and incorporated into chylomicrons that are secreted into 
the lymphatic system and subsequently enter the circulation. Hepatic cells incorporate the 
carotenoids from the chylomicrons into lipoproteins that facilitate further transport of the ca-
rotenoids to the various body tissues. Transport, distribution and uptake of plasma lipoprote-
ins is regulated by apolipoproteins that are produced by many organs including the liver. Apo-
lipoprotein-E (Apo-E), which is produced in the eye by Müller cells and in the retinal pigment 
epithelium (RPE), is known to play part in lipid transport and binding of lipoproteins to target 
sites within the central nervous system and in the targeted uptake of the lipoproteins carrying 
lutein and zeaxanthin within the retina. Intrestingly, Müller cell degeneration seemed to be 
involved in the development of the juvenile maculopathy in SLS.3 Furthermore, normal plas-
ma levels of lutein and zeaxanthin were found in SLS patients (M.A.A.P. Willemsen, Doctor-
al Thesis 2001, http://ubn.ruhosting.nl/dissertatie/dissertaties_1J2001.html, accessed Septem-
ber 6th, 2009). Therefore, a disturbed retinal MP metabolism, presumably located within the 
retinal Müller cells, appears the most probable reason for MP deficiency in SLS. The charac-
teristic crystals seen in patients with SLS typically develop in the first two years of life. The 
metabolic pathway, in which the FALDH deficiency contributes to the appearance of this de-
posits is yet undiscovered. The location and time of manifestation together with absence of 
MP suggests the glistening dots to be spin-offs of a disturbance in MP metabolism. 
The macula has a very active lipid metabolism which could be affected by FALDH deficiency 
in many different ways. Literature search revealed only a single histopathological case report, 
  
Lack of macular pigment in SLS 127 
 
describing the post-mortem retinal changes in a 23-year old SLS patient.30 At the level of the 
macular retinal pigment epithelium, an increased amount of lipofuscin granules and a signifi-
cant decrease in the amount of melanin and melanolipofuscin granules was observed. The 
lack of MP probably leads to uncontrolled oxidative stress, which may cause photoreceptor 
damage and accumulation of waste products indigestible for the RPE. Furthermore, FALDH 
deficiency itself results in the accumulation of many fatty alcohols and fatty aldehydes that in 
vitro can also react with phosphatidylethanolamide forming lipofuscin-like substances.31  
The aforementioned pathophysiologic processes are very likely to cause the focally increased 
FAF in the majority of SLS patients examined here. Recently, two additional cases of with 
similar changes of foveal FAF have been described.32 The authors concluded that the glisten-
ing dots may be the source of increased FAF in SLS. However, in our series of 9 eyes spots of 
increased FAF were not co-located with the crystals seen on fundus photography in any case. 
In contrast, increased FAF mostly occurred at locations where no crystals were visible. There-
fore, we believe that foveal hyperfluorecence in SLS most likely originates from increased 
levels of retinal and sub-retinal fluorophores, i.e., lipofuscin and its derivates. 
In SLS, the presumed Müller cell degeneration with subsequent absence of MP leads to in-
creased photo-oxidative stress. The formation of highly active free oxygen radicals and oxida-
tion of lipofuscin causes damage to the RPE and eventually photoreceptor degeneration. This 
might additionally lead to increased accumulation of lipofuscin and RPE degeneration, re-
flected by focally increased and decreased FAF in SLS, respectively.  
Dietary lutein supplementation, especially for the purpose of age-related macular degenera-
tion (AMD) prevention, has been extensively investigated during the past decades. The macu-
lar response to increased lutein and zeaxanthin serum concentrations is not similar in all pa-
tients, and increase of MPOD varies strongly.8, 33, 34 The role of MP increase in late AMD 
prevention is still controversial. It is also uncertain, whether supplementation of carotenoids 
would be beneficial in SLS patients. First, blood levels of carotenoids are supposed to be 
normal as found by Willemsen et al. ( M.A.A.P. Willemsen, Doctoral Thesis, 2001, 
http://ubn.ruhosting.nl/dissertatie/dissertaties_1J2001.html, accessed September 6th, 2009) and 
it is therefore unsure, if uptake in the retina would be appropriate since the SLS patients 
measured here display very low levels of MP despite normal carotenoid blood levels. Second, 
highly concentrated carotenoids may undergo oxidation into so-called ‘carotenoid derived 
aldehydes’ (CDA), which are highly reactive and can cause significant oxidative stress that is 
comparable to the oxidative stress from lipid peroxidation products.35 Therefore, a risk for 
additional retinal damage due to carotenoid supplementation in SLS patients cannot be ex-
cluded. 
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In conclusion, the juvenile, crystalline maculopathy in Sjögren-Larsson-syndrome shows a 
significant lack of central macular pigment as compared to healthy eyes. This may be caused 
by a reduced carotenoid accumulation in the macula. Additional focal changes of fundus au-
tofluorescence point to increased foveal lipofuscin content and parafoveal atrophy of the re-
tinal pigment epithelium. This may be due to increased photooxidation and cellular toxicity as 
a consequence of macular pigment deficiency. Based on the complex pathobiochemistry in 
Sjögren-Larsson syndrome, a complementary diet with carotenoids may be potentially harm-
ful. 
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ABSTRACT 
OBJECTIVE: To illustrate the spectrum of short-wavelength fundus autofluorescence 
(FAF) abnormalities in a variety of retinal dystrophies.  
METHODS: We examined 112 patients with retinal dystrophies, including Stargardt dis-
ease (8 patients), Best vitelliform macular dystrophy (27 patients), central areolar choroidal 
dystrophy (48 patients), and various pattern dystrophies (29 patients). All retinal dystrophies 
were confirmed by molecular genetic analysis. FAF imaging was performed with a confocal 
scanning laser ophthalmoscope.  
RESULTS: A broad range of characteristic FAF patterns was observed in Stargardt disease, 
Best vitelliform macular dystrophy, central areolar choroidal dystrophy, as well as the pattern 
dystrophies. FAF imaging provided qualitative information, reflecting the degree of accumu-
lation of lipofuscin and its related fluorophores. 
CONCLUSION: FAF imaging constitutes a useful additive tool in the diagnosis and fol-
low-up of various retinal dystrophies. 
INTRODUCTION 
During the last decade, fundus autofluorescence (FAF) imaging of the retina has emerged as a 
useful, non-invasive imaging technique in the diagnosis and follow-up of several retinal dy-
strophies.1-5 Obtaining sufficient-quality FAF images generally becomes feasible starting 
from 5 years of age.5 Short-wavelength excited FAF origins from fluorophores within the 
retinal pigment epithelium (RPE), and RPE lipofuscin distribution is the principal cause for 
the observed FAF patterns.6 Lipofuscin contains a mixture of fluorescent molecules that are 
by-products of the visual cycle, many of which have not been thoroughly characterized to 
date.6-9 
The major lipofuscin fluorophore is A2E, which exerts diverse toxic effects on the RPE.9-18 
While the slight and diffuse increase of lipofuscin with ageing is physiologic, extensive and 
focal accumulation of lipofuscin is pathologic and may be encountered in a variety of retinal 
dystrophies.13,14,17,19 Histopathological studies have found an excessive accumulation of lipo-
fuscin and/or A2E in several retinal dystrophies, including those associated with mutations in 
the ABCA4 gene, the BEST1 (VMD2) gene, and the peripherin/RDS gene.20-22 The present 
study illustrates the appearance of characteristic FAF patterns in selected, relatively frequent 
retinal dystrophies.  
MATERIAL AND METHODS 
FAF imaging was performed with a confocal scanning laser ophthalmoscope (cSLO, Heidel-
berg Retina Angiograph 2; Heidelberg Engineering, Dossenheim, Germany) and all images 
were acquired by the same operator (CJFB). After pupil dilation to at least 6 mm with one 
drop of phenylephrine and one drop of tropicamide, FAF imaging was performed using the 
30º field of view and a resolution of 1536 x 1536 pixels, using an optically pumped solid state 
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laser (488 nm) for excitation. A barrier filter (500 nm) suppressed blue argon excitation light 
at 488 nm, so that reflectance signals did not contribute to the FAF image obtained from the 
posterior pole of the examined eye.  
For the acquisition of FAF images, a standard procedure was followed, which included focus-
ing of the retinal image in the infrared reflection mode at 820 nm, sensitivity adjustment at 
488 nm and acquisition of 9 single 30°x30° FAF images which encompassed the entire macu-
lar area and at least part of the optic disc. In order to improve the signal-to-noise ratio of the 
FAF signal, the nine single images were aligned and a mean image was calculated after detec-
tion and correction of eye movements using the software provided by the manufacturer (Hei-
delberg Eye Explorer, Heidelberg Engineering, Dossenheim, Germany). Images were digi-
tized and saved on hard disc for further analysis and processing. In general, areas of increased 
FAF are believed to represent lipofuscin increase either within or outside RPE cells, whereas 
decreased FAF may indicate RPE cell death and atrophy of the RPE-photoreceptor complex. 
A total of 112 patients with a variety of retinal dystrophies participated in the study. All ex-
aminations were undertaken with the understanding and written consent of each subject, and 
all procedures were conducted in accordance with the Declaration of Helsinki. All patients 
were consecutively seen in a tertiary referral setting at the Department of Ophthalmology of 
the Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.  
We included 8 patients with autosomal recessive Stargardt disease/fundus flavimaculatus 
(STGD1), 27 patients with Best vitelliform macular dystrophy (BVMD), 48 patients with cen-
tral areolar choroidal dystrophy (CACD), and 29 patients with some form of pattern dystro-
phy: 9 of these patients had the adult-onset foveomacular vitelliform dystrophy (AFVD) sub-
type, 16 patients were diagnosed with multifocal pattern dystrophy simulating STGD1, one 
patient had butterfly-shaped pattern dystrophy and 3 patients had pattern dystrophy related to 
“maternally inherited diabetes and deafness” (MIDD).  
In all STGD1 patients, the diagnosis was confirmed by the identification of 2 compound hete-
rozygous mutations in the ABCA4 gene. In all 27 BVMD patients, the diagnosis was con-
firmed by an absent light rise on the electro-oculogram and the finding of a specific variant in 
the BEST1 gene. All patients with CACD and multifocal pattern dystrophy simulating 
STGD1, as well as the patient with butterfly-shaped pattern dystrophy, carried mutations in 
the peripherin/RDS gene. The study population of patients with multifocal pattern dystrophy 
simulating STGD1 was a subset of recently reported patients.23 In the AFVD patients, no mu-
tations in BEST1 or peripherin/RDS were identified. This is in accordance with a recent study 
that found that mutations in these genes are relatively rare in AFVD patients.24 The patients 
with MIDD-related pattern dystrophy carried a mitochondrial 3243A>G mutation. 
After their medical history was obtained, all patients underwent an extensive ophthalmic ex-
amination, including best-corrected Snellen visual acuity, indirect ophthalmoscopy and fun-
dus photography. In addition to FAF imaging, subsequent examination included optical cohe-
rence tomography and, in selected cases, fluorescein angiography, electroretinography and 
electro-oculography.  
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RESULTS  
AUTOSOMAL RECESSIVE STARGARDT DISEASE / FUNDUS FLAVIMACULATUS (STGD1): In 
our study group, all STGD1 patients displayed FAF abnormalities. Sample cases are depicted 
in figure 5.15. Six STGD1 patients showed areas of focally increased FAF, sometimes bor-
dered by a zone of decreased FAF. In addition, spots of decreased FAF were visible in these 
patients. In two patients, these areas of altered FAF were restricted to the macula, while four 
patients showed a distribution of these flecks throughout or beyond the posterior pole. Many 
of these flecks corresponded with irregular yellowish flecks at ophthalmoscopy, but some 
flecks of increased FAF were not seen at ophthalmoscopy. The highest number of these 
extramacular flecks was seen in the nasal retina. Two patients showed a diffusely increased 
FAF pattern throughout the fundus, with a speckled pattern of small areas of decreased FAF. 
In these patients, a large area of markedly decreased FAF could be observed in the macula. 
Seven patients showed relatively normal FAF in the parapapillary zone, but one patient 
showed parapapillary FAF abnormalities. 
Fig. 5.15 
FAF in autosomal recessive Stargardt disease (STGD1). (A) FAF image of a 30-year old 
STGD1 patient (p.Gly1961Glu and p.Lys969Arg mutations in ABCA4 gene), showing FAF 
changes that are restricted to the macula. Flecks of increased and decreased FAF surround 
the fovea, while the central fovea has a relatively normal appearance. The visual acuity was 
20/20. (B) Composition of FAF images of a 29-year-old patient with STGD1 (p.Gly863Ala 
and p.Arg2030X mutation in ABCA4 gene). The macula shows mottled FAF changes, sur-
rounded by irregular flecks of increased FAF, some of which are bordered by a zone of de-
creased FAF. The number of flecks on FAF increases outside the macula, and the flecks are 
most numerous in the nasal retina. These FAF changes are absent in the peripapillary area. 
The visual acuity was 20/200. (C) Composition of FAF images of a 20-year-old STGD1 pa-
tient (p.Tyr1779X and IVS38-10T>C mutation in ABCA4), displaying markedly decreased 
FAF in the central macula. Outside this area, diffusely increased FAF is observed, with 
speckled areas of decreased FAF. In contrast to the patient described in (B), the peripapillary 
retina is not spared by these FAF changes. The visual acuity was 20/200. 
 
BEST VITELLIFORM MACULAR DYSTROPHY: All patients with Best vitelliform macular dy-
strophy (Fig. 5.16) in our study group displayed FAF abnormalities, except both patients who 
were in the carrier stage, in whom FAF abnormalities were either very discrete or absent. Le-
sions in earlier stages, in which vitelliform material appeared more abundant at ophthalmos-
copy, FAF imaging displayed areas of markedly increased FAF. In the vitelliform stage, the 
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Fig. 5.16 
FAF in Best vitelliform macular dystrophy 
(BVMD). (A) carrier stage, no evident FAF 
abnormalities. Visual acuity (VA) was 
20/20. A p.Thr6Pro variant in the BEST1 
gene was found in this patient. (B) Vitelli-
form stage, showing a round macular le-
sion with intensely increased FAF, corres-
ponding with yellow subretinal material on 
ophthalmoscopy; p.Thr6Pro variant in 
BEST1, VA 20/20. (C) pseudohypopyon 
stage, highly increased FAF inferior. Some 
small spots of increased FAF also in the 
superior part of the lesion; p.Thr6Pro va-
riant in BEST1, VA 20/20. (D) Vitelliruptive 
(“scrambled-egg”) stage, dispersed locali-
zation of increased FAF, mainly situated at 
the borders of the lesion, and the central 
part of the lesion with some foci of in-
creased FAF; p.Lys194_ Ala195insVal 
mutation in BEST1,VA 20/20. (E) Example 
of atrophic stage, well-demarcated area of 
absent FAF, corresponding with choriore-
tinal atrophy; VA 20/32, p.Leu82Val va-
riant in BEST1. (F) cicatricial stage of 
BVMD with a central lesion of reduced 
FAF, bordered by a ring-shaped zone of 
slightly increased FAF and two small peri-
pheral lesions with increased FAF; VA 
20/125, p.Thr6Pro variant in BEST1. (G) 
spoke-like FAF changes adjacent to a cen-
tral area of decreased to absent FAF; 
p.Ala243Val variant in BEST1, VA 20/25. 
(H) multifocal vitelliform dystrophy, 
p.Gly299Ala variant in BEST1; VA 20/80.
round lesions showed homogeneously increased FAF. In the pseudohypopyon stage, FAF was 
visible mainly in the inferior portion of the lesion, co-locating with the ophthalmoscopically 
visible pseudohypopyon. In the vitelliruptive or scrambled-egg stage, the amount of autofluo-
rescent material was reduced to a certain extent and condensed mainly at the borders of the 
lesion, whereas the central part of the lesion showed slightly decreased FAF. In the atrophic 
stage, areas corresponding with chorioretinal atrophy corresponded with a major decrease of 
the FAF signal. Reduced FAF also dominated in the cicatricial stage. However, some spots of 
discretely increased FAF were present within these areas of decreased FAF. In general, FAF 
imaging was able to visualize even very small amounts of vitelliform material that were not 
readily seen at ophthalmoscopy. Finally, one patient displayed a spoke-like pattern of FAF 
changes simulating macular pattern dystrophy, while another patient had multifocal vi-
telliform lesions. 
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CENTRAL AREOLAR CHOROIDAL DYSTROPHY (CACD): In CACD (fig. 5.17), FAF charac-
teristics will be described according to the staging of CACD as suggested by Hoyng and 
Deutman (1996). In stage I CACD, a discrete speckled increase of FAF was observed in the 
parafoveal area. The FAF abnormalities corresponding with early stage II involved a 
speckled, round to oval area of predominantly increased FAF. This area of abnormal FAF 
enlarged towards late stage II, and the spots of increased FAF within the lesion decreased in 
favour of speckles of decreased FAF. Stage III was characterized by the appearance of extra-
foveal, well-defined areas of absent FAF, which corresponded with chorioretinal atrophy at 
ophthalmoscopy. These areas enlarged and multiplied on follow-up. Stage IV CACD was 
characterized by foveal involvement of the area of absent FAF. Eventually, a round to oval 
area of virtually absent FAF was seen in patients with end-stage CACD, bordered by a small 
band of increased FAF. 
 
Fig. 5.17 
FAF in central areolar choroidal dystrophy (CACD). All patients carried a p.Arg142Trp 
mutation in the peripherin/RDS gene. (A) Stage I CACD with a diffuse parafoveal increase 
of FAF; visual acuity 20/20. (B) Early stage III CACD, with small extrafoveal foci of absent 
FAF, corresponding with profound chorioretinal atrophy, on a background of speckled FAF 
increase. (C) Same patient as in panel (B), showing enlargement of the existing atrophic 
area after a follow-up period of 1.5 years. In addition, new regions of absent FAF have 
appeared. The visual acuity was still 20/20. Of note, the area of speckled FAF increase has 
not changed. (D) Stage IV CACD, with a round macular lesion of absent FAF, bordered by 
a small band of increased FAF. Note the discrete FAF of larger choroidal vessel underlying 
the lesion; visual acuity 20/800. 
PATTERN DYSTROPHIES  (fig. 5.18): The vitelliform lesions in the patients with ADULT-
ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY corresponded with round to oval lesions 
with increased FAF in 8 patients, sometimes with a small spot of reduced FAF. Two patients 
had unilateral disease. In two patients, zones of increased and decreased AF were seen within 
the same lesion. One of these patients had lesions displaying characteristics of scrambled-egg 
and pseudohypopyon. In another patient, the lesion in one eye showed decreased FAF, cor-
responding with chorioretinal atrophy at ophthalmoscopy. Small multifocal lesions of in-
creased FAF were seen in the macular area of one patient. In all patients, lesions were smaller 
than one disc diameter on FAF.    
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In general, FAF in patients with MULTIFOCAL PATTERN DYSTROPHY SIMULATING STGD1 
shows changes that are very similar to the FAF changes seen in patients with the fundus fla-
vimaculatus subtype of STGD1. In multifocal pattern dystrophy simulating STGD1, the 
STGD1-like flecks displayed highly increased FAF, often with small adjacent zones of de-
creased FAF. In a later stage, these flecks of increased FAF showed confluence towards a 
large ring-shaped area of mottled FAF abnormalities surrounding the macula and optic disc, 
without sparing of the parapapillary retina (Fig. 2.9C). The changes could gradually involve 
the macula. Within this ring-shaped area of increased FAF, granular zones of substantially 
decreased FAF appeared. After one or more decades of disease, profound chorioretinal atro-
phy of the posterior pole could occur, which corresponded with a severely decreased or absent 
FAF signal. In the macular area, FAF changes were variable. In 8 eyes, discrete spots of either 
increased or decreased FAF were seen in the fovea. A group of irregular flecks of mostly in-
creased FAF, comparable to but often larger than the peripheral flecks, was seen in 7 eyes. In 
8 eyes of 5 patients, large, irregularly shaped lesions were seen, showing spots of increased 
and decreased FAF. In one eye, a butterfly-shaped lesion was seen on FAF as well as at oph-
thalmoscopy. One or more well-defined areas of severely decreased FAF could be observed in 
8 eyes of 5 patients, corresponding with profound chorioretinal atrophy.  
We examined one patient with BUTTERFLY-SHAPED PIGMENT DYSTROPHY, in whom the 
butterfly-shaped lesions at ophthalmoscopy were also observed on FAF. The pigmented part 
of the butterfly-shaped lesion showed increased FAF, and was surrounded by decreased FAF.  
In one patient with PATTERN DYSTROPHY ASSOCIATED WITH MATERNALLY INHERITED 
DIABETES AND DEAFNESS (MIDD), spots of decreased and increased FAF were scattered 
throughout the macula, in one eye with a central area of increased FAF corresponding with a 
pseudovitelliform lesion at ophthalmoscopy. Another patient displayed the same speckled 
aspect of spots of increased and decreased FAF, with a relatively normal FAF aspect of the 
fovea. The third MIDD patient who displayed advanced FAF changes in the posterior pole 
and around the optic nerve, showed apparently normal FAF of both foveas, corresponding 
with a normal visual acuity.  
DISCUSSION 
In the present study, FAF abnormalities were observed in all examined eyes with ophthalmos-
copically visible retinal dystrophies. Focally increased FAF was the most common finding, 
frequently accompanied by areas of decreased or even absent FAF. We observed specific FAF 
abnormalities that were dependent on the examined retinal disorder.  
FUNDUS AUTOFLUORESCENCE IN STGD1 
Autosomal recessive Stargardt disease / fundus flavimaculatus (STGD1) is caused by muta-
tions in the ABCA4 gene.25 With disease progression, excessive increase of lipofuscin and 
especially A2E can be observed, which is accelerated by light exposure.26-28 This abnormal 
increase of RPE lipofuscin is probably the first detectable pathophysiological change in 
STGD1.26 Therefore, FAF imaging appears a promising method to monitor patients with 
STGD1.29 
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Fig. 5.18 
FAF in pattern dystrophies. (A) Adult-onset foveomacular vitelliform dystrophy, showing a small 
foveal lesion of increased FAF; visual acuity (VA) 20/32. No mutations in peripherin/RDS or BEST1. 
(B) FAF in multifocal pattern dystrophy simulating STGD1, displaying irregular flecks of increased 
FAF, with small adjacent zones of decreased FAF; FAF characteristics are very similar to those ob-
served in STGD1 (See Fig. 5.15B); VA 20/20;  p.Asp145fsX30 mutation in the peripherin/RDS gene. 
(C) Advanced multifocal pattern dystrophy simulating STGD1, with a large area of speckled increase 
and decrease of FAF extending beyond the retinal vascular arcades and optic disc; multiple, well-
circumscribed patches of absent FAF correspond with RPE atrophy on ophthalmoscopy; VA of 20/25, 
p.Pro147fsX4 mutation in peripherin/RDS. (D) FAF of a patient with butterfly-shaped pigment dy-
strophy; the pigmented butterfly-shaped figure showing increased surrounded by decreased FAF; 
p.Arg220fsX34 mutation in peripherin/RDS, VA 20/20. (E) Patient with maternally inherited diabetes 
and deafness (MIDD)-associated pattern dystrophy (m.3243A>G mutation), a large pseudovitelli-
form macular lesion and satellite lesions showed increased FAF and dispersed spots of decreased 
FAF; VA 20/40. (F) Pattern dystrophy in a MIDD patient (m.3243A>G mutation) with speckled 
changes of increased and decreased FAF; foveal area shows relatively normal FAF aspect; VA 
20/20. (G) Advanced pattern dystrophy in a MIDD patient, m.3243A>G mutation, irregular changes 
of increased and decreased FAF along the temporal retinal vascular arcades and surrounding the 
optic disc. The macula shows a large area of markedly decreased to absent FAF with the exception of 
a spared foveal island, VA 20/20. 
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In our study, central macular lesions showed largely decreased FAF, reflecting chorioretinal 
atrophy. In most patients, these central lesions were surrounded by smaller, well-
circumscribed lesions of predominantly increased FAF, largely corresponding with the irregu-
larly shaped yellowish flecks that were observed at ophthalmoscopy. However, some of these 
lesions on FAF were not readily seen at ophthalmoscopy. This emphasizes the potential of 
FAF to detect pathologic changes in STGD1 in advance to clinically visible abnormalities. 
Lesions were sometimes confined to the macula, but an innumerable amount of flecks of in-
creased FAF, scattered throughout the retina, could also be observed. Like in the normal reti-
na,19 the rate of lipofuscin accumulation in STGD1 shows considerable intraretinal varia-
tion.26,30 A disease sequence of six stages has been proposed by Cideciyan and colleagues,26 
based on lipofuscin accumulation, retinoid cycle kinetics, as well as rod, cone and RPE cell 
loss. Stage I shows entirely normal results, while the only detectable abnormality in stage II is 
an increase in mean FAF intensity. In stage III, these changes are superimposed by a focal 
increase of FAF intensity. Different FAF patterns have been described in STGD1, which ap-
pear to correspond with functional abnormalities.29,31 Lesions tend to enlarge and show con-
fluence, while the initially elevated FAF signal evolves towards decreased to absent FAF in-
tensities. These decreasing FAF intensities are due to the loss of lipofuscin-laden RPE cells, 
accompanied by increasing photoreceptor degeneration and slowing of the retinoid cycle. In 
stage VI (end-stage) ABCA4-related retinal degeneration, variably sized regions of absent 
FAF are observed as a consequence of complete RPE and photoreceptor degeneration.  
In cases of STGD1 with abnormal cone and rod responses on electroretinography, most pa-
tients show a decreased FAF signal at the macula, sometimes in combination with patches of 
decreased FAF beyond the vascular arcades, corresponding with chorioretinal atrophy. This 
group of STGD1 patients also tends to show more visual loss.29 Although there is no direct 
evidence that conventional short-wavelength FAF accelerates the disease process of ABCA4-
related retinal dystrophies, there are indications that some retinal degenerative diseases like 
STGD1 may have lower light damage thresholds.21,30,32,33 Therefore, some authors advocate 
the use of reduced intensity FAF imaging.32,33 
FUNDUS AUTOFLUORESCENCE IN BEST VITELLIFORM MACULAR DYSTROPHY 
Best vitelliform macular dystrophy (BVMD) is an autosomal dominant retinal dystrophy that 
predominantly affects the macula. BVMD is caused by mutations in the BEST1 gene.34 Typi-
cally, BVMD patients show bilateral round to oval yellow subretinal lesions in the macula 
that resemble an egg-yolk at a certain point of time.35 In a minority of cases, multifocal vitelli-
form lesions may be encountered.36,37 Most histopathological studies have found an abnormal 
increase of RPE lipofuscin and A2E in the RPE of donor eyes of BVMD patients.20,37-41  
In our study, FAF imaging allowed a detailed appreciation of the lesions in all BVMD pa-
tients. FAF was also able to visualize small amounts of vitelliform material that were not seen 
at ophthalmoscopy. In early stages, BVMD lesions showed a predominantly increased FAF, 
which decreased towards later stages. Previous studies indicate that lesions may remain rela-
tively constant in size,4 but they may also enlarge when evolving to later stages.42,43 In virtual-
ly all patients, internal FAF characteristics change substantially during follow-up.4 Lower 
visual acuity appears to be associated with a more irregular pattern of increased FAF within 
the lesion, due to scarring or hemorrhage.4,44 In our study, lesions in later stages of BVMD 
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were characterized by a generally decreased FAF. This gradual loss of FAF in later disease 
stages indicates that this subretinal material of increased FAF gradually disappears when RPE 
cell death progresses and atrophy and/or scars develop. 
FUNDUS AUTOFLUORESCENCE IN CENTRAL AREOLAR CHOROIDAL DYSTROPHY 
Most cases of autosomal dominant CACD appear to be associated with mutations in the peri-
pherin/RDS gene, but genetic heterogeneity has been described.45-47 In our study, patients with 
autosomal dominant CACD showed increased FAF in the macular area early in the course of 
the disease, suggesting lipofuscin accumulation in the macular RPE. In late stage II CACD, 
zones of decreased FAF may become more prominent, suggesting gradual loss of RPE cells. 
Thus, our FAF findings indicate a progressive lipofuscin accumulation and consecutive RPE 
damage during the first two stages. With time, lesions may extend beyond the retinal vascular 
arcades and optic nerve head.45,48 FAF in stage III CACD shows sharply demarcated areas of 
severely decreased to absent FAF. These atrophic areas develop within the areas of granular 
FAF changes. Therefore, the initial diffusely affected RPE may finally result in regions of 
total loss of RPE, which enlarge and finally involve the foveal RPE in end-stage CACD. In 
this stage, a well-defined, round to oval area of absent FAF is seen, bordered by a small area 
of increased FAF. Interestingly, FAF abnormalities may precede ophthalmoscopically visible 
changes in CACD.45 This makes FAF imaging especially suitable for non-invasive screening 
of families with CACD. 
FUNDUS AUTOFLUORESCENCE IN PATTERN DYSTROPHIES 
The phenotypically and genetically heterogeneous group of pattern dystrophies is characte-
rized by a variety of deposits of yellow, orange or gray pigment, predominantly in the macular 
area.49-52 The classification of Gass discriminates between five main categories of pattern dy-
strophies: adult-onset foveomacular vitelliform dystrophy (AFVD), butterfly-shaped pigment 
dystrophy, reticular dystrophy of the pigment epithelium, multifocal pattern dystrophy simu-
lating fundus flavimaculatus (MPD), and fundus pulverulentus.35 
In the group of AFVD patients in the present study, all lesions were smaller than one disc 
diameter in size and generally showed increased FAF. These results correspond with previous 
FAF findings in AFVD patients and with the histopathologic finding of increased lipofuscin 
in AFVD lesions.53-55 One patient showed small multifocal lesions of increased FAF, while 
another patient had lesions with a scrambled-egg and pseudohypopyon aspect, features that 
are also seen in BVMD.  
In patients with MPD, which is often caused by peripherin/RDS mutations, the posterior pole 
may be scattered with irregular flecks mimicking STGD1 on FAF, as well as on ophthalmos-
copy and optical coherence tomography.23 Like in STGD1, the flecks in MPD may extend 
beyond the macular area. In later stages, these flecks may show confluence to a ring-shaped 
area of abnormal FAF, surrounding the macula and optic disc. Central macular lesions show a 
broad range of FAF changes, often with predominantly increased FAF, especially in earlier 
stages. In time, macular lesions may also show markedly decreased FAF due to profound cho-
rioretinal atrophy. Therefore, it may be difficult to discriminate between STGD1 and MPD on 
the basis of the FAF aspect. Distinguishing features between MPD and STGD1 are the auto-
somal dominant pattern of inheritance, the relatively late age at onset, the comparatively good 
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and stable visual acuity and the absence of a “dark choroid” on fluorescein angiography.23 
Molecular genetic analysis may aid in the differential diagnosis between these different enti-
ties. 
In butterfly-shaped pigment dystrophy, patients display macular lesions with a spoke-like 
pigment pattern surrounded by a zone of depigmentation, thus somewhat resembling the 
shape of a butterfly.56 The phenotype of butterfly-shaped pigment dystrophy is genetically 
heterogeneous.57,58 In a case caused by a peripherin/RDS missense mutation (Cys213Tyr), 
increased amounts of lipofuscin have been found in the RPE on histopathologic examina-
tion.22 This corresponds with the finding in our study of increased FAF of the pigmented part 
of the lesion in the patient with butterfly-shaped pigment dystrophy.  
Pattern dystrophy phenotypes may also be associated with syndromes, such as myotonic dy-
strophy, pigment dispersion syndrome, and mitochondrial syndromes like maternally inherited 
diabetes and deafness (MIDD) and mitochondrial encephalomyopathy, lactic acidosis, and 
stroke-like episodes (MELAS) syndrome.59-63 MIDD and MELAS are associated with muta-
tions in the mitochondrial DNA, the 3243A>G point mutation being the most frequently iden-
tified mutation.64 As much as 86% of patients with maternally inherited diabetes and deaf-
ness (MIDD) may show some form of pattern dystrophy. In our study, RPE changes in MIDD 
patients were easily defined on FAF as speckled areas of increased and decreased FAF in the 
macula and surrounding the optic disc. The intriguing feature of foveal sparing can be ob-
served on FAF in a MIDD patient with advanced pattern dystrophy,65 which is illustrated in 
Fig. 5.18G. 
CONCLUSIONS 
FAF imaging is a useful tool for the identification and follow-up of lesions associated with 
lipofuscin accumulation or RPE cell loss. As such, FAF imaging may yield important addi-
tional information in a diagnostic setting in relatively frequent retinal dystrophies such as 
STGD1, BVMD and in retinal dystrophies associated with peripherin/RDS mutations. FAF 
may visualize more lesions compared to ophthalmoscopy. Moreover, FAF imaging provides 
qualitative information, as it reflects the lipofuscin content in lesions, and FAF changes ap-
pear to relate to functional abnormalities in at least some retinal dystrophies.1,29,66 However, 
non-lipofuscin accumulating parts of a lesion may be missed with FAF. Therefore, FAF alone 
may not be useful for lesion size measurement. Retinal dystrophies may present with a consi-
derable clinical variability. Late stages with RPE cell loss may look similar in various retinal 
dystrophies and in other retinal disorders such as age-related macular degeneration. In this 
respect, FAF may be of limited use in the differential diagnosis between different forms of 
retinal dystrophy. Molecular genetic testing may be very helpful in these cases. Compared to 
fluorescein angiography, FAF imaging, as a non-invasive imaging modality, is a straightfor-
ward and relatively patient-friendly means to get an overview of the accumulation of fluoro-
phores like lipofuscin and atrophic changes within the RPE-photoreceptor complex.2,6 There-
fore, FAF imaging may constitute a convenient tool for cross-sectional and family studies, as 
well as in the follow-up of various retinal dystrophies. In addition, FAF imaging may also 
play a role as a parameter for the evaluation of therapeutic effects in future clinical treatment 
trials. 
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SUMMARY 
BACKGROUND: Fundus autofluorescence (FAF) may be excited and measured at 
different wavelengths. In the present study we compared short-wavelength and near-infrared 
FAF patterns of retinal dystrophies. 
METHODS: We analyzed both eyes of 108 patients with diverse retinal dystrophies. 
Besides color fundus photographs, FAF images were obtained with the Heidelberg Retina 
Angiograph (HRA 2). We used excitation wavelengths of 488 nm (blue; filter at 500 nm) and 
787 nm (near-infrared; filter at 810 nm). For improvement of signal-to-noise ratio a total of 9 
images were averaged, and the mean images were compared to each other. 
RESULTS: Useful FAF images of both excitation wavelengths were achieved in all 
patients. We observed characteristic FAF patterns, which differed between excitation 
wavelengths dependent on the disease. During time, FAF pattern changes and progression 
could be observed. 
CONCLUSION: FAF of both wavelengths were helpful for phenotype description in retinal 
dystrophies. Apparently near infrared and short wavelength FAF may show different 
pathologic changes in the same eye. However, any conclusions may be limited by the yet 
incomplete knowledge about the prognostic value of FAF in the diseases studied here. 
INTRODUCTION 
After the first reports on fundus autofluorescence (FAF) in the short-wavelength1 and the 
near-infrared2 range there has been a growing scientific and clinical interest in FAF of 
patients with inherited and acquired retinal diseases.3-7 This is hardly surprising, as FAF is an 
inherently non-invasive, patient-friendly technique, which provides a topographical overview 
of the functional state of the retinal pigment epithelium (RPE).1 Due to the strong 
autofluorescence signals, FAF imaging is particularly suited for diseases with excessive 
accumulation of lipofuscin where pathological fundus changes will appear most clearly on 
FAF.8;9 
In recent years, FAF imaging with excitation by short-wavelength light has been established 
for patients with inherited retinal and macular diseases.10-13 The benefit of the technique is 
based on the strong autofluorescence of the frequently accumulated lipofuscin in those cases. 
Lipofuscin fluoresces brightly in the orange-yellow spectrum if irradiated with blue light. 
Usually, a confocal laser scanning ophthalmoscope (Heidelberg Retina Angiograph, HRA) is 
applied, resulting in an 8-bit gray value image giving a topographical overview of FAF, which 
allows a straightforward analysis for clinical applications. 
In addition to blue light, light from the near-infrared spectrum seems to be appropriate for 
exciting RPE fluorophores. Obviously not lipofuscin but melanin seems to play an important 
role in the near-infrared spectrum.14;15 However, this still needs to be established by ex-vivo 
examinations. 
Different compilations and distributions of the causal fluorophores result in significantly 
different appearances of FAF, which appears already in the healthy eye, independent of 
whether the examination was done with either blue light (FAF488) or light of the near infrared 
range (FAF787) (Fig. 5.19). Table 5.2 suggests factors that may affect FAF images at different 
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wavelengths. Our incomplete knowledge of causal fluorophores for FAF787, and in general, 
should be borne in mind. For example, there is lack of data on optical phenomena such as 
light scattering and absorption in FAF. 
This study aimed to compare FAF488 and FAF787 in patients with hereditary retinal diseases 
and significant RPE pathologies in the RPE. In addition to a clinical comparison of FAF488 of 
inherited diseases, we tried to initiate an interpretation of FAF787 in such cases. 
FAF deviation FAF488 FAF787 
↑↑ A2E, LF, unknown FF ↑↑ melanin, MLF, unknown FF ↑↑ 
↑ 
A2E, LF, unknown FF ↑, COL 
(vessel walls in  
atrophic areas)
macula (melanin?, FF in PR) 
↔ background Background 
↓ 
macula (macular pigment) 
subretinal fluid 
RPE vitality ↓ (if focal) 
RPE vitality ↓ 
isolated RPE atrophy 
     (visible choroidal FAF) 
↓↓ 
RPE atrophy 
blockage (i.e. blood, vessels) 
papilla nervi optici 
blockage by vessels 
of retina or choroid 
 
Table 5.2 
Possible causes of FAF change. COL = collagen; FF = fluorophore; LF = lipofuscin; MLF = me-
lanolipofuscin; PR = photoreceptors; RPE = retinal pigment epithelium; ↑↑ = strong increased 
FAF; ↑ = moderate increased FAF; ↔ = normal FAF; ↓ = moderate decreased FAF; ↓↓ = strong-
ly decreased or absent FAF 
PATIENTS AND METHODS 
At total of 108 patients treated for retinal dystrophies at our department were included in this 
prospective, observational study. They were 8 patients with autosomal recessive Stargardt 
disease (STGD1), 27 patients with Best disease (BVMD), 48 patients suffering from central 
areolar choroidal dystrophy (CACD) and 25 patients with pattern dystrophies; to be exact we 
included 9 patients with adult foveomacular vitelliform dystrophy (AFVD) and 16 patients 
with multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus (pseudo-
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Stargardt). The investigation was done in accordance with the Declaration of Helsinki. 
Written informed consent was obtained from every patient prior to their inclusion in the study. 
In all study patients the clinical diagnosis was proven by genetic analysis. In case of STGD1 
at least two mutations were found in the ABCA4 gene; in BVMD we found mutations in the 
VMD2 gene; all patients with CACD as well as every Pseudo-Stargardt patient had mutations 
in the Peripherin/RDS gene. Characteristically, patients with AFVD did not have mutations in 
the VMD2 gene. 
Fig. 5.19 
FAF in a healthy subject excited with short wavelength (FAF488) and near-infrared (FAF787) 
light. The upper row depicts the topographic distribution of FAF, and gray value intensities 
of a line through fovea and optic nerve head (ONH) are plotted in the lower panels. FAF is 
diffusely distributed in both spectra. (a) FAF488 has minima at the ONH and the retinal ves-
sels. A moderate decrease is visible at the macular area. A ring-shaped maximum of FAF488 
is located at 10 degrees from the fovea. (b) Similar to short-wavelength autofluorescence, 
FAF787 shows minimal intensity at ONH and retinal vessels. The maximum of FAF787 is lo-
cated at the macula with a dip at the fovea. 
All FAF examinations were performed according to a standardized study protocol. After pupil 
dilation to at least 6 mm by tropicamid and phenylephrin eye drops, FAF was performed with 
the Heidelberg Retina Angiograph 2 (HRA 2, Heidelberg Engineering, Heidelberg, 
Germany). Images covered the central 30 degrees of the fundus using the High Resolution 
Mode (1536 × 1536 pixels) of the device. 
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Preceding FAF imaging, the HRA2 was focused on the retinal vessels in the blue (488 nm, for 
FAF488) or near-infrared (830 nm, for FAF787) reflection mode. The excitation wavelength for 
FAF488 was 488 nm with a barrier filter at 500 nm. FAF787 was excited at 787 nm and the 
emission signal measured above 800 nm. To improve the signal-to-noise ratio, 9 consecutive 
image frames were registered and an average image of these was calculated and used for 
further analysis. The averaged images were not normalized to obtain the unadulterated gray 
values of autofluorescence. Digital subtraction analysis was performed using ImageJ, Version 
1.39f (http://rsb.info.nih.gov/ij), an open source software for digital image analysis. Images 
depicted in this article were post-processed by histogram stretching to improve visibility of 
pathologies. 
RESULTS 
Compared to healthy individuals, both FAF488 and FAF787 showed considerable alterations in 
all patients. The resulting FAF patterns varied between different diseases, but showed also 
inter-individual dissimilarities within a certain disease.  
STARGARDT DISEASE 
All study participants with STGD1 showed focal alterations of FAF co-located with clinically 
visible flecks, but also on sites without clinical visible flecks. There was considerable 
variation regarding the number and distribution of the lesions. FAF488 revealed mostly 
increased autofluorescence, possibly surrounded by a halo of decreased FAF488 (Fig. 5.20). 
However, FAF787 was predominately decreased in the same areas, with single foci of 
increased FAF787. Interestingly, changes of FAF787 covered larger areas of the fundus than 
alterations of FAF488. Follow-up exams were achieved in four of the STGD patients. It 
appeared that flecks changed their contour and FAF488 properties within 15 to 18 months, 
typically showing decrease of autofluorescence with time (Fig. 5.21). 
MULTIFOCAL PATTERN DYSTROPHY SIMULATING STGD1 
In general, the FAF appearance in pseudo-Stargardt was very similar to that of STGD1. 
However, in most patients the hypofluorescent halo around the lesions in FAF488 appeared 
somewhat more prominent in pseudo-Stargardt (Fig. 5.22). Similar to STGD, the lesions in 
FAF787 were larger and more hypofluorescent than in FAF488. During a follow-up of 6 to 13 
months, only small changes were recorded in 7 of the pseudo-Stargardt patients. Here, there 
was less signal reduction but instead new lesion formation in FAF488 (Fig. 5.23).  
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Fig. 5.20 ◙ 
Morbus Stargardt. (a) Color fundus photography shows typical yellow-white, pisciform flecks. In 
addition, irregularities of the retinal pigment epithelium may be observed at the macula. (b) 
FAF488 reveals focally increased signals at the flecks, but also at some clinically unremarkable 
areas. At the macula, FAF488 appears to be irregularly distributed and shows focally reduced 
intensity. (c) Near-infrared reflectance is increased at flecks and atrophic areas. (d) Using FAF787 
more and larger lesions than in FAF488 appear with a predominantly low autofluorescence signal. 
Fig. 5.21 ◙ 
Longitudinal change of FAF488 in a case of STGD1. (a) At baseline, FAF488 is generally increased 
at lesions and the macular area is hypo-autofluorescent (lower area). (b) At follow-up exam after 
18 months many of the former bright spots appear darker and only single FAF488 increases can be 
observed. (c) Digital subtraction analysis results in mainly reduced FAF488 (blue-black) and some 
increases (orange-red) during the study period. Note that the area of macular hypo-
autofluorescence has enlarged. 
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Fig. 5.22 
Pseudo-Stargardt. (a) FAF488 appears similar to STGD with more prominent 
hypofluorescent halos around lesions. (b) FAF787 is also alike Stargardt disease but with 
more hyperautofluorescent spots in pseudo-Stargardt. 
 
 
Fig. 5.23 ◙ 
Longitudinal change of FAF488 in pseudo-Stargardt. (a) At baseline, flecks wit increased signals 
are predominantly seen in FAF488 surrounded by decreased FAF488, and a hypoautofluorescent 
area is visible at the macula. (b) After a period of 16 months most flecks are unchanged. Addi-
tional solitary foci of increased FAF488 have become visible. (c) Digital subtraction analysis re-
sults in largely unchanged FAF488 (green-yellow) with some solitary increases (orange-red) and 
decreases (blue-black) during follow-up.
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BEST DISEASE 
In all patients with Best disease, important alterations were visible on FAF488 as well as on 
FAF787. Increased autofluorescence of the vitelliform subretinal material was observed at both 
wavelengths (Fig. 5.24). However, in FAF787 the signal intensity was less than in FAF488. In 
vitelliruptive and cicatricial cases the areas of increased autofluorescence were reduced and in 
atrophic stages FAF488 was totally diminished at the lesion sites. 
 
 
 
Fig. 5.24 
FAF patterns in Best disease. In the pseudohypopyon stage a very strong signal of the subretinal 
material can be seen in FAF488 (a) as well as in FAF787 (b). Two years later the stage has 
changed to vitelliruptive with a diffuse-speckled emergence of FAF488 (c) at the lesion. At the 
same time, FAF787 (d) at this site appears reduced. Near-infrared reflectance (c,f) reveals in-
creased reflectivity of the subretinal material. 
ADULT FOVEOMACULAR VITELLIFORM DYSTROPHY 
Lesions in patients with AFVD showed similar patterns of autofluorescence as in patients 
with Best disease. However, atypical and multifocal lesions were more common in AVMD 
than in BVMD. In addition, more dissimilarities between FAF787 and FAF488 were visible 
(Fig. 5.25). Remarkably the vitelliform material showed a strong signal in FAF488 but often 
only a weak or no signal increase in FAF787. 
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Fig. 5.25 
Adult foveomacular vitelliform 
Dystrophy. (a) FAF488 is 
increased at the lesions. (b) In 
contrast, amplification of 
FAF787 is only partially 
present and some lesion parts 
show normal of decreased 
FAF787. 
CENTRAL AREOLAR CHOROIDAL DYSTROPHY 
CACD is a progressive disease with clearly defined stages,16 and both FAF488 and FAF787 
allowed visualization of stage-defined abnormalities in all patients (Fig. 5.26). The changes of 
FAF patterns observed appeared very similar at both wavelengths. In stage I single, small, 
parafoveal spots of increased FAF were evident. In stage II the entire macular area showed 
salt-and-pepper like changes of FAF. Patients in stage III showed one or more discrete 
parafoveal areas of significantly decreased FAF488. In FAF787 choroidal autofluorescence, 
which is hardly visible in healthy eyes, became obvious at the atrophic areas. Longitudinal 
studies showed enlargement of the atrophic lesions, which eventually came together to total 
macular atrophy in stage IV. 
DISCUSSION 
The present paper describes the alterations and longitudinal changes of FAF488 and FAF787 in 
Stargardt disease, Best disease, central areolar choroidal dystrophy, adult foveomacular 
vitelliform dystrophy and multifocal pattern dystrophy simulating Stargardt disease. All 
measurements resulted in important alterations at both wavelengths, with significant 
interindividual variability within the same disease. Dependent on the disease, FAF488 and 
FAF787 appeared comparable or dissimilar for the main part. Of note, FAF patterns were not 
stable but could change in many patients within a few months. 
Interpretation of FAF787 should consider physical phenomena like filter leakage during image 
achievement.17 Comparison of near-infrared reflection images and FAF787 (Figs. 5.20 and 
5.24) revealed not only similarities according increased reflectivity and autofluorescence but 
also strong differences between the FAF787 signal and near-infrared reflectivity. For example, 
the central atrophy in STGD1 (Fig. 5.20) showed a strong hyperreflectivity in the near-
infrared but FAF787 was low at that site. 
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Fig. 5.26 
FAF in different stages of CACD. 
The left column depicts FAF488 
and the right column shows 
FAF787. (a, b) stage 1 CACD (75 
years, female, VA 0,8): focal, 
parafoveal signal increase and 
hypofluorescence are visible. (c, 
d) stage 2 CACD (44 years, 
male, VA 0,8): salt-and-pepper 
like FAF changes at the macula. 
(e, f) stage 3 CACD (44 years, 
female, VA 0,5): besides changes 
similar to those in stage 2 a 
sharply demarcated, parafoveal 
area of reduced FAF488 can be 
observed with good visibility of 
the choroidal background-
fluorescence in FAF787. (g, h) 
stage 4 CACD (65 years, female, 
VA 0.05): large, sharply demar-
cated area of reduced FAF488 
with evident choroidal back-
ground fluorescence on FAF787 at 
the whole macular region. The 
lesion is bordered by a thin zone 
of flecks with increased FAF. 
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The same is true in Fig. 5.24 for the lamina cribrosa. As some of the physical phenomena in 
the near-infrared are different, the role of filter leakage for FAF787 imaging cannot further be 
elucidated by our results. It is, moreover, difficult to compare reflection with autofluorescence 
imaging because of the differences in light pathways of both techniques, i.e. double versus 
single transmission, respectively.18 
STGD1 AND PSEUDO-STARGARDT 
Both diseases revealed very similar phenotypes with many focal alterations of FAF co-located 
with clinically visible flecks. In FAF488 these were predominantly hyperfluorescent and in 
FAF787 mostly hypofluorescent. The focal lesions observed on FAF488 were comparable to 
earlier described changes of FAF, describing flecks of varying FAF intensities and central 
atrophy.10;13 Most interestingly, areas of FAF abnormalities were larger in FAF787 than in 
FAF488. This may point to subcellular pathology, which may be clinically initiated by 
confusion of the RPE melanin metabolism and only later by lipofuscin accumulation and cell 
death.19 Focal increase of FAF787 without increased pigmentation on funduscopy may pick out 
increased amounts of melanolipofuscin, correlating with increased FAF488 at these areas.20 
Accordingly, depletion of melanin and increase of melanolipofuscin as a result of the 
lysosomal cycle of the RPE cell has been observed in healthy eyes by electron microscopy.21 
Analogous to the “dot and halo” lesions in fluorescein angiography22 a dark halo around 
flecks with increased signals was observed in FAF488 of patients with Pseudo-Stargardt. This 
could suggest perifocal injure of the RPE with a possibly disadvantageous clinical course. In 
our study, the frequently favorable clinical course in Pseudo-Stargardt compared to STGD1 
was observable by a significantly lower rate of progression in FAF488 over the course of time. 
BEST DISEASE AND ADULT FOVEOMACULAR VITELLIFORM 
DYSTROPHY 
In both diseases visible changes in FAF covered equivalent fundus parts at both wavelengths. 
Within the vitelliform stage, any lesion could show an increase in size while the degree of 
FAF increase remained the same. A switch to another stage, however, was associated with 
variations in the FAF signal. In patients with Best disease the patterns and signal intensities 
were strikingly similar in FAF488 and FAF787. In contrast, patients suffering from AFVD 
showed only poor agreement between the examinations of different wavelengths. This could 
point to dissimilarities in the composition of the subretinal material in AFVD and Best, finally 
resulting in different autofluorescent properties.23 It is possible that different, genetically 
driven affections of the retinal metabolism could lead to the dissimilar clinical courses of both 
disorders.24 
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CENTRAL AREOLAR CHOROIDAL DYSTROPHY 
In CACD, the lesions showed clear agreement of both FAF488 and FAF787. In addition, it was 
possible to document disease progression during follow-up by FAF imaging. The 
predominately increased signal in stage I and II of CACD on both FAF488 and FAF787 could 
point to focal accumulation of lipofuscin, but also melanopipofuscin and melanin.1;15 The 
atrophy of the late stages appeared comparable to geographic atrophy in patients with age- 
related macular degeneration (AMD).25 In contrast to AMD, there was no so-called junctional 
zone that progressed with the lesion, but the hyperfluorescent area around the atrophy stayed 
stable and thinned during time. 
Fig. 5.27 ◙ 
Comparison of FAF787 (a) and 
color fundus photography (b) of 
the patient in Fig. 8 g,h (stage 4 
CACD). The clearly pigmented 
choroidal naevus (black 
arrowheads) corresponds to a 
focal FAF787 increase (white 
arrowheads), which points to 
melanin as a source of FAF787. 
CONCLUSIONS 
The results of this study suggest FAF as an important tool for phenotyping and follow-up of 
different retinal dystrophies. More precisely, FAF488 implied accumulation of lipofuscin 
associated fluorophores like A2E located within the RPE, extracellular, or at the 
photoreceptor outer segments. In selected cases, focal or diffuse RPE atrophy could be 
observed over the course of time, indicated by significantly reduced FAF488 or visibility of 
choroidal background autofluorescence in FAF787. Additional in vitro studies by fluorescence 
microscopy and also clinical studies with high-resolution optical coherence tomography 
would be useful for identifying the exact anatomical location of the fluorophores and this 
would provide a better understanding of the cellular pathologies of the different diseases. 
Based on the theory that FAF787 may largely be based on melanin (Fig. 5.27) or 
melanolipofuscin,15 changes within the melanin metabolism of RPE cells may be important in 
the retinal disorders investigated here. Dependent on the disease, the topographic distribution 
of FAF787 alterations may show significant variations. However, any interpretation of FAF787 
should be handled with care as long as the causative fluorophores have not been clearly 
identified. 
FAF787 may be a favorable imaging technique for retinal dystrophies caused by mutations in 
the ABCA4-gene.26 Visible, and most importantly blue light used for most standard FAF 
imaging, may be hazardous to retinas in ABCA4-related diseases and should be avoided.27 
Therefore, examination with light of longer (invisible) wavelengths appears advantageous as 
160 Chapter 5.4 
 
it could help to avoid damage by high-energetic excitation light. A disadvantage of FAF787 is 
the reduced signal-to-noise ratio as compared to FAF488 resulting in low image contrast and 
poorer visibility of fundus details.15  
PRACTICAL IMPLICATIONS OF THE STUDY 
Recording fundus autofluorescence in patients with inherited retinal diseases appears to be a 
useful addition to the diagnostic repertoire. Currently FAF488 is used for screening and follow-
up in families with retinal and macular dystrophies. It is possible that FAF787 could also be 
useful. However, there is still lack of evidence-based data concerning this technique. 
Longitudinal studies and comparisons to functional tests are necessary to improve our 
knowledge on the specific changes of fundus autofluorescence in genetically driven retinal 
disorders, as this would help us to use fundus autofluorescence as a diagnostic and prognostic 
instrument in these patients. 
REFERENCES 
1.  Delori FC, Dorey CK, Staurenghi G, et al. In vivo fluorescence of the ocular fundus exhibits retinal pig-
ment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci 1995;36:718-29. 
2.  Piccolino FC, Borgia L, Zinicola E, et al. Pre-injection fluorescence in indocyanine green angiography. 
Ophthalmology 1996;103:1837-45. 
3.  Cideciyan AV, Swider M, Aleman TS, et al. ABCA4-associated retinal degenerations spare structure and 
function of the human parapapillary retina. Investigative Ophthalmology & Visual Science 2005;46:4739-
46. 
4.  Popovic P, Jarc-Vidmar M, Hawlina M. Abnormal fundus autofluorescence in relation to retinal function 
in patients with retinitis pigmentosa. Graefes Archive for Clinical and Experimental Ophthalmology 
2005;243:1018-27. 
5.  Scholl HP, Chong V, Robson AG, et al. Fundus autofluorescence in patients with longstanding Leber 
congenital amaurosis. Investigative Ophthalmology & Visual Science 2004;45:U578. 
6.  Wabbels B, Demmler A, Paunescu K, et al. Fundus autofluorescence in children and teenagers with here-
ditary retinal diseases. Graefes Archive for Clinical and Experimental Ophthalmology 2006;244:36-45. 
7.  Morgan A, Eandi CM, Noble K, et al. Subretinal fluid in Best's vitelliform macular dystrophy associated 
with abnormalities of fundus autofluorescence. Investigative Ophthalmology & Visual Science 2005;46. 
8.  Chung JE, Spaide RF. Fundus autofluorescence and vitelliform macular dystrophy. Arch Ophthalmol 
2004;122:1078-9. 
9.  Delori FC, Staurenghi G, Arend O, et al. In vivo measurement of lipofuscin in Stargardt's disease--Fundus 
flavimaculatus. Invest Ophthalmol Vis Sci 1995;36:2327-31. 
10.  Lois N, Halfyard AS, Bird AC, et al. Fundus autofluorescence in Stargardt macular dystrophy-fundus 
flavimaculatus. Am J Ophthalmol 2004;138:55-63. 
11.  Meyerle CB, Fisher YL, Spaide RF. Autofluorescence and visual field loss in sector retinitis pigmentosa. 
Retina 2006;26:248-50. 
12.  Popovic P, Jarc-Vidmar M, Hawlina M. Abnormal fundus autofluorescence in relation to retinal function 
in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 2005;243:1018-27. 
Fundus autofluorescence at two different wavelengths 161 
 
13.  von Rückmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch 
Ophthalmol 1997;115:609-15. 
14.  Huang ZW, Zeng HS, Hamzavi I, et al. Cutaneous melanin exhibiting fluorescence emission under near-
infrared light excitation. Journal of Biomedical Optics 2006;11. 
15.  Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular 
melanin. Invest Ophthalmol Vis Sci 2006;47:3556-64. 
16.  Hoyng CB, Deutman AF. The development of central areolar choroidal dystrophy. Graefes Arch Clin Exp 
Ophthalmol 1996;234:87-93. 
17.  Weinberger AW, Lappas A, Kirschkamp T, et al. Fundus near infrared fluorescence correlates with fun-
dus near infrared reflectance. Invest Ophthalmol Vis Sci 2006;47:3098-108. 
18.  Theelen T, Berendschot TT, Boon CJ, et al. Analysis of visual pigment by fundus autofluorescence. Exp 
Eye Res 2008;86:296-304. 
19.  Seko Y, Pang JJ, Tokoro T, et al. Blue light-induced apoptosis in cultured retinal pigment epithelium cells 
of the rat. Graefes Archive for Clinical and Experimental Ophthalmology 2001;239:47-52. 
20.  Kayatz P, Thumann G, Luther TT, et al. Oxidation causes melanin fluorescence. Investigative Ophthal-
mology & Visual Science 2001;42:241-6. 
21.  Feeney L. Lipofuscin and melanin of human retinal pigment epithelium. Fluorescence, enzyme cytochem-
ical, and ultrastructural studies. Invest Ophthalmol Vis Sci 1978;17:583-600. 
22.  Boon CJ, van Schooneveld MJ, den Hollander AI, et al. Mutations in the peripherin/RDS gene are an 
important cause of multifocal pattern dystrophy simulating STGD1/fundus flavimaculatus. Br J Ophthal-
mol 2007. 
23.  Docchio F, Boulton M, Cubeddu R, et al. Age-Related-Changes in the Fluorescence of Melanin and Lipo-
fuscin Granules of the Retinal-Pigment Epithelium - A Time-Resolved Fluorescence Spectroscopy Study. 
Photochemistry and Photobiology 1991;54:247-53. 
24.  Boon CJ, Klevering BJ, den Hollander AI, et al. Clinical and genetic heterogeneity in multifocal vitelli-
form dystrophy. Arch Ophthalmol 2007;125:1100-6. 
25.  Holz FG, Bellman C, Staudt S, et al. Fundus autofluorescence and development of geographic atrophy in 
age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:1051-6. 
26.  Cideciyan AV, Swider M, Aleman TS, et al. Reduced-illuminance autofluorescence imaging in ABCA4-
associated retinal degenerations. J Opt Soc Am A Opt Image Sci Vis 2007;24:1457-67. 
27.  Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with 
ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 2000;97:7154-9. 
 
  
162 Chapter 5.4 
 
 
 
CHAPTER 6 
Atlas of retinal scanning laser imaging
164 Chapter 6 
 
  
Atlas of retinal imaging 165 
 
INTRODUCTION 
The current chapter aims to connect the results of the imaging studies included in this thesis 
with the needs of daily work in ophthalmic patient care. An atlas appears to be the ultimate 
format to allow comparative evaluation of clinical findings. The present collection does not 
claim to build a comprehensive overview on ophthalmic diseases to be imaged by confocal 
scanning laser ophthalmoscopy. However, it will provide typical fundus pathologies that were 
studied extensively and will help with the interpretation of most other retinal diseases. This 
atlas integrates imaging results obtained using different techniques. The images are arranged 
according to the diseases and, where possible, suggestions for the most appropriate imaging 
technique to document pathology are given. 
PRACTICAL IMPLICATIONS FOR SCANNING LASER IMAGING 
Before a start is made on recording images, it is helpful to have clear ideas about the imaging 
modalities applied in that specific case. When only near-infrared imaging and OCT shall be 
applied, pupil dilation is not necessary and is possibly even counterproductive for image 
quality. However, in short-wavelength imaging and standard fundus photography, better 
image quality is obtained with maximal dilated pupils. When FAF imaging is necessary, no 
fluorescent dyes should have been injected within 48 hours prior to recording. For patient 
comfort, near-infrared imaging should precede recordings with the bright, blue light. This is 
especially true for photophobic subjects like children or patients with cone-rod dystrophy. 
Focusing for cSLO imaging should always be performed in the reflection mode, as fundus 
visibility and vessel contrast are always better than in the fluorescence mode. In general, blue 
reflectance should be used for FAF488 and fluorescein angiography, and NIR reflectance is 
suitable for OCT exams, indocyanine green angiography and FAF787. For retinal imaging, 
focusing on the large retinal vessels is the most appropriate technique to achieve high-quality 
fundus images. However, in specific cases it may be better to take different focal points. This 
may be the case in prominent tumors, retinal detachment or large staphylomas. Sometimes, it 
is useful to repeat the same recordings with diverse focal planes and to combine information 
of these images. The HRA2 allows for topographic scans with variable depths, which can be a 
valuable tool in such cases. 
For good and equal illumination of the fundus, perfect positioning of patient and pupil 
together with good camera-cornea distance are necessary. If the camera is not well centered to 
the pupil, parts of the image will be obscured by vignetting effects. When the entire image 
periphery is darkened, an inappropriate distance to the eye is the most probable reason. To 
allow for macular follow-up exams, the large retinal vessels as well as the temporal part of the 
optic nerve should be visible on the image. 
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THE HEALTHY RETINA 
 
NEAR INFRARED REFLECTANCE 
Near-infrared light is most strongly reflected by the inner limiting membrane at the foveal 
umbo (visible as central, bright signal) and the lamina cribrosa. The retinal nerve fiber layer, 
which is easily identified at its thickest parts near the optic nerve head, is also shimmering in 
the near infrared. The blood-rich tissues like vessels and optic nerve head absorb near-infrared 
light and appear shady. RPE melanin causes some irregular reflexes in the left eye temporal 
from the macula. The eye on the right has less melanin content of the RPE leading to strong 
reflection of the sclera shaded by choroidal vessels. 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 488NM 
The main part of FAF488 is caused by RPE lipofuscin, which is irregularly distributed at the 
fundus and has its largest concentration at about 10 degrees from the macula. FAF488 is 
therefore brightest in a circle with a diameter of about 3mm around the central retina. As the 
lipofuscin content of every individual RPE cell may vary, small local maxima or minima of 
the FAF488 signal are frequent findings. A relative minimum appears at the fovea, which is 
caused by blue light absorption by macular pigment and also by RPE melanin. The exciting 
light is also largely absorbed by blood and therefore retinal vessels appear dark. At the optic 
nerve head, the lamina cribrosa collagens may cause a weak signal as is the case in the left 
eye.  
 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 787NM 
Melanin is supposed to be one of the major fluorophores of FAF787. The distribution of 
melanin at the ocular fundus is relatively homogeneous with a local maximum at the posterior 
pole. Accordingly, FAF787 is increased at the macula and may have a local dip at the fovea 
like in the right eye. At the retinal vessels near-infrared light is absorbed and FAF787 is low. 
This is similar at the optic nerve head, which does not contain any fluorophores in the near 
infrared. 
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BLEACHING EFFECTS 
The main source of FAF488 is lipofuscin within the RPE. To excite lipofuscin 
autofluorescence, light has to pass the retina with its light-absorbing visual pigments in the 
outermost layer, the retinal photoreceptors. If the retina is dark adapted, only part of the 
exciting light will reach the RPE and the resulting FAF signal will be weak (A). However, if 
the eye is light adapted, more photons will be available at the RPE to elicit fundus 
autofluorescence and the image becomes brighter (B). As a result, the amount of FAF488 
observed may differ dependent on the bleaching state of the retinal photoreceptors. 
Subtraction maps of registered bleached and unbleached FAF488 images can be used to 
estimate the amount of visual pigments in certain fundus areas and may help to ascertain 
photoreceptor integrity (C). In this panel, more visual pigment results in brighter gray values. 
As macular pigment precludes full blue-light induced bleach at the central retina this area 
appears darker. In panel D, a direct comparison of the FAF488 signal at bleached and 
unbleached fundus areas is visible. The central region has been bleached via the square 
reflector of the Heidelberg Retina Angiograph 2 with a 30-degree field of view. Immediately 
thereafter, a single FAF488 image was taken by the 55-degree lens. Note the blueprint-like 
image of the internal mirror. 
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RETINAL IMPACT ON CONFOCAL SCANNING LASER IMAGING 
In a patient with full-thickness macular hole, the optical effects of the retina in scanning laser 
imaging can be observed. At the location of the hole, direct visualization of the RPE is 
possible and can be compared to the indirect view in the periphery. 
 
NEAR INFRARED REFLECTANCE 
The retina does not absorb near infrared light and therefore, virtually no change is observed in 
relationship to areas of unaffected retina. Around the macular hole, darkening of the NIR 
image occurs due to increased scattering and absorption of light by retinal thickening and 
edema. 
 
 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 488NM 
At the macular hole, macular pigment is absent and therefore, full RPE autofluorescence is 
visible at that location. Unmasked and not really increased FAF488 is observed. In contrast, 
macular pigment density in increased around the hole by retina contraction and thickening. In 
addition to increased light absorption, amplified light scattering by the perifocal edema adds 
to ring-like signal attenuation of FAF488 around the macular hole.  
 
 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 787NM 
There is scarcely any optical effect of the retina at this spectrum. Retinal edema and cysts 
around the macular hole lead to a slight, spherical signal attenuation while the major part of 
the FAF787 image remains unchanged. 
  
Atlas of retinal imaging 171 
 
 
  
172 Chapter 6 
 
 
 
CENTRAL SEROUS CHORIORETINOPATHY 
In central serous chorioretinopathy (CSC) active leakage from the RPE leads to serous 
detachments of the central neuroretinal. In the acute phase of the condition, the detached 
photoreceptors show elongation and the tips of the outer segments of the photoreceptors may 
drop to the RPE. In recurrent and chronic cases, the outer retina may become atrophic with 
photoreceptor and RPE loss. 
In this recurrent CSC case, multiple areas of yellowish colored retina with central atrophic 
spots are visible. 
 
 
 
 
Autofluorescence imaging reveals increased and decreased FAF at the areas of 
funduscopically visible changes as well as at unremarkable fundus areas. Fundus parts with 
atrophic RPE appear dark and are surrounded by halos of increased FAF, which is partially 
speckled. OCT studies have revealed seriously detached areas as relatively homogenous FAF 
increases that change to spotted FAF in re-attached but atrophic parts of the retina. 
 
 
 
 
 
 
Detail of the FAF image above showing the border of bleached and unbleached parts of the 
fundus (arrow). The upper part of the image covers unaffected retina whilst the lower shows 
an area of former serous retinal detachment. Note that bleaching effects (arrow) are only visi-
ble at healthy fundus parts and disappear in diseased areas due to absence of bleachable pho-
toreceptors. 
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AGE RELATED MACULAR DEGENERATION 
In AMD many changes may occur that may have impact on the appearance of fundus images. 
Main confounders in AMD are drusen, pigment alterations, choroidal neovascularization as 
well as sub- and intraretinal fluids. 
 
 
 
 
 
 
SOFT DRUSEN 
Soft indistinct drusen may appear relatively uniform on color fundus photographs. However, 
other imaging modalities may discover a variety of optical properties within different drusen. 
COLOR FUNDUS PHOTOGRAPHY (A) 
On color fundus photos, soft drusen have a whitish to yellowish appearance with poorly 
defined borders. Between drusen, brown pigment clumping may occur. It is hard to decide 
whether fluids are present or not. 
NEAR INFRARED REFLECTANCE (B) 
On NIR, large drusen appear as dark ring-shaped structures with relatively normal internal 
reflectance. The darkening may account for discrete subretinal fluid and photoreceptor 
disorder leading to increased scatter of near-infrared light. Pigment clumps lead to very strong 
signals on NIR. 
FUNDUS AUTOFLUORESCENCE EXCITED AT 488NM (C) 
Most large drusen show a slightly increased signal and some smaller drusen have 
considerably increased FAF488. At the fovea, there are also areas of increased FAF488 not co-
located with drusen, suggesting alteration of the FAF488 signal by photoreceptor loss. The 
pigment clumps do not appear to influence FAF488 results. 
FUNDUS AUTOFLUORESCENCE EXCITED AT 787NM (D) 
Slight FAF787 signal decreases suggest masking of RPE autofluorescence by drusen, which 
largely do not appear to incorporate active fluorophores at that wavelength. Only a few small 
drusen fluoresce weak in the near infrared. A strong signal is co-located with the pigment 
clumps, possibly caused by the incorporated melanin.  
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BASAL LAMINAR DRUSEN 
Typically basal laminar drusen are not limited to the macular area but are also distributed 
peripheral to the vascular arcades. They are much smaller than soft drusen and may be 
relatively inconspicuous on funduscopy. 
 
FLUORESCEIN ANGIOGRAPHY 
After injection of fluorescein, basal laminar drusen become visible as multifocal dot-like 
staining (hydrophilic behavior). This results in a typical “stars-in-the-sky” appearance. 
However, larger, confluent drusen complexes may also be hydrophobic and can cause local 
blockage phenomena. 
 
 
 
 
 
NEAR INFRARED REFLECTANCE 
Most of the basal laminar drusen show unchanged (small drusen) of slightly decreased NIR 
(large drusen). However when drusen confluence, NIR may be dramatically increased and a 
strong signal can be observed. This points to changes of the biochemical drusen structure by 
time. 
 
 
 
 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 488NM 
Small drusen appear as hypo-autofluorescent dots surrounded by generally increased, 
speckled background fluorescence, while large drusen result in irregularly decreased FAF488. 
This particular pattern of FAF488 may be caused through blockage of RPE autofluorescence 
by drusen and intermittent lipofuscin accumulation. 
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GEOGRAPHIC ATROPHY 
Geographic atrophy is the end-stage of dry age-related macular degenerations. It is 
characterized by a progressive atrophy of the RPE and the overlying outer retina. The 
simultaneous presence of drusen and atrophy is characteristic and discriminates the imaging 
appearance of this type of age-related macular degeneration from inherited atrophic macular 
diseases like in central areolar choroidea dystrophy or in Stargardt disease. 
 
COLOR FUNDUS PHOTOGRAPHY 
A large region of RPE atrophy releases direct view on the choroidal vessels. Around the 
atrophy numerous soft drusen of various size are visible. A tiny retinal remnant at the center 
allows visual acuity of 20/25 despite a large scotoma. 
 
NEAR INFRARED REFLECTANCE 
The NIR signal is significantly increased at the atrophic area by strong reflections from the 
sclera. The central, preserved retina appears darker than the surrounding atrophy. Some 
drusen show increased reflectivity possibly due to some calcification.  
 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 488NM 
The atrophy appears dark as a result of absence of fundus fluorophores at that wavelength. At 
the undestroyed fovea a spot of increased autofluorescence is visible, pointing to 
photoreceptor elongation and lipofuscin accumulation. The central atrophy is surrounded by a 
thin, hyper-fluorescent halo (junctional zone). 
 
 
 
FUNDUS AUTOFLUORESCENCE EXCITED AT 787NM  
At the atrophic area, the choroidal background fluorescence is readily visible. Two spots of 
hypo-fluorescence may be caused by blockage phenomena through calcified drusen. The 
junctional zone is fairly quiet and shows occasional fluorescence increase. This image is 
supportive to discriminate the part of FAF787 caused by RPE and that attributable to the 
choroid. 
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CHOROIDAL NEOVASCULARIZATION 
The occurrence of fibrovascular membranes is a complication in many cases of age-related 
macular degeneration but may also take place in other diseases like high myopia, uveitis, 
macular dystrophies, etc. New vessels may appear beneath the RPE (type 1, mainly “occult” 
on fluorescein angiography) or subretinal (type 2, mostly “classic” on fluorescein 
angiography). A large number of cases are mixed-type. The neovascular membrane consists 
of blood vessels and fibrous tissue and leads to sub- and intraretinal fluid accumulation, fibrin 
exudation and pigment clumping. Therefore, complex optical interactions may be expected. 
 
 
 
 
 
 
FLUORESCEIN ANGIOGRAPHY (A) 
Active dye leakage is a major characteristic in fluorescein angiography. This classic case has 
partially dried and shows reduced leakage. Around the neovascular membrane some staining 
is visible. 
NEAR INFRARED REFLECTANCE (B) 
The fibrovascular membrane appears as a bright ring with a dark halo, suggesting a blood-rich 
core and surrounding strongly reflecting substances like fibrin and melanin. This reflects 
former histological studies showing pigment clumps and fibrinous exudates around a 
fibrovascular center. There is a poorly defined decrease if NIR parallels the leakage zone on 
FFA. 
FUNDUS AUTOFLUORESCENCE EXCITED AT 488NM (C) 
At the choroidal neovascularization, FAF488 is markedly reduced. This is often associated 
with local RPE and photoreceptor loss and thus with a poor visual prognosis. A large 
hyperfluorescent nimbus exceeds the leakage zone, suggesting photoreceptor loss but 
preserved RPE owing to former serous retinal detachment. 
FUNDUS AUTOFLUORESCENCE EXCITED AT 787NM (D) 
In FAF787 a strong ring-like signal is co-located with the bright corona on NIR. Even though 
there is scarcely any filter leakage at this wavelength, pseudofluorescence is a possible reason 
for this signal increase. A halo of slightly increased FAF787 co-located with that on FAF488 
suggests changes to the RPE melanin due to former subretinal fluid accumulation. 
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HERIDITARY RETINAL DISEASE 
In most cases of genetically driven retinal disease the primary pathology is located in the 
retinal photoreceptors or the RPE. This leads to significant changes in confocal scanning laser 
imaging of FAF and fundus reflectance. The reasons for change may be manifold, from 
lipofuscin accumulation and serous retinal detachment to photoreceptor loss and scarring. 
 
 
 
 
 
 
 
 
 
 
AUTOSOMAL RECESSIVE STARGARDT DISEASE (STGD1) 
STGD1 is characterized by excessive accumulation of lipofuscin within the RPE with retinal 
degeneration and consecutive RPE atrophy, leading to yellowish, pisciform flecks (A). In this 
case a central retinal atrophy is already present. Typically, STGD1 shows a dark choroid on 
FFA (B), possibly caused by diffuse lipofuscin accumulation in the RPE. On NIR (C) the cen-
tral photoreceptor atrophy shows decreased reflectivity, the flecks have centrally increased 
NIR with a dark halo, and pigment clumping is associated with a markedly increased signal. 
The dim NIR signal in STGD1 may be caused by a loss of photoreceptors. FAF488 imaging 
(D) of STGD1 is characterized by hyper-autofluorescent flecks by lipofuscin in the RPE and 
loss of FAF488 at RPE atrophies. Areas with photoreceptor loss but with undamaged RPE 
show a slightly increased signal, possibly by absent bleaching effects compared to the sur-
rounding clinically healthy retina. FAF787 signals (E) are largely decreased at the fundus le-
sions, which is probably due to changes in the melanin content. Only on odd occasions do 
flecks show increased FAF787, which may point to melanolipofuscin accumulation at such 
flecks.  
Atlas of retinal imaging 183 
 
  
184 Chapter 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MULTIFOCAL PATTERN DYSTROPHY SIMULATING STGD1 
The imaging appearance of Pseudo-Stargardt is similar to that of STGD1. However, in most 
cases, no dark choroid is seen on FFA. The color image (A) shows irregular, yellow-white 
flecks and clear-cut, paracentral atrophic areas as well as a slightly glowing macula. On NIR 
(B), the atrophic parts show high reflectivity from the sclera and some decrease if NIR can be 
seen at the macula, possibly due to some photoreceptor damage. The flecks in Pseudo-
Stargardt show greater variation in hyper- and hyporeflectivity for infrared light than those in 
STGD1. On FAF488 (C) the atrophic areas appear dark with some minor signal increases in-
side, pointing to only partial atrophy with preserved parts of retina and RPE. The flecks have 
largely increased FAF488 with a thin hypfluorescent ring around. The FAF787 (D) shows flecks 
of increased and decreased fluorescence. A paramacular ring of hypoautofluorescence indi-
cates decrease of RPE melanin content exceeding the clinically visible lesions. 
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BEST VITELLIFORM MACULAR DYSTROPHY 
Except for the carrier stage, patients with Best disease will show abnormalities in all imaging 
modalities. The abnormalities vary dependent on the clinical stage. 
 
VITELLIFORM STAGE (1) 
The color fundus photograph (a) shows an egg-yolk like lesion at the macula with relatively 
homonymous increased FAF488 (c). However, infrared imaging reveals irregular NIR (b) and 
FAF787 (d). Obviously, near-infrared imaging can detect some RPE change that is masked by 
the yellow, lipofuscin containing subretinal material. 
 
 
PSEUDOHYPOPYON STAGE (2) 
All imaging techniques show inferior-located, subretinal material with increased NIR (a), 
FAF488 (b) and FAF787 (c). A central change visible in the near-infrared also becomes 
apparent on FAF488 due to demasking by displacement of the subretinal material. 
 
 
VITELLIRUPTIVE STAGE (3) 
Autofluorescence imaging at both 488 (b) and 787 (c) nm shows dispersed signals, pointing to 
partially resorbed subretinal material. Some darkening in FAF488 indicated focal RPE atrophy. 
In NIR (a), a membrane-like structure in visible. However, this is not demarked on autofluo-
rescence.  
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BEST VITELLIFORM MACULAR DYSTROPHY 
In the late stages of the disease, atrophy and scarring may occur and change the typical 
appearance visible in earlier stages. 
 
ATROPHIC STAGE 
A well-demarcated area of central atrophy is visible on color fundus photography. NIR at the 
lesion is relatively normal, with a thin ring of decreased NIR around this. FAF488 is centrally 
attenuated with spots of increased autofluorescence around this as well as within the atrophic 
area. On FAF787 the lesion appears dark. The results suggest partial damage of the RPE and 
the outer retina. 
 
 
 
 
 
 
 
 
CICATRICIAL STAGE 
This case shows central scarring with residual pseudohypopyon and subretinal fluid on color 
fundus photography. The scar is highly reflective on NIR and shows a ring-like increase of 
FAF488 and FAF787. The imaging results imply atrophic changes on top of the scar with sur-
rounding lipofuscin increase within residual RPE.   
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ADULT ONSET FOVEOMACULAR VITELLIFORM DYSTROPHY 
The lesions in AFVD patients have a similar appearance to those in Best patients. The 
subretinal, yellow material has an increased FAF488 and is partially invisible in the near-
infrared.  
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CENTRAL AREOLAR CHOROIDAL DYSTROPHY 
During the course of the disease, lipofuscin accumulates in the macular RPE and gradually 
leads to RPE loss and outer retinal degeneration. RPE atrophy can be nicely documented by 
FAF488. However, there may be more residual retina than FAF488 examination may suggest. 
Therefore, additional NIR or OCT examinations are necessary. 
 
 
 
 
 
 
This case of CACD demonstrates the disparate information of different imaging modalities on 
tissue changes in CACD. The FAF488 image (A) shows a large, darkened lesion corresponding 
to RPE atrophy on funduscopy. A thin peninsula of positive autofluorescence signal is visible 
in the upper part. The lesion is surrounded by a thin area of stippled FAF488 increase, similar 
to end-stage geographic atrophy in age-related macular degeneration. On NIR (B) the retained 
tissue peninsula appears much broader then on FAF488 and correlates with a preserved part of 
outer retina on Fourier domain OCT (C, arrows). It appears that FAF488 is superior for RPE 
imaging and NIR is better for obtaining an overview of the outer retinal situation. 
 
 
 
 
 
 
A longitudinal FAF488 image series documents the disease progression in a female patient 
aged 52 years at baseline. Typically, the CACD lesion consists of speckled FAF488 increase of 
the whole macula. When atrophy starts, one or more dark lesions occur within this area of 
changed autofluorescence. From left to right enlargement of the atrophy from baseline to 2 
and 4 years follow-up can be observed. 
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DISCRETE ARCS IN FUNDUS AUTOFLUORESCENCE 
Hereditary diseases with primary photoreceptor involvement and centrifugal or centripetal 
spread of the disease show a peculiar phenomenon on FAF488 imaging, namely ring-like 
increase of autofluorescence around the macula. Those rings are at the border of clinically 
healthy tissue and affected parts of the fundus and may be of varying intensity and thickness. 
Typical diseases that show discrete arcs on FAF488 are retinitis pigmentosa, cone dystrophy 
and cone-rod dystrophy. Various other disorders may, however, display the phenomenon as 
well. 
 
 
 
 
 
 
 
 
 
RETINITIS PIGMENTOSA 
On color fundus photography (A) the macula appears unaffected, surrounded by the atrophic 
peripheral retina, which shows the so-called tapeto-retinal reflex. A sample OCT (B) demon-
strates preserved central photoreceptors with gradual loss of outer segments to the periphery 
(arrows). In that area, a zone of circular FAF488 enhancement (C) is visible. The periphery 
shows generally low FAF488 with some spots of darkening. On FAF787 (D) the central signal 
of normal intensity diminishes at the location of the discrete arc of increased FAF488. In the 
periphery, only choroidal and no RPE autofluorescence is visible. 
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CONE-ROD DYSTROPHY 
The typical bulls-eye appearance of eyes with CRD is visible on fluorescein angiography. The 
outer border of the diseased area is darker and centrally, a bright ring is visible around the 
fovea due to window effects. 
 
 
 
 
 
NIR imaging shows only very discrete changes with spotted increase of reflectivity at the two 
rings on fluorescein angiography. 
 
 
 
 
On FAF488 a double ring structure is also visible. Here, the outer ring shows considerable 
signal increase and the inner ring is dark. This suggests RPE atrophy at the central arc and 
increased visibility of fundus fluorophores at the outer ring.  
 
 
 
Fundus autofluorescence at longer wavelengths (green-yellow) with a fundus camera demon-
strates a less attenuated signal from the outer ring. This implies that lipofuscin is not an im-
portant fluorophore for the appearance of the ring, because if it was, the signal would increase 
at the yellow-orange spectrum. Therefore, it is probable that precursors of lipofuscin, located 
in the photoreceptors, are responsible for the discrete arc of increased autofluorescence. Those 
precursors fluoresce at shorter wavelengths. Note the pseudo-fluorescence of the optic nerve 
and the peripheral retina by the lens autofluorescence.  
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CONE DYSTROPHY 
The color fundus photo shows increased reflectivity of the macula with some yellowish 
subretinal spots around this. The peripheral retina appears normal. 
 
 
 
 
At the lesion site, NIR is markedly reduced with some dots of increased NIR in that area. The 
periphery is of normal reflectivity on NIR.  
 
 
 
 
FAF488 appears mottled at the lesion with spots of increased and decreased signal. In general, 
the affected area appears somewhat smaller on FAF488 than on infrared imaging, suggesting 
subretinal changes not visible at short wavelengths. The ring of increased FAF488 is weakly 
indicated. 
 
 
 
 
 
On FAF787 the lesion contains many spots of decreased and only few of increased autofluo-
rescence. The spots of decreased signal a largely co-located on FAF787 and FAF488, which 
suggests multifocal RPE loss with little (melano-)lipofuscin formation but with increase of 
retinal fluorophores and photoreceptor loss. 
  
Atlas of retinal imaging 199 
 
 
200 Chapter 6 
 
 
 
 
 
 
 
 
 
DISEASES WITH MACULAR PIGMENT LOSS 
If macular pigment is not built up or fades away retinal damage can occur, which leads to 
typical changes in scanning laser ophthalmoscopy. To date, two disorders with macular 
pigment loss are known, Sjögren-Larsson syndrome (autosomal recessive inheritance, 
congenital loss) and idiopathic macular teleangiectasia type 2 (unknown inheritance, acquired 
loss). 
SJÖGREN-LARSSON SYNDROME (1) 
Color fundus photography reveals intraretinal crystals around the fovea (A). At the location of 
the crystals, the attenuation of confocal blue light reflectance is missing due to absence of 
macular pigment (B). The crystals are split into two fractions, one reflecting blue and one 
near-infrared light. In addition, a slight attenuation of NIR is visible at the fovea (C), 
corresponding to a minuscule loss of photoreceptors on Fourier domain OCT (D). Fluorescein 
angiography reveals no leakage but mottled staining at the macula in the late phase (E). On 
FAF488 a signal increase instead of attenuation is visible at the fovea (F), suggesting 
accumulation of lipofuscin. 
IDIOPATHIC MACULAR TELEANGIECTASIA (2) 
The color fundus photo shows the typical grayish appearance of the macula in this disease 
(A). In that area macular pigment is missing and confocal blue reflectance is increased (B). 
NIR shows macular signal decrease (C), which is co-located with slight thickening and pseu-
do-cyst formation on Fourier-domain OCT (D). The area of increased blue reflectance shows 
strong leakage from teleangiectatic vessels on late phase fluorescein angiograohy (E). FAF488 
is less affected than in SLS and shows increase at cyst locations and in areas of photoreceptor 
loss (F).  
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X-LINKED RETINOSCHISIS 
In X-linked juvenile retinoschisis a cystoid degeneration of the retina can be observed. 
Fourier domain OCT reveals multiple retinal tissue columns surrounded by pseudo-cystic 
spaces. 
 
 
 
 
On NIR imaging these pseudo-cysts appear as bright regions with interlaced dark spots, which 
correspond with the tissue columns on OCT. Thus, NIR gives a fine topographic overview of 
lesion distribution in a non-invasive manner. 
 
 
 
 
 
 
FAF488 reveals signal increase at the fovea due to pseudo-cyst formation and with this, 
disappearance of macular pigment. 
 
 
 
 
 
 
On FAF787 no change of autofluorescence is visible at the pseudo-cysts. However, at the tis-
sue bridges the FAF787 signal is attenuated, probably by increased scattering of near-infrared 
light.  
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INTRODUCTION 
Today’s retinal specialists use modern imaging devices more than ever and have access to 
exceedingly advanced imaging technologies, which allow non-invasive in vivo investigation 
of the living human retina on a micrometer scale. Whilst new OCT devices are gaining huge 
popularity due to their pseudo-histologic assessment of retinal structures, the role of confocal 
scanning laser ophthalmoscopy is somewhat underestimated. Analysis of research activity on 
“retina” AND “optical coherence tomography” OR “confocal scanning laser 
ophthalmoscopy” resulted in a 10-fold higher scientific output for OCT (ISI Web of 
Knowledge, assessed at http://apps.isiknowledge.com on March 30, 2010). Although cSLO 
imaging offers a clinical view on the ocular fundus, interpretation of the imaging results of 
OCT appear to be easier for the general user. The three-dimensionality of modern Fourier-
domain OCT images allows the user to more easily observe the retinal changes. However, 
current OCT can only give a static impression of the existing situation, and straightforward 
conclusions about the function or metabolic situation are not possible. 
DIGITAL PROCESSING OF RETINAL IMAGES 
Comprehensive analysis of retinal images may not rely on an expert’s impression of an image 
alone. On the contrary, area and intensity measurements of retinal images allow for accurate 
investigation and longitudinal recording of fundus lesions.1-6 It is therefore useful to apply 
digital image analysis techniques when retinal imaging studies are performed. A large variety 
of software is available for digital image processing. Although proprietary software products 
may be very user friendly, they are costly and inflexible and often cannot implement 
individual image analysis algorithms for specific projects. Open source software, however, is 
made to allow user-defined software adaptation and to implement macros and plug-ins for 
particular study aims. In this thesis, ImageJ (http://rsbweb.nih.gov/ij), as one of the most 
flexible yet easy to use tools, is proposed for ophthalmic image analysis. The software for 
Windows 32-bit as well as for Mac OS X together with a comprehensive manual written by 
the program’s authors are added as an appendix on the attached CD-ROM. 
CONFOCAL SCANNING LASER IMAGING FOR RETINAL DISEASES 
Currently the Heidelberg Retina Angiograph 2 (HRA2, Heidelberg Engineering, Heidelberg, 
Germany) is the only available cSLO device for clinical use in retinal imaging. The device is 
also implemented in the SPECTRALIS™ (Heidelberg Engineering, Heidelberg, Germany), 
which is a multimodal machine, combining a modern Fourier domain OCT with the cSLO 
and all its currently available imaging methods, fundus reflectance, fundus autofluorescence 
and fluorescence angiographic techniques. 
The observation of the retina by monochromatic confocal imaging, which is feasible with the 
HRA2, enables answers to be given to specific issues like fluid prevalence, waste 
accumulation, RPE topography or macular and visual pigment.1;4;7-13 Combining the HRA2 
with Fourier domain OCT provides an improved understanding of the cSLO appearance of 
many diseases and promises to increase our knowledge of diseases that have been poorly 
understood up until now.14;15 
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NEAR INFRARED FUNDUS IMAGING 
In contrast to light of the visible spectrum, near-infrared light is not absorbed by the retina 
and can reach the deep layers such as choroid and sclera.16 Therefore, a NIR image of the 
fundus summarizes information on the retina and the subretinal layers, giving a multifaceted 
impression of fundus pathology. Although absorption of near-infrared light by the healthy 
retina is limited, this may change in case of fluid accumulation, making NIR imaging useful 
for the monitoring of diseases with retinal edema.13;17 Other than OCT, dynamic retinal fluids 
may be detected by NIR even without retinal thickening or cyst formation, which to date still 
requires invasive techniques like FFA. The patient-friendly, straightforward NIR technique 
has the same specificity as FFA in subthreshold laser treatment.18 Future studies should 
investigate whether NIR could usefully replace FFA to follow diseases with high dynamics of 
retinal fluids like diabetic maculopathy. 
A major advantage is the visualization of subretinal changes by near-infrared light, as is the 
case in diseases like uveitis or angioid streaks.19;20 This may help to monitor affections that 
were only accessible by indocyanine green angiography. The commencement of studies on 
uveitis would be a useful way of assessing whether NIR could replace FFA for the often 
multiple follow-up examinations of these patients. 
NIR has also been used to record physiologic retinal light responses.21;22 Although the en face 
approach of NIR provides a good overview on the retina, a depth localization is not possible 
with standard optics. Recently, advanced adaptive optics technology has allowed in vivo 
functional imaging of single cones.23 Research in this area is still relatively new; however, 
recent studies using ultra-high speed OCT devices without adaptive optics allowed recording 
responses from single retinal layers.24 Combining ultra-high speed OCT with adaptive optics 
is a highly-promising approach for gene therapy studies in retinal dystrophies, as even 
minuscule improvements could be documented objectively. 
FUNDUS AUTOFLUORESCENCE IMAGING 
The increasing interest in fundus autofluorescence imaging is a consequence of the growing 
understanding of FAF as a tool for functional fundus imaging. Short wavelength excited 
autofluorescence (FAF488) was originally used to map RPE lipofuscin in retinal diseases and it 
was believed to be relatively static.8;25-27 Later on changes of FAF during the course of a 
disease were used to monitor RPE metabolism and to find prognostic parameters.6;28 Another 
important step in understanding autofluorescence phenomena of the ocular fundus was 
differentiating between FAF488 increase based on genuine accumulation of lipofuscin and its 
derivates,29 by disturbed outer segment breakdown and photoreceptor-RPE interaction12;30 or 
by pseudo-increase of FAF488 due to loss of the photoreceptor-related blue light absorption.31 
The innovative concept of studies with a multimodal imaging approach, combining FAF488 
and other imaging modalities, provides us with a better understanding of the pathophysiology 
and should be applied to the entire spectrum of retinal diseases with affected 
autofluorescence.15;32 
The dependence of FAF488 imaging on the retinal light adaptation can be used to measure the 
optical density of the visual pigments within the retinal photoreceptors.4;33 Although visual 
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pigment measurements can also be performed by fundus reflectometry, FAF has the 
advantage of a single-pass method, which makes it less dependent on reflectors like the inner 
limiting membrane.34 It would be very useful to develop a single-flash FAF imaging device 
with standardized bleaching light to allow for topographic measurements of visual pigments, 
as this would allow the mapping of undamaged photoreceptors. This approach would provide 
significant advantages for patient selection in future studies on artificial vision. 
Little research has been performed with respect to autofluorescence imaging of the retina in 
the near infrared (FAF787).1;35-37 It appears that melanin plays a major role at that wavelength, 
and obviously, FAF787 can help to get new insight in RPE pathophysiology if both 
autofluorescence techniques are combined. In addition, the infrared spectrum of FAF787 can 
be advantageous for patients with increased light sensitivity, for example, in diseases related 
to ABCA4 mutations.38 Interestingly, fundus parts showing FAF787 alterations do not 
necessarily reveal FAF488 changes.1;39 In a longitudinal study on autosomal recessive 
Stargardt disease, we found that areas with FAF787 decrease, yet unaffected on funduscopy 
and FAF488, may later on exhibit lipofuscin accumulation (unpublished data). This points to a 
part of RPE melanin loss in the pathogenesis of flecks in Stargardt disease. 
There are obviously many more facets of FAF imaging. One of these is the impact of macular 
pigment on the image appearance, which may be direct by filtering blue light,40 or indirect, by 
secondary retinal damage. We found a different distribution of macular pigment and FAF488 
patterns in patients with macular teleangiectasia type 2 and patients with Sjögren-Larsson 
syndrome (unpublished data). In contrast to earlier findings, outer retinal integrity seems to 
exert more influence on the appearance of macular autofluorescence than the macular pigment 
itself. 
CONCLUSIONS 
A new era of retinal imaging has dawned. Researchers have stopped focusing on just one or 
two central techniques like fluorescein angiography and optical coherence tomography. 
Multimodal imaging approaches are increasingly being used for clinical studies, including 
fundus reflectance and autofluorescence at different wavelengths, and these approaches are 
being combined with digital image analysis. The growing knowledge about comprehensive 
retinal imaging may be both a blessing and a curse for the clinician. Although a better 
understanding of the pathophysiology may help to develop new therapeutic strategies, the 
interpretation of the results of unfamiliar techniques like NIR and FAF may be challenging, 
just as it has been for FFA images.41  
The most important development of recent years is the introduction of adaptive optics and the 
combination with ultra-high speed, ultra-high resolution OCT. Grouping with highly 
developed image-capturing techniques, like eye trackers and online averaging united with 
advanced post-processing, already enables single-cell observation of retinal photoreceptor 
light response and outer segment regeneration.23;42 Polarization-sensitive devices allow fine 
discrimination of retinal tissue and may also be of value for future studies on subcellular 
changes.43  
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The time is now ripe for engineers and ophthalmologists to work together on the design of 
imaging instruments for the needs of modern ophthalmology. With today’s repeated 
intravitreal injection treatments and gene therapy on the horizon, non-invasive techniques 
with excellent repeatability and ready-to-do functional measurements are needed. Adaptive 
optics should be available on those devices so that single retinal cells in the region of interest 
can also be assessed. 
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SUMMARY 
Imaging is a rapidly developing field within ophthalmology and is widely used for research 
and routine patient care. In the majority of cases, color fundus photography, fluorescein 
angiography and optical coherence tomography are used. However, a wealth of information 
can be gleaned from additional techniques like scanning laser ophthalmoscopy. This work 
provides an overview of the technical aspects of current digital retinal imaging using a 
confocal scanning laser ophthalmoscope and shows several of its many applications for 
clinical use. 
CHAPTER 1 takes the reader through the history of retinal imaging and provides an 
introduction to the optically relevant anatomy of the human eye.  
CHAPTER 2 provides a technical overview of ophthalmoscopic imaging and compares 
conventional fundus photography and confocal scanning laser ophthalmoscopy. The broad 
spectrum of routine clinical use for confocal scanning laser ophthalmoscopy is described. 
Instructions for best possible image acquisition are given and future perspectives of the 
techniques are discussed. 
CHAPTER 3 provides a comprehensive overview of digital retinal image processing. It 
starts with fundamental information about digital imaging, image storage, pixel mathematics, 
color scales and image resolution. It then describes an open source digital image analysis 
software package (ImageJ) used for several studies in this thesis. Practical aspects for retinal 
image processing by ImageJ are explained, such as image registration and segmentation, 
which are important for comparative and longitudinal clinical studies. 
CHAPTER 4 covers confocal near-infrared reflectance imaging of the retina. It provides an 
introduction to general aspects of fundus reflectance and the use of near-infrared reflectance 
for functional imaging. Chapter 4.1 is a comprehensive overview of confocal fundus near-
infrared reflectance in choroidal neovascularization, based on the histological aspects of the 
neovascular membranes. Chapter 4.2 focuses on neovascular age-related macular 
degeneration and its appearance in near-infrared reflectance. Here, the viability for near-
infrared reflectance to detect active leakage in a non-invasive manner is described, a feature 
that is important for longitudinal treatment studies. 
CHAPTER 5 deals with confocal fundus autofluorescence and its various applications in 
retinal imaging. An introduction to the physical aspects of autofluorescence, its distribution at 
the ocular fundus and how it causes fluorophores is given. Factors that may influence fundus 
autofluorescence independent of fluorophores are also discussed. Chapter 5.1 evaluates the 
use of fundus autofluorescence for the measurement of visual pigment in the healthy and 
diseased retina. It shows that the technique is useful for measuring the bleaching dynamics of 
the retina and for visualizing localized and general losses of visual pigments. In Chapter 5.2, 
juvenile crystalline macular dystrophy in patients with Sjögren-Larsson syndrome is 
investigated. This study is the first that describes a disease with congenital loss of macular 
pigment. The retinal degeneration resulting from macular pigment absence leads to significant 
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changes of macular autofluorescence, which gives clues for lipofuscin accumulation and 
photoreceptor state. Chapter 5.3 describes the patterns of blue light induced fundus 
autofluorescence in hereditary retinal diseases and illustrates the diagnostic value of the 
technique in retinal dystrophies. Chapter 5.4 takes up this issue and focuses on wavelength 
dependence and longitudinal changes of fundus autofluorescence in inherited retinal diseases. 
It compares near-infrared and blue light induced autofluorescence, which are supposed to 
originate from different fluorophores, melanin and lipofuscin, respectively. It appears that 
near-infrared imaging provides additional information on cell physiology when combined 
with blue light autofluorescence. Furthermore, blue light fundus autofluorescence seems to be 
useful for documentation of disease progression in patients with macular dystrophies. 
CHAPTER 6 provides a diagnostic atlas covering the diseases and imaging techniques used 
in the above studies of this thesis. It starts with practical suggestions for confocal scanning 
laser imaging of the retina. Then, the imaging results of healthy retinas and the optical impact 
of the retina in confocal fundus imaging are illustrated. The appearances of acquired and 
hereditary macular diseases in the diverse confocal imaging modalities are then described. 
CHAPTER 7 is a general discussion about the findings of this thesis in view of the latest 
developments of retinal imaging.  
Future retinal imaging devices will allow anatomical and physiological recordings on a 
cellular level in a fast and non-invasive manner. The results of fundus imaging will then lead 
to better patient selection for treatment studies of many retinal diseases, especially for gene 
therapy and age-related macular degeneration. 
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SAMENVATTING 
Beeldvorming in de oogheelkunde ontwikkelt zich in hoog tempo en wordt tegenwoordig 
veelvuldig gebruikt, zowel voor wetenschappelijk onderzoek als voor de dagelijkse 
patiëntenzorg. Ondanks dat specifieke onderzoekstechnieken zoals ‘confocal scanning laser 
ophthalmoscopy’ veel belangrijke informatie verstrekken, worden er in de meerderheid van 
de gevallen alleen kleuren-fundusfoto’s en fluorescentieangiografie alsmede optische 
coherentietomografie toegepast. Dit proefschrift biedt inzicht in de technische aspecten van 
hedendaagse digitale beeldvorming van het netvlies met behulp van een confocal scanning 
laser ophthalmoscope en er worden een aantal van de veelzijdige toepassingen voor klinisch 
gebruik gepresenteerd. 
HOOFDSTUK 1 leidt de lezer door de historie van de beeldvorming van het netvlies en 
biedt een introductie in de optisch belangrijke anatomie van het menselijk oog. 
HOOFDSTUK 2 geeft een overzicht van beeldvorming door middel van oftalmoscopische 
technieken en vergelijkt conventionele fundusfotografie en ‘confocal laser scanning 
ophthalmoscopy’. Tevens wordt het uitgebreide spectrum voor klinisch gebruik van confocal 
laser scanning ophthalmoscopy gepresenteerd. Er worden aanwijzingen gegeven voor het 
vervaardigen van een optimaal scanning laser image. Een overzicht van de toekomstige 
ontwikkelingen van de techniek rondt dit hoofdstuk af. 
HOOFDSTUK 3 biedt een algemeen overzicht van digitale beeldverwerking van 
netvliesfoto’s. In het begin wordt er basisinformatie verstrekt over digitale beeldvorming, het 
opslaan van digitale beeldbestanden, pixel mathematica, kleurenschalen en resolutie. 
Vervolgens wordt er gedetailleerd bericht over een ‘open source image analyse software’ 
(ImageJ), welke gebruikt werd voor een aantal studies in dit proefschrift. De praktische 
kanten van retinale beeldverwerking met ImageJ worden besproken. Dit betreft in het 
bijzonder beeldregistratie en segmentering, onderwerpen welke belangrijk zijn voor 
vergelijkende en longitudinale studies. 
HOOFDSTUK 4 houdt zich bezig met confocal reflectance imaging in het nabije infrarood. 
Er wordt een introductie gegeven over algemene aspecten van fundus reflectance en het 
belang van ‘infrared reflectance imaging’ voor het in beeld brengen van retinale fysiologie. 
Hoofdstuk 4.1 is een omvangrijke weergave van de functie van ‘confocal fundus reflectance’ 
in het nabije infrarood in het kader van choroidale neovascularisatie, gebaseerd op de 
histologische eigenschappen van de nieuwgevormde membranen. Hoofdstuk 4.2 neemt de 
optische verschijnselen van natte leeftijdsgebonden maculadegeneratie in het nabije infrarood 
onder de loep. Dit stuk toont aan dat de reflectiviteit in het nabije infrarood niet-invasief 
uitsluitsel kan geven over actieve lekkage uit nieuwe subretinale vaten. Dit kan van nut kan 
zijn in longitudinale onderzoeken over behandelingen van leeftijdsgebonden 
maculadegeneratie. 
HOOFSTUK 5 gaat over confocale fundus-autofluorescentie en de verschillende applicaties 
op netvliesgebied. Het begint met een introductie over de fysische achtergrond van 
autofluorescentie en gaat verder met de fysiologische topografie van fundus-autofluorescentie 
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en de verwekkende fluorophoren. In het vervolg wordt ook de invloed besproken, die niet zelf 
fluorescerende stoffen kunnen hebben op fundus-autofluorescentie. Hoofdstuk 5.1 onderzoekt 
het nut van fundus-autofluorescentie om visueel pigment te meten. Er wordt aangetoond, dat 
deze techniek goed gebruikt kan worden om het dynamiek van netvliesbleking door licht te 
meten alsmede om plaatselijk beperkt of gegeneraliseerd verlies van visueel pigment 
zichtbaar te maken. In hoofdstuk 5.2 wordt de juveniele kristallijne macula dystrofie bij 
patiënten met Sjögren-Larsson-syndroom onderzocht. Deze studie beschrijft voor de eerste 
keer een ziektebeeld met aangeboren afwezigheid van het macula pigment. De macula 
degeneratie, die als gevolg van afwezigheid van macula pigment bij deze patiënten optreedt, 
veroorzaakt duidelijke afwijkingen van de fundus autofluorescentie, hetgeen aanwijzingen 
geeft voor lipofuscine stapeling en fotoreceptor beschadiging. Hoofdstuk 5.3 beschrijft de 
autofluorescentiepatronen bij erfelijke netvliesaandoeningen als er met blauw licht 
geëxciteerd wordt. De diagnostische meerwaarde van fundus-autofluorescentie bij patiënten 
met retinale dystrofieën wordt geïllustreerd. Hoofdstuk 5.4 gaat verder in op de golflengte 
afhankelijkheid van autofluorescentie en de longitudinale veranderingen bij erfelijke 
netvliesziekten. Er wordt autofluorescentie in het nabije infrarood en door blauw licht 
geëxciteerd vergeleken. Verschillende fluorophoren worden oorzakelijk geacht, namelijk 
melanine in het nabije infrarood en lipofuscine in het blauw. De resultaten van deze studie 
duiden aan, dat door autofluorescentie in het nabije infrarood aanvullende informatie over de 
celfysiologie wordt verkregen. Bovendien blijkt dat door blauw licht verwekte 
autofluorescentie goed te gebruiken is om veranderingen bij patiënten met maculadystrofieën 
longitudinaal te volgen. 
HOOFDSTUK 6 is een diagnostische atlas gebaseerd op de ziektebeelden en de 
beeldvormende technieken welke in bovenstaande studies van dit proefschrift verwerkt zijn. 
Het begint met een praktische handleiding voor confocal laser scanning imaging van het 
netvlies. Vervolgens worden resultaten van imaging van gezonde ogen vertoond en wordt het 
effect van het netvlies zelf op fundus imaging toegelicht. Verder worden verschijnselen bij 
verworven en erfelijke macula-aandoeningen geïllustreerd. 
HOOFDSTUK 7 biedt een algemene discussie van de resultaten van dit proefschrift en 
levert een schets van de nieuwste ontwikkelingen van retinale beeldvorming. 
Toekomstige apparatuur voor retinale beeldvorming zal in staat zijn de anatomie en fysiologie 
van het netvlies op celniveau te laten zien. Binnenkort zullen de uitkomsten van deze nieuwe 
technieken de selectie van patiënten voor studies over behandelingen van vele 
netvliesaandoeningen vergemakkelijken. Dit betreft in het bijzonder onderzoek over 
gentherapie en leeftijdsgebonden maculadegeneratie. 
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INHALTSANGABE 
Die bildgebende Diagnostik in der Augenheilkunde entwickelt sich in hohem Tempo und ist 
aus der heutigen Forschung und Patientenversorgung nicht mehr wegzudenken. Obwohl 
spezialisierte Verfahren, z.B. die Scanning Laser Ophthalmoskopie, wertvolle 
Zusatzinformationen liefern können, werden häufig nur etablierte Techniken wie 
Fundusfotografie, Fluoreszeinangiografie oder Optische Kohärenz Tomografie verwendet. 
Die hier vorliegende Arbeit vermittelt einen Abriss über die technischen Aspekte der 
modernen digitalen Bildgebung der Netzhaut mittels eines Scanning Laser Ophthalmoskops 
und erläutert Möglichkeiten der klinischen Anwendung dieser Methode. 
KAPITEL 1 fasst die Geschichte der Fundusfotografie zusammen und führt in die optisch 
bedeutsame Anatomie des menschlichen Auges ein. 
KAPITEL 2 vermittelt eine Übersicht der technischen Gesichtspunkte ophthalmoskopischer 
Bildgebung. Hierbei werden die klassische Fundusfotografie und die Technik der Scanning 
Laser Ophthalmoskopie miteinander verglichen. Daneben wird der breite klinische 
Anwendungsbereich der konfokalen Scanning Laser Ophthalmoskopie erörtert. Außerdem 
wird eine Anleitung zur optimalen Bildgewinnung gegeben und die Perspektiven der 
konfokalen Scanning Laser Ophthalmoskopie für die retinale Bildgebung werden erläutert. 
KAPITEL 3 bietet eine eingehende Beschreibung der digitalen Bildverarbeitung im Bereich 
der Netzhautdiagnostik. Zu Beginn werden wesentliche Informationen über den Aufbau 
digitaler Bilder und deren Speicherung, über Pixelberechnung und verwendete Farbskalen 
sowie über die Bildauflösung vermittelt. Danach folgt eine detaillierte Beschreibung der für 
viele Studien dieser Arbeit verwendeten „open-source“ Bildanalysesoftware (ImageJ). Der 
Schwerpunkt liegt auf den praktischen Gesichtspunkten der Bildbearbeitung mit ImageJ, 
insbesondere auf Bildregistrierung und Segmentierung, denn diese Aspekte sind sehr 
bedeutsam für vergleichende und longitudinale klinische Studien. 
KAPITEL 4 beschäftigt sich mit dem konfokalen Reflexionsbild der Netzhaut im nahen 
Infrarotbereich. Zunächst wird eine Einführung in allgemeine Gesichtspunkte der 
Fundusreflexion sowie den Gebrauch des infraroten Reflexionsbildes zur funktionellen 
Fundusdiagnostik gegeben. Kapitel 4.1 umfasst eine eingehende Beschreibung der konfokalen 
infraroten Fundusreflexion bei choroidaler Neovaskularisation. Die Analyse der Fundusbilder 
basiert auf den histologischen Eigenschaften der untersuchten neovaskulären Membranen. 
Kapitel 4.2 beschäftigt sich mit dem Erscheinungsbild der nassen, altersabhängigen 
Makuladegeneration im Infrarotreflexionsbild. Diese Studie verdeutlicht die Möglichkeit, 
mittels des infraroten Reflexionsbildes aktive Leckage nichtinvasiv darzustellen. Diese 
Technik könnte sich als wertvoll erweisen in Behandlungsstudien für Makuladegeneration. 
KAPITEL 5 stellt die konfokale Fundusautofluoreszenz mit ihren vielfältigen 
Anwendungsmöglichkeiten in den Mittelpunkt des Interesses. Zunächst wird eine Einführung 
in die physikalischen Aspekte des Phänomens „Autofluoreszenz“ gegeben. Anschließend 
wird  die typische Verteilung der normalen Fundusautofluoreszenz unter Beachtung der 
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ursächlichen Fluorophoren beschrieben. Schließlich werden die Einflussfaktoren besprochen, 
die auf indirekte Weise die Fundusautofluoreszenz beeinflussen können. Kapitel 5.1 
untersucht die Fundusautofluoreszenz als Messinstrument für das Sehpurpur bei Gesunden 
und im Falle von Netzhautdystrophien. Es zeigt sich, dass die Methode geeignet ist, 
dynamische Veränderungen der retinalen Lichtadaptation zu messen, und dass hiermit ein 
örtlich begrenzter, aber auch ein allgemeiner Verlust von Sehpurpur dokumentiert werden 
kann. In Kapitel 5.2 wird die juvenile kristalline Makuladystrophie bei Patienten mit Sjögren-
Larsson Syndrom untersucht. In dieser Studie wird zum ersten Mal ein Krankheitsbild mit 
einem angeborenen Verlust von Makulapigment beschrieben. Hierdurch kommt es zu einer 
zentralen Netzhautdegeneration mit Veränderungen der makulären Fundusautofluoreszenz, 
was auf erhöhtes Lipofuszin unter der Fovea sowie Störungen der zentralen Photorezeptoren 
hinweist. Kapitel 5.3 beschreibt die Fundusautofluoreszenz bei erblichen 
Netzhauterkrankungen und veranschaulicht den diagnostischen Wert dieser bildgebenden 
Methode bei Patienten mit Netzhautdystrophien. Kapitel 5.4 führt dieses Thema weiter aus 
und legt einen Schwerpunkt auf die Abhängigkeit der Fundusautofluoreszenz von dem 
Wellenlängenbereich, in dem gemessen wurde. Ferner werden die Veränderungen der 
Fundusautofluoreszenz bei Netzhautdystrophien im Laufe der Zeit untersucht. Es werden 
Autofluoreszenzmuster im kurzwelligen Bereich und im nahen Infrarot miteinander 
verglichen. Hier geht man davon aus, dass die blaulichtinduzierte Fundusautofluoreszenz 
maßgeblich durch Lipofuszin, die infrarotinduzierte Fundusautofluoreszenz jedoch 
überwiegend durch Melanin verursacht wird. Die Ergebnisse der Studie zeigen, dass im nahen 
Infrarot zusätzliche Informationen über die Zellphysiologie gewonnen werden können, wenn 
man die Resultate aus dem kurzwelligen Bereich mit hinzuzieht. Ferner zeigt sich, dass die 
Blaulicht-induzierte Fundusautofluoreszenz gut geeignet ist, um langfristige Veränderungen 
bei erblichen Netzhautleiden zu dokumentieren. 
KAPITEL 6 umfasst einen diagnostischen Atlas, der sich mit den untersuchten 
Krankheitsbildern mittels der in dieser Arbeit besprochenen bildgebenden Verfahren 
beschäftigt. Zu Beginn des Kapitels wird eine praxisorientierte Einführung in die konfokale 
Scanning Laser Ophthalmoskopie geboten. Im folgenden finden sich Normalbefunde sowie 
eine Darstellung des Einflusses, den die Netzhaut optisch am Zustandekommen des 
Fundusbildes hat. Anschließend werden diverse erworbene und erbliche Makulaerkrankungen 
in den verschiedenen konfokalen Bildgebungstechniken dargestellt. 
KAPITEL 7 bietet eine zusammenfassende Diskussion der Ergebnisse dieser Arbeit im 
Hinblick auf die neuesten Entwicklungen der retinalen Bildgebung. 
In naher Zukunft wird uns eine vielseitige Apparatur zur Verfügung stehen, die sowohl die 
Anatomie als auch die Physiologie der lebenden Netzhaut auf dem Niveau einzelner Zellen 
darstellen kann. Mithilfe solcher Techniken wird es uns möglich sein, geeignete Patienten für 
moderne Therapiestudien verschiedenster Netzhauterkrankungen gezielt auszuwählen. Dies 
ist ein Kernpunkt bei den bevorstehenden Studien zur Gentherapie und zur altersabhängigen 
Makuladegeneration. 
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Fig. 1.2 ◙ 
Fundus paintings in an atlas for ophthalmology published 1870 by A. de 
Montmeja, entitled “Pathologie iconographique du Fond de l'Œil” 
 (Stanford Medical History Center; with permission) 
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Fig. 3.3 ◙ 
24-bit color image of a patient with cone-rod dystrophy (A). The image consists of the 
blue (B), green (C) and red (D) channel. Note that the optic nerve head is best 
visualized in blue, macular pathology is best visible in green and the red channel gives 
an impression of melanin distribution. 
Fig. 3.9 ◙ 
Results of image overlay 
with and without 
registration of source 
and target image. Note 
the ghost vessels as a 
result of bad pixel 
correspondence in the 
upper row. In the color 
image, yellow and black 
pixels represent good 
correlation while red 
and green ones stand for 
bad correspondence. 
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Fig. 4.4 ◙ 
Near­infrared reflectors and absorbers in choroidal neovascularization. A multitude of 
reflecting (arrows point up) and absorbing (arrows point down) elements add  to  the 
near­infrared reflectance  image of a choroidal neaovascularization (CNV). The  length 
of  the  arrows  indicated  the  strength  of  the  optical  effects.  Unmasked  fibrin  (yellow 
dots)  is  a  strong  reflector  while  fluid  appears  main  the  absorber.  CL=CNV; 
CH=choroidea; OC=occult CNV; RE= retina
Fig 4.2 ◙ 
Reflecting retinal layers in the 
near-infrared. The illuminating 
beam (red arrows) is reflected by 
diverse intra- and subretinal layers 
for diverse extents. Strongest 
reflection is provided by the sclera 
(SCL), a smaller amount by the 
retinal photoreceptor layer (PRL) 
and the retinal pigment epithelium 
(RPE). Small amounts of 
reflections originate from the inner 
limiting membrane (ILM) while the 
retinal nerve fiber layer (RFNL) 
only gives important reflections in 
the near vicinity of the optic nerve. 
The number and length of the blue 
arrows indicate the degree of near 
infrared reflectance. 
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Fig. 4.16 ◙ 
Follow-up during intravitreal anti-VEGF therapy of a RAP lesion. The left image faction 
shows early (left column) and late phase FFA (middle column) as well as NIR (right 
column) before (A-C) and after three (D-F) and six (G-I) intravitreal applications of 
bevacizumab. Late leakage on FFA becomes markedly reduced (B,E,H) whilst the initial 
dark halo on NIR disappears (C,F,I) during treatment. Digital subtraction analysis of the 
standardized NIR images illustrates the increase of NIR around the RAP lesion after the 
first treatment series (J, yellow-red spots). Some foci of extreme NIR elevation, which 
appear as lipid exudates on funduscopy (L-M), disappear in the due course (K, blue 
spots). Images were contrast enhanced for improved visualization. 
Fig. 4.17 ◙ 
Illustrated co-localization analysis of melanin and increased NIR in CNV. In a classic 
CNV case, regions with increased pigmentation on color fundus photograph (A) and areas 
of increased NIR (C) were segmented by thresholding and superimposed after image 
alignment (B). Total areas summed up to 0.44 mm², where 0.32 mm² accounted to melanin 
and 0.25 mm² to NIR increase. Both areas shared 0.14 mm², which resulted in a co-
localization of 32%.  Images were contrast enhanced for better performance.  Segmented 
layers (B): green = melanin, red = NIR increase, yellow = shared pixels of melanin and 
NIR increase 
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Fig. 5.7 ◙ 
Image series from a video mode SW-AF measurement (panel A, 5 frames per second, 
plotted left to right and top to bottom) and the mean gray values of the images (panel B), 
demonstrating bleaching kinetics. During SW light illumination, AF increase (panel A; 
false colors specify AF intensity) occurred largely within a circular area of 11° 
eccentricity centered to the fovea. The total increase of SW-AF during photopigment 
bleaching, which is 20.6 per cent of baseline, fits asymptotic kinetics (panel B; black 
curve). The resulting change of photopigment density during this measurement is 0.08. 
Fig. 5.9 ◙ 
Topographic analysis of visual pigment density difference map by SW-AF in a healthy 
subject. The red graph (panel A) depicts the multiple peak Gaussian fit of the plotted 
gray values within 360 pixels radius around the fovea (panel B; red circle). While the 
density difference between dark adapted and bleached state peaked temporally and 
nasally it declined superiorly and inferiorly. Two-dimensional distribution of differences 
in optical density are better noticeable in the false color coded density map (panel C); 
according to the color level definition in panel A, warmer colors indicate increased 
optical density. S=superior, T=temporal, I=inferior, N=nasal 
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Fig. 5.12 ◙ 
Fundus appearance of the macula in Sjögren-Larsson syndrome. Color fundus 
photographs of a patient with Sjögren-Larsson syndrome (A) and a normal control (B). 
The brightness of macular background is relatively homogenous in the patient, while a 
considerable central darkening due to macular pigment is present in the healthy control. 
Note the huge amount of intraretinal crystals in the Sjögren-Larsson patient. 
  
Fig. 5.20 ◙ 
Morbus Stargardt. (a) Color fundus photography shows typical yellow-white, pisciform 
flecks. In addition, irregularities of the retinal pigment epithelium may be observed at the 
macula. (b) FAF488 reveals focally increased signals at the flecks, but also at some 
clinically unremarkable areas. At the macula, FAF488 appears to be irregularly distributed 
and shows focally reduced intensity. (c) Near-infrared reflectance is increased at flecks 
and atrophic areas. (d) Using FAF787 more and larger lesions than in FAF488 appear with 
a predominantly low autofluorescence signal. 
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Fig. 5.27 ◙ 
Comparison of FAF787 (a) and color fundus photography (b) of the 
patient in Fig. 8 g,h (stage 4 CACD). The clearly pigmented choroidal 
naevus (black arrowheads) corresponds to a focal FAF787 increase 
(white arrowheads), which points to melanin as a source of FAF787. 
Fig. 5.21 ◙ 
Longitudinal  change of FAF488  in a  case of STGD1.  (a) At baseline, FAF488  is generally 
increased at  lesions and the macular area  is hypo­autofluorescent (lower area). (b) At 
follow­up exam after 18 months many of the former bright spots appear darker and only 
single FAF488 increases can be observed. (c) Digital subtraction analysis results in mainly 
reduced FAF488  (blue­black) and  some  increases  (orange­red) during  the  study period. 
Note that the area of macular hypo­autofluorescence has enlarged. 
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Fig. 5.23 ◙ 
Longitudinal change of FAF488 in pseudo-Stargardt. (a) At baseline, flecks wit increased 
signals are predominantly seen in FAF488 surrounded by decreased FAF488, and a 
hypoautofluorescent area is visible at the macula. (b) After a period of 16 months most 
flecks are unchanged. Additional solitary foci of increased FAF488 have become visible. (c) 
Digital subtraction analysis results in largely unchanged FAF488 (green-yellow) with some 
solitary increases (orange-red) and decreases (blue-black) during follow-up. 
Atlas (p. 173) 
Central serous chorioretinopathy 
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Atlas (p. 175)  
Soft drusen in age-related macular degeneration 
  
Atlas (p. 179)  
Geographic atrophy in age-related macular degeneration 
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Atlas (p. 183) Stargardt disease 
Atlas (p. 185) Pseudo-Stargardt 
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Atlas (p. 187) Best disease 
Atlas (p. 191) 
Adult onset foveomacular vitelliform dystrophy 
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Atlas (p. 189) Best disease 
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Atlas (p. 195) Retinitis pigmentosa 
Atlas (p. 199) Cone dystrophy
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Atlas (p. 201)  
Macular pigment loss. 
Sjögren-Larsson syndrome (1) 
Idiopathic macular 
teleangiectasia type 2A (2) 
Color images 249 
 
 
